[go: up one dir, main page]

WO2025019173A1 - Copper-based antimicrobial clear and colorless reactive coatings including copper(i) and additives - Google Patents

Copper-based antimicrobial clear and colorless reactive coatings including copper(i) and additives Download PDF

Info

Publication number
WO2025019173A1
WO2025019173A1 PCT/US2024/037025 US2024037025W WO2025019173A1 WO 2025019173 A1 WO2025019173 A1 WO 2025019173A1 US 2024037025 W US2024037025 W US 2024037025W WO 2025019173 A1 WO2025019173 A1 WO 2025019173A1
Authority
WO
WIPO (PCT)
Prior art keywords
copper
alkyl
biocidal
additive
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/US2024/037025
Other languages
French (fr)
Inventor
Theresa Chang
Sean Nichols SACKS
Joel Teye TETTEH
Shu Yuan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corning Inc
Original Assignee
Corning Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corning Inc filed Critical Corning Inc
Publication of WO2025019173A1 publication Critical patent/WO2025019173A1/en
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P1/00Disinfectants; Antimicrobial compounds or mixtures thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/08Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
    • A01N25/10Macromolecular compounds
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/16Heavy metals; Compounds thereof
    • A01N59/20Copper

Definitions

  • the present disclosure relates to biocidal compositions. More particularly, the disclosure relates to biocidal compositions comprising polyurethanes and/or epoxy resins, or precursors thereof, copper(I) salts, and copper-assisting additives.
  • the availability of copper at a surface may be a challenge.
  • Reactive systems dependent upon cross-linking and curing of reactive precursors, such as polyurethanes and epoxy resins, involve the added challenge of ensuring that copper ligands do not interfere with the curing process so as to retain high durability performance of a highly crosslinked coating material.
  • the transmittance may be within 10 percentage points of a second transmittance of an otherwise identical composition or film thereof without either the copper(I) salt or the copper-assisting additive when measured at a thickness of 40 pm.
  • a method of preparing the biocidal composition may include adding a biocidal additive formulation to a carrier; wherein when the carrier is a polyurethane or an epoxy resin, the biocidal additive formulation includes the copper(I) salt and the copper-assisting additive; wherein when the carrier is a second polyurethane precursor, the biocidal additive formulation includes a first polyurethane precursor, the copper(I) salt, and the copper-assisting additive; and wherein when the carrier is a second epoxy resin precursor, the biocidal additive formulation includes a first epoxy resin precursor, the copper(I) salt, and the copper-assisting additive.
  • L*, a*, and b* are CIE values of the biocidal composition after preparing and then storing the biocidal composition at ambient temperature and ambient relative humidity for 90 days or at least 90 days (or any other time period disclosed herein), and L’ control, 3- control, and b” control are CIE values of an otherwise identical composition without either the copper(I) salt or the copper-assisting additive.
  • the biocidal additive formulation may further include an organic solvent, a first polyurethane precursor, a first epoxy resin precursor, or any combination thereof.
  • the copper(I) salt may be a copper(I) halide, iodo(triethyl phosphite)copper(I), or a tetrakis(acetonitrile)copper(I) salt.
  • the copper(I) salt may be copper(I) bromide or copper(I) iodide.
  • the copper-assisting additive may include a phosphite, a phosphine, or a combination thereof.
  • the phosphite may be a compound of formula (I): wherein each R 1 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally fluorosubstituted.
  • the phosphine may be a compound of formula (I): wherein each R 2 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally substituted with a hydroxy group.
  • each R 1 may be independently selected from C2-C13 alkyl and phenyl.
  • each R 2 may be independently selected from C2-C13 alkyl.
  • the biocidal additive formulation may further include a reducing agent.
  • the formulation may be in a sealed container including an inert atmosphere.
  • FIG. 2 illustrates a plot of antimicrobial efficacy for examples of biocidal compositions including two-part polyurethanes as carrier, copper sources such as tetrakis(acetonitrile)copper(I) and CCG, triethyl phosphite (“TEP”) as copper-assisting additive, and also including 2-ethylhexyl phosphate (“EHP”), prepared according to the principles of the present disclosure;
  • copper sources such as tetrakis(acetonitrile)copper(I) and CCG
  • TEP triethyl phosphite
  • EHP 2-ethylhexyl phosphate
  • FIG. 4 illustrates a plot of antimicrobial efficacy for examples of biocidal compositions including two-part polyurethanes as carrier, iodo(triethyl phosphite)copper(I) (“CuI(TEP)”) as copper source, TEP as copper-assisting additive, and also including EHP, prepared according to the principles of the present disclosure;
  • CuI(TEP) iodo(triethyl phosphite)copper(I)
  • TEP copper-assisting additive
  • EHP iodo(triethyl phosphite)copper(I)
  • FIG. 6 illustrates a plot of antimicrobial efficacy for examples of biocidal compositions including epoxy resins as carrier, including iodo(tri ethyl phosphite)copper(I) and various molar ratios of potassium phosphate monobasic, prepared according to the principles of the present disclosure;
  • FIG. 7 illustrates a plot of antimicrobial efficacy for examples of biocidal compositions including two-part polyurethanes as carrier, copper(I) bromide as copper source, TEP as copper-assisting additive, and also including EHP, prepared according to the principles of the present disclosure;
  • FIG. 9 illustrates a plot of antimicrobial efficacy for examples of biocidal compositions including two-part polyurethanes as carrier, copper(I) bromide as copper source, TEP as copper-assisting additive, and varied molar ratios of tributyl citrate or tributyl borate, prepared according to the principles of the present disclosure.
  • FIG. 10 illustrates a plot of antimicrobial efficacy for examples of biocidal compositions including two-part polyurethanes as carrier, copper(I) bromide as copper source, tributyl phosphine (“TBP”) as copper-assisting additive in varying molar ratios relative to copper, and also including EHP, prepared according to the principles of the present disclosure; and
  • the term “antimicrobial” refers to a composition, a material, or a surface of a material, including when such composition or material is in the form of a coating or dry film, that will kill or inhibit the growth of microbes including, but not limited to, bacteria, viruses, mildew, mold, algae, fungi, or any combination thereof.
  • the term “antimicrobial,” as used herein, does not necessarily mean the material or the surface of the material will kill or inhibit the growth of all species of microbes within such families, but that the material or the surface of the material will kill or inhibit the growth of one or more species of microbes from such families.
  • biocidal refers to a composition or material with an active substance that is intended to destroy, deter, render harmless, prevent the action of, or otherwise exert a controlling effect on undesired organisms such as bacteria, viruses, mildew, mold, algae, and/or fungi, and in some aspects a biocidal composition has antimicrobial properties.
  • Examples include methyl, ethyl, propyl, isopropyl, cyclopropyl, butyl, isobutyl, ec-butyl, tert-butyl, cyclobutyl, methylcyclopropyl, cyclopropylmethyl, pentyl, neopentyl, hexyl, and cyclohexyl.
  • Other examples are -(Ci-Cis)alkyl, -(Ci-Cis)alkyl, -(Ci-Cio)alkyl, -(Ci-Cs)alkyl, -(Ci- Ce)alkyl, and -(C2-Ce)alkyl.
  • a -(Ci-C3o)alkyl group may not be a -Cialkyl group, and/or may not be a -C2alkyl group, and/or may not be a -Cnalkyl group, and/or may not be a -C4alkyl group, and/or may not be a -Csalkyl group, and/or may not be a -Cealkyl group, and/or may not be a -C?alkyl group, and/or may not be a -Csalkyl group, and/or may not be a -Chalky 1 group, and/or may not be a -Cioalkyl group, and/or may not be a -Cnalkyl group, and/or may
  • aryl(Ci-C4)alkyl refers to a functional group wherein a one to four carbon alkylene chain is attached to an aryl group, for example, -CEh-CEh-phenyl. Examples may include benzyl.
  • carrier may refer to a melamine resin, a polyurethane, a precursor thereof, an epoxy resin, a precursor thereof, or a combination thereof, as described herein.
  • polyurethane refers to a class of polymers, such as alternating copolymers, including organic units joined by carbamate (urethane) links. po yure ane n linkage polyurethane
  • epoxy resin refers to a class of copolymers also known as “polyepoxides.” Examples of commercially available epoxy resins may include WiseBond® Bar & Table Top 1 : 1 Ratio. Examples of epoxy resins may be produced by reacting together two separate epoxy resin precursors. In certain examples, an epoxy resin precursor may include an epoxide functional group. Examples of epoxy resin precursors that include an epoxide functional group may include bisphenol A diglycidyl ether: bisphenol A diglycidyl ether.
  • an epoxy resin precursor may include a polyfunctional amine, carboxylic acid, phenol, alcohol, thiol, or any combination thereof, which may react as a nucleophile with an epoxide-containing monomer to form the epoxy resin, and which may be compatible with examples of copper(I) salts and examples of copper-assisting additives of the present disclosure.
  • halide refers to a negative ion (“anion”) of a halogen atom bearing a -1 formal charge.
  • halides include fluoride (F' 1 ), chloride (Cl -1 ), bromide (Br 1 ), and Iodide (I’ 1 ).
  • copper-assisting additive refers to an additive that promotes the availability and/or persistence of copper(I) ions in a composition or material, including promoting availability of copper(I) at a surface and/or interface of a composition or material, consisting with the following explanation.
  • copper(I) is largely colorless and more antimicrobially efficacious, while copper(II) is typically energetically favorable but produces color and has lower antimicrobial efficacy.
  • copper(I) is generally favored for function and color, but copper(II) is usually more stable.
  • a reducing agent for example, to reduce copper(II) to copper(I), or to reduce other oxidants that may be present
  • an antioxidant for example, to scavenge oxidants either by reduction or by sequestering by coordination or binding so as to make such oxidants unavailable to oxidize copper(II) to copper(I)
  • a ligand with a hydrophobic and/or bulky side chain for example, to limit oxidant access to copper(I) in a copper complex
  • a ligand that favors complexation with copper(I) over copper(II) for example, to energetically favor copper(I) to be maintained
  • a ligand that facilitates migration of copper(I) to a surface and/or interface or any combination thereof.
  • the copper-assisting additive is a reducing agent, an antioxidant, a copper-coordinating ligand (for example, coordinating with copper(I) and/or copper(II)) with one or more hydrophobic side chains, a copper-coordinating ligand (for example, coordinating with copper(I) and/or copper(II)) with one or more bulky side chains, a copper-coordinating ligand (for example, coordinating with copper(I) and/or copper(II)) that complexes with copper(I) preferentially over complexing with copper(II), a copper-coordinating ligand (for example, coordinating with copper(I) and/or copper(II)) that has two or more copper coordination sites, or any combination thereof.
  • a copper-coordinating ligand for example, coordinating with copper(I) and/or copper(II) with one or more hydrophobic side chains
  • a copper-coordinating ligand for example, coordinating with copper(I) and/or copper(II) with one or more bulky side chains
  • the term “at.%” refers to atomic weight percent.
  • “at.%” is used in reference to an amount of copper in a composition.
  • the biocidal composition may include copper in an amount of “X at.%” (where X is a number), and this means the mass of copper atoms (using molecular weight) is summed and expressed as a percent relative to a given basis (for example, based on mass of biocidal composition).
  • the mass of other species in a copper complex or molecule for example, the oxygen atom in CU2O
  • the amount of copper in terms of at.% may be determined by methods known in the art.
  • weight and “mass” are used interchangeably.
  • the naming convention for functional groups containing phosphorus are standardized herein. Generally, the naming convention of a functional group with respect to a given phosphorus atom is determined by how many oxygen atoms are double bonded to a phosphorus atom (“A”), the total number of carbon and hydrogen atoms single-bonded to the phosphorus atom (“B”), and the number of oxygen atoms single-bonded to the phosphorus atom (“C”). In this regard, the coordinate “(A,B,C)” may be employed to identify a phosphorus-containing functional group.
  • a “phosphate” has coordinate (1,0,3); a “phosphite” has coordinate (0,0,3); a “phosphine” has coordinate (0,3,0).
  • Formula (I) is an example of a phosphite.
  • Formula (II) is an example of a phosphine.
  • Formula (III) is an example of a phosphate.
  • ambient temperature refers to the temperature of the atmosphere in the immediate surrounding environment of an objection or equipment.
  • ambient relative humidity refers to an amount of water vapor present in a specific volume of immediately surrounding atmosphere at ambient temperature expressed as a percentage of the amount of water vapor needed for saturation at the same temperature. In certain examples, ambient relative humidity may have a value of 42%.
  • percentage point refers to a unit for an arithmetic difference between two percentages. For example, a difference between transmittance values of 88 percent and 98 percent for a particular measurement is a difference of 10 percentage points on the same measurement scale (calculated by subtracting 98 from 88; or 88 from 98). Percentages, by contrast, indicate the relative or proportionate part of a total; in the above example, 88 constitutes 90% of 98 (calculated by dividing 88 by 98 and multiplying by 100), and 98 constitutes 111% of 88 (calculated by dividing 98 by 88 and multiplying by 100).
  • the present disclosure provides a biocidal composition, including a carrier, a copper(I) salt, and a copper-assisting additive different from the carrier.
  • a molar ratio of the copper-assisting additive to the copper(I) salt is at least 0.5: 1.
  • the copper-assisting additive may be combined with the copper(I) salt and added to a carrier at a sum total concentration of both components of from 1 to 300 grams per liter of biocidal composition.
  • the copper(I) salt may include a copper(I) halide, iodo(triethyl phosphite)copper(I), or a tetrakis(acetonitrile)copper(I) salt, or any combination thereof.
  • the copper(I) halide may be copper(I) fluoride, copper(I) chloride, copper(I) bromide, copper(I) iodide, or any combination thereof.
  • the tetrakis(acetonitrile)copper(I) salt may be tetrakis(acetonitrile)copper(I) hexafluorophosphate, tetrakis(acetonitrile)copper(I) tetrafluoroborate, tetrakis(acetonitrile)copper(I) perchlorate, tetrakis(acetonitrile)copper(I) trifluoromethanesulfonate, tetrakis(acetonitrile)copper(I) hydrogen oxalate-oxalic acid-acetonitrile, or any combination thereof.
  • the biocidal composition may include a carrier, a copper(I) salt, and a copper-assisting additive.
  • the carrier may include a polyurethane, a polyurethane precursor, an epoxy resin, an epoxy resin precursor, a melamine resin, or any combination thereof.
  • the copper(I) salt may be combined with a copper- assisting additive and a carrier while maintaining antimicrobial efficacy (or preventing a decrease in antimicrobial efficacy to below a particular level) and/or stabilizing the color of the carrier when the copper(I) salt is combined with the copper-assisting additive and the carrier or when then copper(I) salt and the copper-assisting additive are combined with the carrier.
  • Examples of the present disclosure may maintain antimicrobial efficacy (or prevent a decrease in antimicrobial efficacy to below a particular level) and/or reduce changes in color of the carrier at the time of combining the copper(I) salt with the copper-assisting additive and the carrier or combining the copper(I) salt and the copper-assisting additive with the carrier.
  • Examples of the present disclosure may reduce changes in the antimicrobial efficacy and/or reduce changes in the color of the carrier between a period of time after combining the copper(I) salt with the copper-assisting additive and the carrier or combining the copper(I) salt and the copper-assisting additive with the carrier and the final antimicrobial efficacy and/or color of the carrier.
  • a material for example, a coating such as a dry film
  • a material may exhibit the logarithmic reductions described herein under one or more of the U.S. Environmental Protection Agency “Test Method of Efficacy of Copper Alloy as a Sanitizer” (2009) (also referred to herein as “the EPA Test”), the Modified Japanese Industrial Standard (JIS) Z 2801 Test for Bacteria and/or the Modified JIS Z 2801 Test for Viruses, for a period of one month or greater or for a period of three months or greater, or any of the other time periods described elsewhere herein.
  • JIS Japanese Industrial Standard
  • the time periods may commence a tor after the application of the material to a surface as a layer.
  • the layer exhibits the logarithmic reductions described herein.
  • Each of the EPA Test, the Modified Japanese Industrial Standard (JIS) Z 2801 Test for Bacteria, and the Modified JIS Z 2801 Test for Viruses are incorporated herein by reference in their entireties.
  • JIS Modified Japanese Industrial Standard
  • JIS Z 2801 Test for Viruses are incorporated herein by reference in their entireties.
  • antimicrobial efficacy of a composition or coating may be maintained, or at least a decrease in antimicrobial efficacy to below a particular level may be prevented, in the biocidal compositions disclosed herein, for example, by use of a copper-assisting additive.
  • the effectiveness of a composition (for example, a coating such as a dry film) of the present disclosure as a biocidal composition may be measured as a function of the logarithmic reduction of the biocidal composition.
  • the logarithmic reduction value of the biocidal composition may be relevant to the ability of the biocidal composition to kill a wide variety of biological organisms to which the biocidal composition is exposed, but may also allow the copper(I) salt to act as a preservative for the composition during storage (for example, in a container such as, but not limited to, a tank, a can, a bucket, a drum, a bottle, or a tube).
  • a logarithmic reduction of the biocidal composition may be at least 2, at least 3, at least 4, at least 5, at least 6, at least 7, at least 8, at least 9, at least 10, in a range from 1 to 10, 3 to 7, 4 to 6, or less than, equal to, or greater than 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10.
  • the logarithmic reduction may be maintained (for example, prevented from falling below) at or above any of the aforementioned values over a given time period, as described elsewhere herein.
  • the biocidal properties of the composition may make it effective for substantially killing a wide variety of biological organisms including bacteria, viruses, and fungi.
  • suitable examples of bacteria include Staphylococcus aureus, Enterobacter aerogenes, Pseudomonas aeruginosa, Methicillin Resistant Staphylococcus aureus, E. coli, and mixtures thereof.
  • the copper(I) salt exhibits at least a logarithmic reduction, a 4 logarithmic reduction, a 5 logarithmic reduction, or even a 6 logarithmic reduction in the concentration of at least one of Staphylococcus aureus, Enterobacter aerogenes, Pseudomonas aeruginosa bacteria, Methicillin Resistant Staphylococcus aureus, and E coli under the EP A Test, or a 3 logarithmic reduction or greater, or a 4 logarithmic reduction or greater (for example, 5 logarithmic reduction or greater) under JIS Z 2801 (2000) testing conditions or under the Modified JIS Z 2801 Test for Bacteria.
  • the copper(I) salt exhibits a 2 logarithmic reduction or greater, a 3 logarithmic reduction or greater, a 4 logarithmic reduction or greater, or a 5 logarithmic reduction or greater in the concentration of Murine Novovirus or severe acute respiratory syndrome (“SARS”) coronavirus 2 (“SARS- CoV-2”) under a Modified JIS Z 2801 for Viruses test.
  • SARS Murine Novovirus or severe acute respiratory syndrome
  • SARS- CoV-2 Murine Novovirus or severe acute respiratory syndrome coronavirus 2
  • the procedures for the Modified JIS Z 2801 (2000) Test for Bacteria, and the Modified JIS Z 2801 (2000) Test for Viruses are provided in International Patent Application Pub. No. WO 2021/055300 Al, COLOR STABILIZATION OF BIOCIDAL COATINGS, which is incorporated by reference herein in its entirety.
  • Modified JIS Z 2801 Test for Bacteria includes evaluating the bacteria under the standard JIS Z 2801 (2000) test with modified conditions including heating the glass or article to a temperature of 23 degrees Celsius to 37 degrees Celsius at a humidity of 38 percent to 42 percent for 6 hours.
  • the Modifed JIS Z 2801 (2000) Test for Viruses includes the following procedure.
  • a biocidal composition for example, a biocidal composition, a composition including the copper(I) salt, a composition including the copper- assisting additive, control compositions
  • three samples of the material are each inoculated with a 20 pL aliquot of a test virus (where antimicrobial activity is measured) or a test medium including an organic soil load of 5% fetal bovine serum with or without the test virus (where cytotoxicity is measured).
  • the inoculum is then covered with a film and the film is pressed down so the test virus and/or the test medium spreads over the film, but does not spread past the edge of the film.
  • the exposure time begins when each sample was inoculated.
  • the inoculated samples are transferred to a control chamber set to room temperature or “ambient” temperature (20 °C) in a relative humidity of 42% for 2 hours. Exposure time with respect to control samples are discussed below. Following the 2-hour exposure time, the film is lifted off using sterile forces and a 2.00 mL aliquot of the test virus and/or test medium is pipetted individually onto each sample of material and the underside of the film (or the side of the film exposed to the sample) used to cover each sample. The surface of each sample is individually scraped with a sterile plastic cell scraper to collect the test virus or test medium. The test virus and/or test medium is collected (at 10 2 dilution), mixed using a vortex type mixer and serial 10-fold dilutions are prepared. The dilutions are then assayed for antimicrobial activity and/or cytotoxicity.
  • control sample for testing antimicrobial activity (which are also referred to as “zero time vims controls”) for the Modified JIS Z 2801 Test for Viruses
  • three control samples (contained in individual sterile petri dishes) are each inoculated with a 20 pL aliquot of the test virus.
  • a 2.00 mL aliquot of test virus is pipetted onto each control sample.
  • the surface of each sample was individually scraped with a sterile plastic cell scraper to collect test virus.
  • the test virus is collected (at 10 2 dilution), mixed using a vortex type mixer, and serial 10-fold dilutions were prepared. The dilutions are assayed for antimicrobial activity.
  • control samples for cytotoxicity which are also referred to as “2 hour control virus” for the Modified JIS Z 2801 Test for Viruses
  • one control sample (contained in an individual sterile petri dish) is inoculated with a 20 pL aliquot of a test medium containing an organic soil load (5% fetal bovine serum), without the test virus.
  • the inoculum is covered with a film and the film is pressed so the test medium spreads over the film but does not spread past the edge of the film.
  • the exposure time begins when each control sample is inoculated.
  • the control sample is transferred to a controlled chamber set to room temperature (20 °C) in a relative humidity of 42% for a duration of 2 hours exposure time.
  • test medium is lifted off using sterile forceps and a 2.00 mL aliquot of the test medium is pipetted individually onto each control sample and the underside of the film (the side exposed to the sample). The surface of each sample is individually scraped with a sterile plastic cell scraper to collect the test medium. The test medium is collected (at 10 2 dilution), mixed using a vortex type mixer, and serial 10-fold dilutions were prepared. The dilutions were assayed for cytotoxicity.
  • a representative description of performing the EPA Test is as follows.
  • a copper(I) salt is milled to powder using a 2-inch jet mill.
  • the jet milled powder of the copper(I) salt is then added to a carrier (for example, commercially available Eastwood® two-part urethane) and mixed.
  • Control coupons coated with a carrier without copper(I) salt were prepared alongside coupons coated with the copper(I) salt.
  • a 7-mil wet film thickness drawdown bar was used to form films onto Lenata Scrub Charts (P121-10N). The films were dried for 2 days at ambient lab temperature before the antimicrobial test was conducted. Dry film thickness was around 80 m.
  • 1-Inch x 1-inch square coupons were cut from the center of the painted scrub test panels.
  • Stainless steel carriers used as reference, were cleaned and sterilized by immersion in a 75% ethanol solution following by rinsing with DI water.
  • Vials containing Staphylococcus aureus (ATCC 6538) bacterial stock culture were stored at -80° C until use. 20 pL aliquots of thawed bacterial cultures were added to 10 mL of Tryptic Soy Broth. These bacterial suspensions were serially incubated 3X at 36°C for 18-24 hours in an orbital shaker, and then IX in polypropylene snap tubes for 48 hours. Cultures were subsequently mixed on a vortex mixer and allowed to settle. The upper two-thirds of suspension from each tube was aspirated and ODeoo was measured to estimate bacterial density.
  • the culture was diluted with phosphate buffer saline to achieve a bacterial inoculum concentration near a target value of 1.0- 10 7 CFU/mL. 0.25 mL of 5% fetal bovine serum and 0.05 mL TritonTM X-100 were added to 4.70 mL bacterial suspension to aid in spreading the inoculum.
  • Each test coupon was inoculated with 20 pL of the bacterial test culture. The inoculum volume was spread evenly using bent sterile pipette tips to ensure full and even coverage, spreading as close to the edge of the coupon as possible. Coupons were then incubated in a controlled environment set at 42% relative humidity and 23 °C for a period of 120 minutes.
  • the copper(I) salt with a copper-assisting additive to prevent reduction of antimicrobial efficacy below a certain threshold (for example, less than a 3 logarithmic reduction or any other value disclosed herein) and/or limit the shift of the color of the biocidal composition form the color of a standard carrier (for example, the carrier in the absence of either the copper(I) or the copper-assisting additive).
  • a certain threshold for example, less than a 3 logarithmic reduction or any other value disclosed herein
  • a standard carrier for example, the carrier in the absence of either the copper(I) or the copper-assisting additive
  • a CIE L*a*b* AE* between the observed color and a standard of less than 30, less than 25, less than 20, less than 15, less than 12, less than 10, less than 9, less than 8, less than 7, less than 6, less than 5, less than 4, less than 3, less than 2, less than 1, in a range of from 1 to 30, 2 to 25, 5 to 15, 3 to 8, 4 to 7, 5 to 6, less than, equal to, or greater than 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, or 30.
  • the CIE L*a*b* color space is a color scale for determining a color.
  • the L* component closely matches human perception of lightness.
  • CIE L*a*b* color space is a cylindrical representation of the three perceptual color correlates: lightness, chroma, and hue.
  • the axial component of CIE L*C*h* is the same lightness attribute L* as CIE L*a*b*
  • the radial component is the chroma
  • the angular component is hue.
  • a biocidal composition including: a carrier; a copper(I) salt; and a copper-assisting additive.
  • the carrier may include a polyurethane, a polyurethane precursor, an epoxy resin, an epoxy resin precursor, a melamine resin, or any combination thereof.
  • the biocidal composition is in liquid form at ambient conditions (1 atm (-101.3 kPa) and 20 °C).
  • the biocidal composition does not contain (for example, and/or the composition is not in the form of) a polyurethane, and/or does not contain a polyurethane precursor, and/or does not contain an epoxy resin, and/or does not contain an epoxy resin precursor, and/or does not contain a melamine precursor.
  • employing a copper-assisting additive allows the achievement of a desired level of antimicrobial efficacy (for example, via any test disclosed herein, such as the EP A Test).
  • the carrier and the copper-assisting additive are different.
  • “different” means that a given chemical species (for example, a polyurethane) cannot qualify as both the carrier and the copper-assisting additive; rather, if the carrier is, for example, a polyurethane, then the copper assisting additive cannot be a polyurethane but must instead be another chemical species (for example, triethyl phosphite).
  • the biocidal composition includes a polymer, a monomer, a binder, an organic solvent, an inorganic solvent, water, a dispersion of finely divided solids in a liquid medium that may be applied to a surface to form a film, a pigment, a filler, an extender, a drier, a rheology modifier, or any combination thereof.
  • the biocidal composition does not contain (for example, and/or the carrier is not or does not contain) a polymer, and/or does not contain a monomer, and/or does not contain a binder, and/or does not contain an organic solvent, and/or does not contain an inorganic solvent, and/or does not contain water, and/or does not contain a dispersion of finely divided solids in a liquid medium that may be applied to a surface to form a film, and/or does not contain a pigment, and/or does not contain a filler, and/or does not contain an extender, and/or does not contain a drier, and/or does not contain a rheology modifier.
  • a copper-assisting additive is or includes a phosphite, a phosphine, or any combination thereof.
  • the copper-assisting additive may be hydrophobic, hydrophilic, or amphiphilic, and any of the aforementioned copper-assisting additives (or any other copper-assisting additive disclosed herein) may be characterized as hydrophobic, hydrophilic, or amphiphilic.
  • the copper-assisting additive may be or may include a hydrophobic phosphite, a hydrophobic phosphine, or any combination thereof.
  • the biocidal composition does not contain (for example, and/or the copper-assisting additive is not) a phosphite, and/or does not contain a phosphine, and/or does not contain a hydrophobic copper-assisting additive, and/or does not contain a hydrophilic copper-assisting additive, and/or does not contain an amphiphilic copper-assisting additive.
  • a copper-assisting additive is a compound of formula (I), formula (II), or any combination thereof.
  • a copper-assisting additive may be a compound of formula (I): wherein each R 1 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, and of which may be optionally fluorosubstituted.
  • each R 1 is independently selected from Ci-Cs alkyl.
  • each R 1 is independently selected from C1-C5 alkyl.
  • the alpha-carbon of at least one R 1 is a secondary or tertiary carbon.
  • Certain examples of compounds of formula (I) may include particular combinations of R 1 selected independently such that the compounds of formula (I) complex with, interact with, or otherwise affect copper (for example, by affecting the persistence of a given oxidation state, such as copper(I)), but not as desirably or preferably as other particular combinations of R 1 due to the combined effects of chemical phenomena understood by those skilled in the art, including, but not limited to, hydrophobicity, solubility, electronic effects, and/or steric effects resulting from the chemical structure of a particular compound of formula (I).
  • each R 1 independently may not be any one of C1-C20 alkyl, and/or may not be aryl, and/or may not be aryl(Ci-C4)alkyl.
  • a biocidal composition does not include a compound of formula (I) and/or the copper-assisting additive is not a compound of formula (I).
  • Examples of compounds of formula (I) may include trimethyl phosphite, triethyl phosphite, triphenyl phosphite, tris(2,2,2-fluoroethyl) phosphite, tris(2-ethylhexyl) phosphite, triisopropyl phosphite, and tris(l,l,l,3,3,3-hexafluoro-2-propyl) phosphite.
  • the biocidal composition does not include (for example, the copper-assisting additive is not) trimethyl phosphite, and/or does not include triethyl phosphite, and/or does not include tris(2,2,2-fluoroethyl) phosphite, and/or does not include tris(2-ethylhexyl) phosphite, triisopropyl phosphite, and/or does not contain tri s( 1,1, 1,3, 3,3 -hexafluoro-2-propyl) phosphite, and/or does not include triphenyl phosphite.
  • Ci- C20 alkyl may include C1-C19 alkyl, Ci-Cis alkyl, C1-C17 alkyl, C1-C16 alkyl, C1-C15 alkyl, Ci- C14 alkyl, C1-C13 alkyl, C1-C12 alkyl, C1-C11 alkyl, C1-C10 alkyl, C1-C9 alkyl, Ci-C 8 alkyl, Ci- C 7 alkyl, Ci-C 6 alkyl, C1-C5 alkyl, C1-C4 alkyl, C1-C3 alkyl, C1-C2 alkyl, C2-C20 alkyl, C2-C19 alkyl, C2-C18 alkyl, C2-C17 alkyl, C2-C16 alkyl, C2-C15 alkyl, C2-C14 alkyl, C
  • each R 1 may not be Ci alkyl, and/or may not be optionally fluorosubstituted Ci alkyl, and/or may not be C 2 alkyl, and/or may not be optionally fluorosubstituted C 2 alkyl, and/or may not be C3 alkyl, and/or may not be optionally fluorosubstituted C3 alkyl, and/or may not be C 4 alkyl, and/or may not be optionally fluorosubstituted C 4 alkyl, and/or may not be C5 alkyl, and/or may not be optionally fluorosubstituted C5 alkyl, and/or may not be Ce alkyl, and/or may not be optionally fluorosubstituted Ce alkyl, and/or may not be C 7 alkyl, and/or may not be optionally fluorosubstituted C 7 alkyl, and/or may not be C
  • a biocidal composition containing a compound of formula (I) or any salt thereof exhibits one or more effects when combined with a copper(I) salt, including maintaining antimicrobial efficacy of a biocidal composition, preventing reduction of antimicrobial efficacy of a biocidal composition below a certain level (for example, less than 3 logarithmic reduction), minimizing color drift of a biocidal composition, or any combination thereof.
  • Antimicrobial efficacy may be measured as described elsewhere herein, such as by using the EPA Test.
  • a copper-assisting additive may be a compound of formula (II) or any salt thereof: wherein each R 2 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally substituted with a hydroxy group.
  • each R 2 is independently selected from C2-C13 alkyl, any of which is optionally substituted with a hydroxy group.
  • each R 2 is independently selected from C1-C10 alkyl, any of which is optionally substituted with a hydroxy group.
  • each R 2 is independently selected from Ci-Ce alkyl, any of which is optionally substituted with a hydroxy group.
  • an alpha-carbon of at least one R 2 is a secondary carbon or a tertiary carbon.
  • Certain examples of compounds of formula (II) may include combinations of R 2 selected independently such that the compounds of formula (II) complex with, interact with, or otherwise affect copper (for example, by affecting the persistence of a given oxidation state, such as copper (I)), but not as desirably or preferably as other particular combinations of R 2 due to the combined effects of chemical phenomena understood by those skilled in the art, including, but not limited to, hydrophobicity, solubility, electronic effects, and/or steric effects resulting from the chemical structure of a particular compound of formula (II).
  • each R 2 independently may not be Ci alkyl, and/or may not be Ci alkyl optionally substituted with a hydroxy group, and/or may not be C2 alkyl, and/or may not be C2 alkyl optionally substituted with a hydroxy group, and/or may not be C3 alkyl, and/or may not be C3 alkyl optionally substituted with a hydroxy group, and/or may not be C4 alkyl, and/or may not be C4 alkyl optionally substituted with a hydroxy group, and/or may not be C5 alkyl, and/or may not be C5 alkyl optionally substituted with a hydroxy group, and/or may not be Ce alkyl, and/or may not be Ce alkyl optionally substituted with a hydroxy group, and/or may not be C7 alkyl, and/or may not be C7 alkyl optionally substituted with a hydroxy group, and/or may not be Cs als alkyl, and/or may not
  • Examples of compounds of formula (II) may include tris(hydroxypropyl) phosphine and tributyl phosphine.
  • the biocidal composition does not include (for example, the copper-assisting additive is not) one or more of tris(hydroxypropyl) phosphine or tributyl phosphine.
  • a biocidal composition of the present disclosure may include a compound of formula (III), (IV), (V), or any combination thereof: wherein each R 3 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-
  • each R 4 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R 4 are not simultaneously hydrogen; and wherein each R 5 is independently selected from hydrogen, Ci-
  • each R 3 is independently selected from the group consisting of hydrogen, C1-C13 alkyl, phenyl, and benzyl, provided that all R 3 are not simultaneously hydrogen.
  • the alpha-carbon of at least one R 3 is a secondary or tertiary carbon.
  • Certain examples of compounds of formula (III) may include particular combinations of R 3 selected independently such that the compounds of formula (III) complex with, interact with, or otherwise affect copper (for example, by affecting the persistence of a given oxidation state, such as copper (I)), but not as desirably or preferably as other particular combinations of R 3 due to the combined effects of chemical phenomena understood by those skilled in the art, including, but not limited to, hydrophobicity, solubility, electronic effects, and/or steric effects resulting from the chemical structure of a particular compound of formula (III).
  • each R 3 independently may not be hydrogen, and/or may not be any one of C1-C20 alkyl, and/or may not be aryl, and/or may not be aryl(Ci-C4)alkyl.
  • a biocidal composition does not include a compound of formula (III).
  • Examples of compounds of formula (III) may include 2-ethylhexyl phosphate, bis(2- ethylhexyl)phosphate, tris(2-ethylhexyl)phosphate, methyl phosphate, diethyl phosphate, trimethyl phosphate, butyl phosphate (for example, //-butyl, sec-butyl, or tert-butyl), dibutyl phosphate (for example, //-butyl, sec-butyl, and/or tert-butyl), tributyl phosphate (for example, //-butyl, sec-butyl, and/or tert-butyl), phenyl phosphate, diphenyl phosphate, triphenyl phosphate, benzyl phosphate, dibenzyl phosphate, tribenzyl phosphate, or any combination thereof.
  • the biocidal composition does not include 2-ethylhexyl phosphate, and/or does not include bis(2-ethylhexyl)phosphate, and/or does not include tris(2- ethylhexyl)phosphate, and/or does not include methyl phosphate, and/or does not include dimethyl phosphate, and/or does not include trimethyl phosphate, and/or does not include butyl phosphate (for example, //-butyl, sec-butyl, or tert-butyl), and/or does not include dibutyl phosphate (for example, //-butyl, sec-butyl, or tert-butyl), and/or does not include tributyl phosphate (for example, //-butyl, sec-butyl, or tert-butyl), and/or does not include phenyl phosphate, and/or does not include diphenyl phosphate, and/or does not include triphen
  • each R 3 may not be Ci alkyl, and/or may not be C2 alkyl, and/or may not be C3 alkyl, and/or may not be C4 alkyl, and/or may not be C5 alkyl, and/or may not be Ce alkyl, and/or may not be C7 alkyl, and/or may not be Cs alkyl, and/or may not be C9 alkyl, and/or may not be C10 alkyl, and/or may not be Cn alkyl, and/or may not be C12 alkyl, and/or may not be C13 alkyl, and/or may not be C14 alkyl, and/or may not be C15 alkyl, and/or may not be Ci6 alkyl, and/or may not be C17 alkyl, and/or may not be Cis alkyl, and/or may not be C19 alkyl, and/or may not be C20 alkyl.
  • each R 4 is independently selected from the group consisting of hydrogen, C1-C13 alkyl, phenyl, and benzyl, provided that all R 4 are not all simultaneously hydrogen.
  • the alpha-carbon of at least one R 4 is a secondary or tertiary carbon.
  • Certain examples of compounds of formula (IV) may include particular combinations of R 4 selected independently such that the compounds of formula (IV) complex with, interact with, or otherwise affect copper (for example, by affecting the persistence of a given oxidation state, such as copper(I)), but not as desirably or preferably as other particular combinations of R 4 due to the combined effects of chemical phenomena understood by those skilled in the art, including, but not limited to, hydrophobicity, solubility, electronic effects, and/or steric effects resulting from the chemical structure of a particular compound of formula (IV).
  • each R 4 independently may not be hydrogen, and/or may not be any one of C1-C20 alkyl, and/or may not be aryl, and/or may not be aryl(Ci-C4)alkyl.
  • a biocidal composition does not include a compound of formula (IV).
  • Examples of compounds of formula (IV) may include tributyl borate.
  • the biocidal composition does not include tributyl borate.
  • each R 4 may not be Ci alkyl, and/or may not be C2 alkyl, and/or may not be C3 alkyl, and/or may not be C4 alkyl, and/or may not be C5 alkyl, and/or may not be Ce alkyl, and/or may not be C7 alkyl, and/or may not be Cs alkyl, and/or may not be C9 alkyl, and/or may not be C10 alkyl, and/or may not be Cn alkyl, and/or may not be C12 alkyl, and/or may not be C13 alkyl, and/or may not be C14 alkyl, and/or may not be C15 alkyl, and/or may not be Ci6 alkyl, and/or may not be C17 alkyl, and/or may not be Cis alkyl, and/or may not be C19 alkyl, and/or may not be C20 alkyl.
  • each R 5 is independently selected from the group consisting of hydrogen, C1-C13 alkyl, phenyl, and benzyl, provided that all R 5 are not all simultaneously hydrogen.
  • the alpha-carbon of at least one R 5 is a secondary or tertiary carbon.
  • Certain examples of compounds of formula (V) may include particular combinations of R 5 selected independently such that the compounds of formula (V) complex with, interact with, or otherwise affect copper (for example, by affecting the persistence of a given oxidation state, such as copper(I)), but not as desirably or preferably as other particular combinations of R 5 due to the combined effects of chemical phenomena understood by those skilled in the art, including, but not limited to, hydrophobicity, solubility, electronic effects, and/or steric effects resulting from the chemical structure of a particular compound of formula (V).
  • each R 5 independently may not be hydrogen, and/or may not be any one of C1-C20 alkyl, and/or may not be aryl, and/or may not be aryl(Ci-C4)alkyl.
  • a biocidal composition does not include a compound of formula (V).
  • Examples of compounds of formula (V) may include tributyl citrate.
  • the biocidal composition does not include tributyl citrate.
  • the biocidal composition includes copper in an amount of at least 0.01 at.% based on 100 weight percent of the biocidal composition. In certain examples, the biocidal composition includes copper in an amount of less than 10 at.% based on a total 100 weight percent of the biocidal composition.
  • the biocidal composition includes copper in an amount (at.% based on 100 weight percent of the biocidal composition) of 0.01 - 10, 0.01 - 9, 0.01 - 8, 0.01 - 7, 0.01 - 6, 0.01 - 5, 0.01 - 4, 0.01 - 3, 0.01 - 2, 0.01 - 1, 0.01 - 0.9, 0.01 - 0.8, 0.01 - 0.7, 0.01 - 0.6, 0.01 - 0.5, 0.01 - 0.4, 0.01 - 0.3, 0.01 - 0.2, 0.01 - 0.1, 0.01 - 0.05, 0.02 - 10, 0.02 - 9, 0.02 - 8, 0.02 - 7, 0.02 - 6, 0.02 - 5, 0.02 - 4, 0.02 - 3, 0.02
  • the copper(I) salt alone, the copper-assisting additive alone, or a sum total of both the copper(I) salt and the copper-assisting additive may be described by any of the following numbers and ranges: from 0.01 wt.% based on total 100 wt.% of the carrier or the biocidal composition to 20 wt.% based on weight of the carrier of the biocidal composition, such as, an amount (wt.% based on 100 wt.% of the carrier or the biocidal composition) of 0.01
  • 0.01 - 19 0.01 - 18, 0.01 - 17, 0.01 - 16, 0.01 - 15, 0.01 - 14, 0.01 - 13, 0.01 - 12, 0.01 - 11, 0.01 -10, 0.01 - 9, 0.01 - 8, 0.01 - 7, 0.01 - 6, 0.01 - 5, 0.01 - 4.9, 0.01 - 4.8, 0.01 - 4.7, 0.01 - 4.6, 0.01 - 4.5, 0.01 - 4.4, 0.01 - 4.3, 0.01 - 4.2, 0.01 - 4.1, 0.01 - 4, 0.01 - 3.9, 0.01 - 3.8, 0.01 - 3.7, 0.01 - 3.6, 0.01 - 3.5, 0.01 - 3.4, 0.01 - 3.3, 0.01 - 3.2, 0.01 - 3.1, 0.01 - 3, 0.01 - 2.9, 0.01 - 2.8, 0.01 - 2.7, 0.01 - 2.6, 0.01 - 2.5, 0.01 - 2.4, 0.01
  • Such numbers may refer to the absolute amount present, or to the amount added to a composition.
  • the basis weight may be either the carrier or the biocidal composition, as will be made clear from context because, in certain examples, the carrier is a main component of the biocidal composition. As such, in certain examples, the amount of a given component (or components) relative to either the carrier or the biocidal composition will be a similar value.
  • the copper(I) salt and the copper-assisting additive may be present in a sum total amount of at least 10 grams per liter of carrier (or biocidal composition), or at least 15 grams per liter of carrier (or biocidal composition), or at least 20 grams per liter of carrier (or biocidal composition), or at least 25 grams per liter of carrier (or biocidal composition), or at least 30 grams per liter of carrier (or biocidal composition), or at least 35 grams per liter of carrier (or biocidal composition), or at least 40 grams per liter of carrier (or biocidal composition).
  • the copper(I) salt and copper-assisting additive may be present in a sum total amount (grams per liter of carrier or biocidal composition) of from 1 - 50, 1 - 45, 1 - 40, 1 - 35, 1 - 30, 1 - 25, 1 - 20, 1 - 15, 1 - 10, 1 - 5, 2 - 50, 2 - 45, 2 - 40, 2 - 35, 2 - 30, 2 - 25, 2 - 20, 2 - 15, 2 - 10, 2 - 5, 3 - 50, 3 - 45, 3 - 40, 3 - 35, 3 - 30, 3 - 25, 3 - 20, 3 - 15, 3 - 20, 3 - 15, 3 - 20, 3 - 15, 3 - 20, 3 - 15, 3 - 20, 3 - 15, 3 - 20, 3 - 15, 3
  • the basis may be expressed as either carrier or biocidal composition.
  • the copper(I) salt may be present in the biocidal composition in an amount of at least 1 gram per liter of biocidal composition or carrier. In certain examples, the copper(I) salt may be present in the biocidal composition or carrier in an amount of less than 135 grams per liter of biocidal composition or carrier.
  • the copper(I) salt may be present in the biocidal composition or carrier in an amount (grams per liter of biocidal composition or carrier) of 1 - 135, 1 - 130, 1 - 125, 1 - 120, 1 - 115, 1 - 110, 1 - 105, 1 - 100, 1 - 95, 1 - 90, 1 - 85, 1 - 80, 1 - 75, 1 - 70, 1 - 65, 1 - 60, 1 - 55, 1 - 50, 1 - 45, 1 - 40,
  • the molar ratio of the copper-assisting additive to the copper(I) salt in the biocidal composition may be from 0.1 : 1 to 50: 1, including, for example, from 0.1:1 to 49: 1, from 0.1:1 to 48:1, from 0.1:1 to 47:1, from 0.1:1 to 46:1, from 0.1:1 to 45:1, from 0.1:1 to 44:1, from 0.1:1 to 43:1, from 0.1:1 to 42:1, from 0.1:1 to 41:1, from 0.1:1 to 40:1, from 0.1:1 to 39:1, from 0.1:1 to 38:1, from 0.1:1 to 37:1, from 0.1:1 to 36:1, from 0.1:1 to 35:1, from 0.1:1 to 34:1, from 0.1:1 to 33:1, from 0.1:1 to 32:1, from 0.1:1 to 31:1, from 0.1:1 to 30:1, from 0.1:1 to 29:1, from 0.1:1 to 28:1, from 0.1:1 to 27:
  • the composition for example, biocidal composition
  • the composition may be formed into a desired article or be applied to a surface.
  • the composition includes or is, for example, a polyurethane, a polyurethane precursor, an epoxy resin, an epoxy resin precursor, a melamine resin, or the like
  • a composition may be applied to a surface as a layer.
  • surfaces to which the biocidal composition may be applied include wood, polymer, metal, glass, ceramic, stone, concrete, cement, mineral, drywall, asphalt, or any combination thereof.
  • Examples of articles that may be formed using the compositions described herein include housings or cases for electronic devices (for example, mobile phones, smart phones, tablets, video players, information terminal devices, laptop computers), architectural structures (for examples, countertops, walls, trim, ceilings, floors, exterior facades, and trim), appliances 9for example, cooktops, refrigerator doors, and dishwasher doors), information displays (for example, whiteboards), automotive components (for example, dashboard panels, windshields, window components), and high touch surfaces (for example, a computer mouse, a computer keyboard, a railing, a door, a doorknob, a door push plate, a phone, a phone button, or an elevator button).
  • electronic devices for example, mobile phones, smart phones, tablets, video players, information terminal devices, laptop computers
  • architectural structures for examples, countertops, walls, trim, ceilings, floors, exterior facades, and trim
  • appliances 9 for example, cooktops, refrigerator doors, and dishwasher doors
  • information displays for example, whiteboards
  • automotive components for example, dashboard panels, windshields, window components
  • Articles may be formed by any method known in the art, such as by molding (for example, injection molding), or otherwise forming the article into a desired shape.
  • an entire article may include the biocidal composition (for example, an entire article is formed from the biocidal composition).
  • a method of forming an article the method including providing a masterbatch of the biocidal composition, and then forming the article therefrom by any known technique, such as by extrusion or molding (for example, injection molding).
  • a method of preparing a masterbatch including mixing a concentrated form of the biocidal composition.
  • compositions described herein may include pigments to impart color. Accordingly, the coatings or layers made from such compositions may exhibit a wide variety of colors, depending on the carrier color, mixtures of carriers, and amount of particle loading. Moreover, it is contemplated that the compositions and/or coatings described herein will show no adverse effect to paint adhesion as measured by ASTM D4541. In certain examples, the adhesion of the composition or coating to an underlying substrate is greater than the cohesive strength of the substrate. In other words, in testing, the adhesion between the coating and the substrate is so strong that the underlying substrate failed before the coating was separated from the surface of the substrate.
  • the biocidal composition may be in the form of an article, a layer, a coating, a dry film, or as a liquid composition including suspensions and solutions, which may be applied on a surface or stored in a container (for example, prior to use).
  • the biocidal composition is not in the form of a molded article, e.g., an injection molded article, or an extruded article.
  • One or more examples of the biocidal compositions of the present disclosure may include the copper(I) salt (which may optionally be pre-treated with a pretreatment solution), a copper-assisting additive, and a carrier with a loading level of the copper(I) salt such that the composition may exhibit resistance or preservation against the presence or growth of foulants (for example, microbes).
  • Foulants include fungi, bacteria, viruses, mold, mildew, algae, and combinations thereof.
  • the presence of foulants in materials, such as polyurethanes, epoxy resins, and the like may cause color changes to the composition, may degrade the integrity of the composition, and may negatively affect various properties of the composition.
  • the foulants may be eliminated or reduced.
  • a minimum loading of copper(I) salt for example, 5 weight % or less, 4 weight % or less, 3 weight % or less, 2 weight % or less, or 1 weight % or less; alternatively, or additionally, in an amount of 0 weight % or more, for example, greater than 0 weight %, 0.01 weight % or more, 0.05 weight % or more, 0.1 weight % or more, 0.5 weight % or more, 1 weight % or more, 2 weight % or more, 3 weight % or more, or 4 weight % or more, based on weight of the carrier or composition) and copper-assisting additive in the carrier, the foulants may be eliminated or reduced.
  • compositions may or may not include certain components, when fouling is eliminated or reduced. Therefore, the formulations used in one or more examples of the compositions described herein may have more flexibility and variations than previously possible, when used in known compositions that do not include the copper(I) salt.
  • a biocidal composition may exhibit one or more of the following effects: (1) a greater than 3 logarithmic reduction in a concentration of a microbe selected from the group consisting of Staphylococcus aureus, Enterobacter aerogenes, Pseudomonas aeruginosa, Methicillin Resistant Staphylococcus aureus, E. coli, SARS-Cov-2, and mixtures thereof; (2) a change in color in the biocidal composition is minimized relative to a change in color of a mixture of the carrier and the copper(I) salt in the absence of the copper-assisting additive or the carrier and the copper-assisting additive absent the copper(I) salt; or (3) any combination thereof.
  • Antimicrobial efficacy may be measured as described elsewhere herein, such as by using the EP A Test.
  • a biocidal composition including a carrier, a copper(I) salt, and a copper- assisting additive has better antimicrobial efficacy over time (for example, for 7 days or at least 7 days, or any other time period disclosed herein, such as 30 days or at least 30 days, or 90 days or or at least 90 days) compared to an otherwise identical composition that does not include the copper-assisting additive or does not include the copper(I) salt (for example, in the amounts specified, such as copper in an amount of 0.01 at.% to 10 at.% or 0.01 at.% to 2 at.%; copper(I) salt in the composition in an amount of 0.01 wt.% to 15 wt.%; and/or a molar ratio of the amount of the copper-assisting additive to the amount of copper is from 0.1 : 1 to 50: 1).
  • such a biocidal composition also has minimized color change (for example, color drift and/or color shift) compared to an otherwise identical composition, as disclosed
  • the biocidal composition when the biocidal composition is formed into a coating (for example, a dry film) within one day of preparing the biocidal composition and the coating is stored at ambient conditions for 7 days or at least 7 days (for example, 10 days or at least 10 days, 15 days or at least 15 days, 20 days or at least 20 days, 25 days or at least 25 days, 30 days or at least 30 days, 40 days or at least 40 days, 50 days or at least 50 days, 60 days or at least 60 days, 75 days or at least 75 days, 90 days or at least 90 days, 100 days or at least 100 days, 120 days or at least 120 days, 150 days or at least 150 days, 180 days or at least 180 days, 365 days or at least 365 days, 2 years or at least 2 years, 3 years or at least 3 years, 4 years or at least 4 years, 5 years or at least 5 years, or 6 years or at least 6 years; alternatively, or additionally, less than 6 years, less than 5 years, less than 4 years, less than 3 years, less than 2 years, less than 2
  • Antimicrobial efficacy can be measured as described elsewhere herein, such as by using the EP A Test.
  • the term “for X days” or “for X years” in which X is a number means that the longevity of a specified property lasts minimally for X days (or for X years). The longevity of the specified property may last for a longer period of time, and after such longer period of time the specified property (e.g., log reduction or color value) may begin to decrease; however, “for X days” (or “for X years”) is met if the specified property was present at X days (or X years).
  • the terms “for X days” and the term “for at least X days” are meant to be synonymous terms.
  • the biocidal composition when stored as a liquid composition, mixture, or suspension at ambient conditions for a period of 7 days or at least 7 days (for example, 10 days or at least 10 days, 15 days or at least 15 days, 20 days or at least 20 days, 25 days or at least 25 days, 30 days or at least 30 days, 40 days or at least 40 days, 50 days or at least 50 days, 60 days or at least 60 days, 75 days or at least 75 days, 90 days or at least 90 days, 100 days or at least 100 days, 120 days or at least 120 days, 150 days or at least 150 days, 180 days or at least 180 days, 365 days or at least 365 days (1 year), 2 years or at least 2 years, 3 years or at least 3 years, 4 years or at least 4 years, 5 years or at least 5 years, or 6 years or at least 6 years; alternatively, or additionally, less than 6 years, less than 5 years, less than 4 years, less than 3 years, less than 2 years, less than 365 days, less than 180 days, less than 150
  • the above feature shows the antimicrobial efficacy of a coating (for example, dry film) or article after the biocidal composition has been stored in liquid form (for example, a can of polyurethane precursor or epoxy resin precursor) for a certain period of time.
  • Antimicrobial efficacy may be measured as described elsewhere herein, such as by using the EPA Test.
  • minimizing a change in color corresponds to a CIE AE* value of the biocidal composition being less than 10, or less than 9, or less than 8, or less than 7, or less than 6, or less than 5, or less than 4, or less than 3, or less than 2, as measured according to formula (VI): wherein L*, a*, and b* are the CIE L*, a*, and b* values of the biocidal compositions and the L’ control, 3- control, and b* CO ntroi are the CIE L*, a*, and b* values of an otherwise identical composition without either the copper(I) salt or the copper-assisting additive.
  • a biocidal composition or a film prepared from the biocidal composition may exhibit (1) a transmittance as measured at each wavelength from 400 to 700 nm, and/or (2) an average transmittance as measured over the wavelength range of from 400 to 700 nm, of at least 50%, or at least 51%, or at least 52%, or at least 53%, or at least 54%, or at least
  • Average transmittance is calculated by summing the transmittance at each wavelength between 400 and 700 nm and dividing by the total number of such wavelengths.
  • a biocidal composition, or a film thereof may exhibit a transmittance as measured at each wavelength from 400 to 700 nanometers that is within 20 percentage points of a second transmittance of an otherwise identical composition or film thereof without either the copper(I) salt or the copper-assisting additive when measured at a thickness of 40 pm; including, for example, within 19.5 percentage points, or within 19.0 percentage points, or within 18.5 percentage points, or within 18.0 percentage points, or within 17.5 percentage points, or within 17.0 percentage points, or within 16.5 percentage points, or within 16.0 percentage points, or within 15.5 percentage points, or within 15.0 percentage points, or within 14.5 percentage points, or within 14.0 percentage points, or within 13.5 percentage points, or within 13.0 percentage points, or within 12.5 percentage points, or within 12.0 percentage points, or within 11.5 percentage points, or within 11.0 percentage points, or within 10.5 percentage points, or within 10.0 percentage points, or within 9.9 percentage points, or within 9.8 percentage points, or within 9.7 percentage points, or within 9.6 percentage
  • a film of a biocidal composition may have a thickness of from 30 pm to 3000 pm, including, for example, from 40 pm, or from 50 pm, or from 60 pm, or from 70 pm, or from 80 pm, or from 90pm, or from 100 pm, or from 110 pm, or from 120 pm, or from 130 pm, or from 140 pm, or from 150 pm, or from 160 pm, or from 170 pm, or from 180 pm, or from 190 pm, or from 200pm, or from 210 pm, or from 220 pm, or from 230pm, or from 240 pm, or from 250 pm, or from 260 pm, or from 270 pm, or from 280 pm, or from 290 pm, or from 300 pm, or from 310pm, or from 320 pm, or from 330 pm, or from 340pm, or from 350 pm, or from 360 pm, or from 370 pm, or from 380 pm, or from 390 pm, or from 400 pm, or from 410 pm, or from 420pm, or from 430 pm
  • 1050 pm or from 1100 pm, or from 1150 pm, or from 1200 pm, or from 1250 pm, or from 1300 pm, or from 1350 pm, or from 1400 pm, or from 1450 pm, or from 1500 pm, or from 1550 pm, or from 1600 pm, or from 1650 pm, or from 1700 pm, or from 1750 pm, or from 1800 pm, or from 1850 pm, or from 1900 pm, or from 1950 pm, or from 2000 pm, or from 2050 pm, or from 2100 pm, or from 2150 pm, or from 2200 pm, or from 2250 pm, or from 2300 pm, or from 2350 pm, or from 2400 pm, or from 2450 pm, or from 2500 pm, or from 2550 pm, or from 2600 pm, or from 2650 pm, or from 2700 pm, or from 2750 pm, or from
  • a method of preparing a biocidal composition including adding a biocidal additive formulation to a carrier.
  • the biocidal additive formulation may include the copper(I) salt and the copper-assisting additive.
  • the carrier is a polyurethane or an epoxy resin
  • the biocidal additive formulation may include a first polyurethane precursor, the copper(I) salt, and the copper-assisting additive.
  • the carrier is a second epoxy resin precursor
  • the biocidal additive formulation may include a first epoxy resin precursor, the copper(I) salt, and the copper-assisting additive.
  • a method including applying a biocidal composition to a surface may include any of the components described elsewhere herein.
  • the surface is or includes wood polymer (for example, plastic or rubber), metal (for example, steel, iron, copper, gold, silver, aluminum, tin, platinum, alloys thereof, or any combination thereof), glass (for example, lithium aluminosilicate, borosilicate, chemical strengthened, or ion-exchanged), ceramic, glass-ceramic, stone, concrete, cement, mineral, drywall, asphalt, or any combination thereof.
  • the method of applying to a surface may be any suitable method, including spraying, spin coating, dipping, and the like, or any combination thereof.
  • the composition may be sprayed on a surface.
  • the copper(I) species for example, the ion or salt
  • the copper(I) species may be at least partially in a solubilized form (for example, facilitated by complexation with a copper-assisting additive), though such copper(I) species may alternatively or additionally be in a suspension.
  • a method of improving or sustaining antimicrobial efficacy in a biocidal composition including: combining a carrier, a copper(I) salt, and a copper-assisting additive, wherein the biocidal composition includes copper in an amount of 0.01 at.% to 10 at.%, and the carrier and the copper-assisting additive are different.
  • a molar ratio of the amount of copper-assisting additive to the amount of copper is from 0.1 : 1 to 50: 1.
  • the copper(I) salt is first combined with the copper-assisting additive to form a mixture, and the mixture is then combined with the carrier to form the biocidal composition.
  • the color change in the biocidal composition is minimized relative to a change in color of an otherwise identical composition in the absence of the copper-assisting additive, or an otherwise identical composition absent the copper(I) salt, or an otherwise identical composition absent both the copper-assisting additive and the copper(I) salt.
  • the copper-assisting additive is any compound or formula disclosed herein (for example, a compound of formula (I), (II), or any combination thereof), by itself or themselves, or together with a compound of formula (III), (IV), (V), or any combination thereof.
  • a method of minimizing a color change in a biocidal composition wherein the copper-assisting additive is any compound disclosed herein, such as trimethyl phosphite, triethyl phosphite, triphenyl phosphite, tris(2,2,2-trifluoroethyl) phosphite, tris(2-ethylhexyl) phosphite, triisopropyl phosphite, tris(l,l,l,3,3,3-hexafluoro-2-propyl) phosphite, tris(hydroxylpropyl) phosphine, tributyl phosphine, or any combination thereof, by itself or themselves, or together with a compound such as 2-ethylhexyl phosphate, bis(2-ethylhexyl)phosphate, tris(2- ethylhexyl)phosphate, methyl phosphate,
  • a method of minimizing a color change in a biocidal composition wherein the composition demonstrates a greater than 3 logarithmic reduction in a concentration of a microbe selected from the group consisting of Staphylococcus aureus, Enterobacter aerogenes, Pseudomonas aeruginosa, Methicillin Resistant Staphylococcus aureus, E. coli, SARS-Cov-2, and mixtures thereof.
  • Antimicrobial efficacy may be measured as described elsewhere herein, such as by using the EPA Test.
  • a method of minimizing a color change in a biocidal composition wherein a CIE AE* value of the biocidal material is less than 10, as measured according to formula (VI): wherein L*, a*, and b* are the CIE L*, a*, and b* values of the biocidal material and the L* CO ntroi, a*controi, and b* con troi are the CIE L*, a*, and b* values of an otherwise identical composition without either the copper(I) salt or the copper-assisting additive.
  • a biocidal composition may exhibit a AE of less than 10, or less than 9, or less than 8, or less than 7, or less than 6, or less than 5, or less than 4, or less than 3, or less than 2, as measured according to formula (VI): wherein L*, a*, and b* are CIE values of the biocidal composition after preparing and then, within one day of preparing, storing the biocidal composition at ambient temperature and ambient relative humidity for 7 days (for example, 10 days, 15 days, 20 days, 25 days, 30 days, 40 days, 50 days, 60 days, 75 days, 90 days, 100 days, 120 days, 150 days, 180 days, 365 days, 2 years, 3 years, 4 years, or 5 years, and the L’ control, 3- control, and b* CO ntroi are CIE values of an otherwise identical composition without either the copper(I) salt or the copper-assisting additive.
  • L*, a*, and b* are CIE values of the biocidal composition after preparing and then, within one day of preparing,
  • the present disclosure provides a biocidal additive formulation that includes a copper(I) salt and a copper-assisting additive.
  • the biocidal additive formulation may be a relatively concentrated formulation to be added to a carrier so as to provide a biocidal composition.
  • the biocidal additive formulation may be in the form of a package that may be added to, for example, a polyurethane, a polyurethane precursor, an epoxy resin, an epoxy resin precursor, or a melamine resin by an end user, so as to make the polyurethane, the polyurethane precursor, the epoxy resin, the epoxy resin precursor, or the melamine resin have antimicrobial properties without substantially impacting color and/or transparency.
  • Such a biocidal additive formulation may also be added by a manufacturer during or after production of a bulk quantity of polyurethane precursor or epoxy resin precursor so as to impart, for example, desired antimicrobial properties.
  • a form of a biocidal additive formulation may include a powder, a slurry, a gel, a liquid, a concentrate, and a solution.
  • the biocidal additive formulation is in liquid form at ambient conditions (1 atm (-101.3 kPa) and 20 °C).
  • the biocidal additive formulation comprises solubilized copper(I) salt in the form of a copper complex, in which the copper(I) salt is coordinated to or otherwise associated with a copper-assisting additive that facilitates the solubility of the copper(I) salt.
  • a biocidal additive formulation for addition to a composition, rather than simply adding a copper salt to a composition, or rather than simply adding a copper salt and a copper-assisting additive separately to a composition.
  • addition of copper salt alone, or addition of copper salt and an additive separately to the same composition (without premixing) may, in some cases, not allow the copper-assisting additive to sufficiently promote the availability and/or persistence of copper(I) ions.
  • separate addition may not allow the copper-assisting additive to find and associate with the copper salt.
  • the biocidal additive formulation may include an antioxidant package.
  • Antioxidant packages may include single components or ternary mixtures.
  • antioxidant packages may include primary antioxidants; phenolics, such as BHT; secondary antioxidants, such as UltranoxTM 626, WestonTM 430 ZP, thioester-based antioxidants (thiosynergists), such as dioctadecyl 3,3 ’-thiodipropionate; ascorbate esters, such as ascorbyl palmitate; or any combination thereof.
  • the biocidal additive formulation may include a reducing agent.
  • reducing agents may include ascorbic acid, hydroxylamine hydrochloride, various phosphines, sulfite compounds, oxalic acid, sodium thiosulfate, or any combination thereof.
  • Examples of a form of a biocidal additive formulation may include a powder, a slurry, a gel, a liquid, a concentrate, and a solution.
  • the biocidal additive formulation may include an antioxidant package.
  • Antioxidant packages may include single components or ternary mixtures. Examples of antioxidant packages may include primary antioxidants; phenolics, such as BHT; secondary antioxidants, such as UltranoxTM 626, WestonTM 430 ZP, thioester-based antioxidants (thiosynergists), such as dioctadecyl 3,3’- thiodipropionate; ascorbate esters, such as ascorbyl palmitate; or any combination thereof.
  • the biocidal additive formulation may include a reducing agent.
  • reducing agents may include ascorbic acid, hydroxylamine hydrochloride, various phosphines, sulfite compounds, oxalic acid, sodium thiosulfate, or any combination thereof.
  • the biocidal additive formulation may be in a sealed container including an inert atmosphere.
  • the biocidal additive formulation has a molarity of the copper(I) salt dissolved in the biocidal additive formulation of from 20 mA/ to 200 mA/, including, for example, from 25 mA/, or from 30 mA/, or from 35 mA/, or from 40 mA/, or from 45 mA/, or from 50 mA/, or from 55 mA/, or from 60 mA/, or from 65 mA/, or from 70 mA/, or from 75 mA/, or from 80 mA/, or from 85 mA/, or from 90 mA/, or from 95 mA/, or from 100 mA/, or from 105 mA/, or from 110 mA/, or from 115 mA/, or from 120 mA/, or from 125 mA/, or from 130 mA/, or from 135 mA/, or from 140 mA/, or from 145
  • the biocidal additive formulation may include a copper-assisting additive at a molarity of the copper-assisting additive in the biocidal additive formulation of from 0.06 mA/ to 0.6 mA/; including, for example, from 0.065 mA/, or from 0.07 mA/, or from 0.075 mA/, or from 0.08 mA/, or from 0.085 mA/, or from 0.09 mA/, or from 0.095 mA/, or from 0.1 mA/, or from 0.105 mA/, or from 0.110 mA/, or from 0.115 mA/, or from 0.120 mA/, or from 0.125 mA/, or from 0.130 mA/, or from 0.135 mA/, or from 0.140 mA/, or from 0.145 mA/, or from 0.150 mA/, or from 0.155 mA/, or from 0.160 mA/, or from 0.165 mA/
  • the biocidal additive formulation may include a copper(I) salt and a copper-assisting additive at any of the ratios disclosed elsewhere herein.
  • the biocidal additive formulation may include a solvent at a molarity of the solvent in the biocidal additive formulation of from 0.8 mA/ to 8.00 mA/, including, for example, from 0.85 mA/, or from 0.90 mA/, or from 0.95 mA/, or from 1.00 mA/, or from 1.05 mA/, or from 1.10 mA/, or from 1.15 mA/, or from 1.20 mA/, or from 1.25 mA/, or from 1.30 mA/, or from 1.35 mA/, or from 1.40 mA/, or from 1.45 mA/, or from 1.50 mA/, or from 1.55 mA/, or from 1.60 mA/, or from 1.65 mA/, or from 1.70 mA/, or from 1.75 mA/, or from 1.80 mA/, or from 1.85 mA/, or from 1.90 mA/, or
  • the present disclosure provides a biocidal composition, including: a carrier, including a polyurethane, a polyurethane precursor, an epoxy resin, an epoxy resin precursor, a melamine resin, or any combination thereof; a copper(I) salt; and a copper- assisting additive different from the carrier; wherein the copper-assisting additive includes a phosphite, a phosphine, or a combination thereof; and wherein the biocidal composition or a film thereof exhibits an antimicrobial efficacy of at least 3 log kill as measured with an EPA Test after storage of the biocidal composition or the film thereof at ambient temperature and ambient relative humidity for 90 days or at least 90 days (or any other time period disclosed herein).
  • the phosphite may be a compound of formula (I): wherein each R 1 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally fluorosubstituted.
  • the phosphine may be a compound of formula (II): wherein each R 2 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally substituted with a hydroxy group.
  • the carrier may include a polyurethane, a polyurethane precursor, or a combination thereof.
  • the carrier may include an epoxy resin, an epoxy resin precursor, or a combination thereof.
  • the carrier may include an organic solvent.
  • the copper(I) salt may be a copper(I) halide, iodo(triethyl phosphite)copper(I), or a tetrakis(acetonitrile)copper(I) salt.
  • the copper(I) salt may be copper(I) bromide or copper(I) iodide.
  • each R 1 may be independently selected from C2-C13 alkyl, Ci-Cs alkyl, Ci-Ce alkyl, C2-C5 alkyl, C2-C4 alkyl, or phenyl.
  • each R 2 may be independently selected from C2-C13 alkyl, Ci-Cs alkyl, Ci-Ce alkyl, C2-C5 alkyl, or C2-C4 alkyl.
  • the copper-assisting additive may be triethyl phosphite, tributyl phosphine, triphenyl phosphite, or any combination thereof.
  • a molar ratio of the copper-assisting additive to the copper(I) salt may be at least 0.5: 1.
  • the biocidal composition may further include a compound of formula (III), (IV), (V), or any combination thereof: wherein eachR 3 may be independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci- C4)alkyl, provided that all R 3 are not simultaneously hydrogen; wherein each R 4 may be independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R 4 are not simultaneously hydrogen; and wherein each R 5 may be independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R 5 are not simultaneously hydrogen.
  • each R 3 may be independently selected from C1-C13 alkyl, Ci-Cs alkyl, Ci-Ce alkyl, C2-C5 alkyl, or C2-C4 alkyl.
  • the biocidal composition may further include 2-ethylhexyl phosphate.
  • each R 4 may be independently selected from C1-C13 alkyl, Ci-Cs alkyl, Ci-Ce alkyl, C2-C5 alkyl, or C2-C4 alkyl.
  • the biocidal composition may further include tributyl borate.
  • each R 5 may be independently selected from C1-C13 alkyl, Ci-Cs alkyl, Ci-Ce alkyl, C2-C5 alkyl, or C2-C4 alkyl.
  • the biocidal composition may further include tributyl citrate.
  • the biocidal composition may exhibit a AE of less than 6, as calculated according to wherein L*, a*, and b* are CIE values of the biocidal composition after preparing and then storing the biocidal composition at ambient temperature and ambient relative humidity for 90 days or at least 90 days (or any other time period disclosed herein), and L” control, 3- control, and b* CO ntroi are CIE values of an otherwise identical composition without either the copper(I) salt or the copper-assisting additive.
  • the biocidal composition or the film thereof may exhibit a transmittance of at least 98% as measured at each wavelength from 400 to 700 nanometers when measured at a thickness of 40 pm.
  • the transmittance may be within 10 percentage points of a second transmittance of an otherwise identical composition or film thereof without either the copper(I) salt or the copper-assisting additive when measured at a thickness of 40 pm.
  • a method of preparing the biocidal composition may include: adding a biocidal additive formulation to a carrier; wherein when the carrier is a polyurethane or an epoxy resin, the biocidal additive formulation may include the copper(I) salt and the copper-assisting additive; wherein when the carrier is a second polyurethane precursor, the biocidal additive formulation may include a first polyurethane precursor, the copper(I) salt, and the copper-assisting additive; and wherein when the carrier is a second epoxy resin precursor, the biocidal additive formulation may include a first epoxy resin precursor, the copper(I) salt, and the copper-assisting additive.
  • a biocidal additive formulation including: a copper(I) salt; and a copper-assisting additive; wherein a biocidal composition including the biocidal additive formulation and a carrier, or a film of the biocidal composition, exhibits an antimicrobial efficacy of at least 3 log kill as measured with an EPA Test after storage of the biocidal composition or the film thereof at ambient temperature and ambient relative humidity for 90 days or at least 90 days (or any other time period disclosed herein); wherein the carrier includes a polyurethane, a polyurethane precursor, an epoxy resin, an epoxy resin precursor, a melamine resin, or any combination thereof; wherein the biocidal composition exhibits a AE of less than 6, as calculated according to wherein L*, a*, and b* are CIE values of the biocidal composition after preparing and then storing the biocidal composition at ambient temperature and ambient relative humidity for 90 days or at least 90 days (or any other time period disclosed herein), and L’ control, 3- control, and
  • the biocidal additive formulation may include an organic solvent, a first polyurethane precursor, a first epoxy resin precursor, or any combination thereof.
  • the copper(I) salt may be a copper(I) halide, iodo(triethyl phosphite)copper(I), or a tetrakis(acetonitrile)copper(I) salt.
  • the copper(I) salt may be copper(I) bromide or copper(I) iodide.
  • the copper-assisting additive may include a phosphite, a phosphine, or a combination thereof.
  • the phosphite may be a compound of formula (I): wherein each R 1 may be independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally fluorosubstituted, provided that all R 1 are not simultaneously hydrogen.
  • the phosphine may be a compound of formula (II): wherein each R 2 may be independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally substituted with a hydroxy group, provided that all R 2 are not simultaneously hydrogen.
  • each R 1 may be independently selected from C2-C13 alkyl, Ci-Cs alkyl, Ci-Ce alkyl, C2-C5 alkyl, or C2-C4 alkyl, or phenyl.
  • each R 2 may be independently selected from C2-C13 alkyl, Ci-Cs alkyl, Ci-Ce alkyl, C2-C5 alkyl, or C2-C4 alkyl.
  • the copper-assisting additive may be triethyl phosphite, tributyl phosphine, triphenyl phosphite, or any combination thereof.
  • a molar ratio of the copper-assisting additive to the copper(I) salt may be at least 0.5: 1.
  • the biocidal additive formulation may further include a compound of formula (III), (IV), (V), or any combination thereof: wherein eachR 3 may be independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci- C4)alkyl, provided that all R 3 are not simultaneously hydrogen; wherein each R 4 may be independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R 4 are not simultaneously hydrogen; and wherein each R 5 may be independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R 5 are not simultaneously hydrogen.
  • each R 3 may be independently selected from C1-C13 alkyl, Ci-Cs alkyl, Ci-Ce alkyl, C2-C5 alkyl, or C2-C4 alkyl.
  • the biocidal additive formulation may further include 2-ethylhexyl phosphate.
  • each R 4 may be independently selected from C1-C13 alkyl, Ci-Cs alkyl, Ci-Ce alkyl, C2-C5 alkyl, or C2-C4 alkyl.
  • the biocidal additive formulation may further include tributyl borate.
  • each R 5 may be independently selected from C1-C13 alkyl, Ci-Cs alkyl, Ci-Ce alkyl, C2-C5 alkyl, or C2-C4 alkyl.
  • the biocidal additive formulation may further include tributyl citrate.
  • the biocidal composition or the film thereof may exhibit a transmittance of at least 98% as measured at each wavelength from 400 to 700 nanometers when measured at a thickness of 40 pm.
  • the transmittance may be within 10 percentage points of a second transmittance of an otherwise identical composition or film thereof without either the copper(I) salt or the copper-assisting additive when measured at a thickness of 40 pm.
  • the biocidal additive formulation may further include an antioxidant.
  • the biocidal additive formulation may further include a reducing agent.
  • the formulation may be in a sealed container including an inert atmosphere.
  • a first aspect relates to a biocidal composition, comprising: a carrier, comprising a polyurethane, a polyurethane precursor, an epoxy resin, an epoxy resin precursor, a melamine resin, or any combination thereof; a copper(I) salt; and a copper-assisting additive different from the carrier; wherein the copper-assisting additive comprises a phosphite, a phosphine, or a combination thereof; and wherein the biocidal composition or a film thereof exhibits an antimicrobial efficacy of at least 3 log kill as measured with an EPA Test after storage of the biocidal composition or the film thereof at ambient temperature and ambient relative humidity for 90 days or at least 90 days (or any other time period disclosed herein).
  • a second aspect relates to the biocidal composition of aspect 1, or any preceding aspect, wherein the phosphite is a compound of formula (I): wherein each R 1 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally fluorosubstituted.
  • a third aspect relates to the biocidal composition of any preceding aspect, wherein the phosphine is a compound of formula (II): wherein each R 2 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally substituted with a hydroxy group.
  • a fourth aspect relates to the biocidal composition of any preceding aspect, wherein the carrier comprises a polyurethane, a polyurethane precursor, or a combination thereof.
  • a fifth aspect relates to the biocidal composition of aspects 1 to 3, or any preceding aspect, wherein the carrier comprises an epoxy resin, an epoxy resin precursor, or a combination thereof.
  • a sixth aspect relates to the biocidal composition of any preceding aspect, wherein the carrier comprises an organic solvent.
  • a seventh aspect relates to the biocidal composition of any preceding aspect, wherein the copper(I) salt is a copper(I) halide, iodo(triethyl phosphite)copper(I), or a tetrakis(acetonitrile)copper(I) salt.
  • the copper(I) salt is a copper(I) halide, iodo(triethyl phosphite)copper(I), or a tetrakis(acetonitrile)copper(I) salt.
  • An eighth aspect relates to the biocidal composition of any preceding aspect, wherein the copper(I) salt is copper(I) bromide or copper(I) iodide.
  • a ninth aspect relates to the biocidal composition of aspects 2 to 8, or any preceding aspect, wherein each R 1 is independently selected from C2-C13 alkyl (or Ci-Cs alkyl, or Ci-Ce alkyl, or C2-C5 alkyl, C2-C4 alkyl), or phenyl.
  • a tenth aspect relates to the biocidal composition of aspects 3 to 9, or any preceding aspect, wherein each R 2 is independently selected from C2-C13 alkyl (or Ci-Cs alkyl, or Ci-Ce alkyl, or C2-C5 alkyl, or C2-C4 alkyl).
  • An eleventh aspect relates to the biocidal composition of any preceding aspect, wherein the copper-assisting additive is triethyl phosphite, triphenyl phosphite, tributyl phosphine, or any combination thereof.
  • a twelfth aspect relates to the biocidal composition of any preceding aspect, wherein a molar ratio of the copper-assisting additive to the copper(I) salt is at least 0.5: 1.
  • a thirteenth aspect relates to the biocidal composition of any preceding aspect, further comprising a compound of formula (III), (IV), (V), or any combination thereof: wherein each R 3 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci- C4)alkyl, provided that all R 3 are not simultaneously hydrogen; wherein each R 4 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R 4 are not simultaneously hydrogen; and wherein each R 5 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R 5 are not simultaneously hydrogen.
  • a fourteenth aspect relates to the biocidal composition of aspect 13, or any preceding aspect, wherein each R 3 is independently selected from C1-C13 alkyl (or Ci-Cs alkyl, or Ci-Ce alkyl, or C2-C5 alkyl, or C2-C4 alkyl).
  • a fifteenth aspect relates to the biocidal composition of any preceding aspect, further comprising 2-ethylhexyl phosphate.
  • a sixteenth aspect relates to the biocidal composition of aspect 13, or any preceding aspect, wherein each R 4 is independently selected from C1-C13 alkyl (or Ci-Cs alkyl, or Ci-Ce alkyl, or C2-C5 alkyl, or C2-C4 alkyl).
  • a seventeenth aspect relates to the biocidal composition of any preceding aspect, further comprising tributyl borate.
  • An eighteenth aspect relates to the biocidal composition of aspect 13, or any preceding aspect, wherein each R 5 is independently selected from C1-C13 alkyl (or Ci-Cs alkyl, or Ci-Ce alkyl, or C2-C5 alkyl, or C2-C4 alkyl).
  • a nineteenth aspect relates to the biocidal composition of any preceding aspect, further comprising tributyl citrate.
  • a twentieth aspect relates to the biocidal composition of any preceding aspect, wherein the biocidal composition exhibits a AE of less than 6, as calculated according to wherein L*, a*, and b* are CIE values of the biocidal composition after preparing and then storing the biocidal composition at ambient temperature and ambient relative humidity for 90 days or at least 90 days (or any other time period disclosed herein), and L” control, 3- control, and b* CO ntroi are CIE values of an otherwise identical composition without either the copper(I) salt or the copper-assisting additive.
  • a twenty-first aspect relates to the biocidal composition of any preceding aspect, wherein the biocidal composition or the film thereof exhibits a transmittance of at least 98% as measured at each wavelength from 400 to 700 nanometers when measured at a thickness of 40 pm.
  • a twenty-second aspect relates to the biocidal composition of aspect 21, or any preceding aspect, wherein the transmittance is within 10 percentage points of a second transmittance of an otherwise identical composition or film thereof without either the copper(I) salt or the copper-assisting additive when measured at a thickness of 40 pm.
  • a twenty -third aspect relates to a method of preparing the biocidal composition of any preceding aspect, comprising: adding a biocidal additive formulation to a carrier; wherein when the carrier is a polyurethane or an epoxy resin, the biocidal additive formulation comprises the copper(I) salt and the copper-assisting additive; wherein when the carrier is a second polyurethane precursor, the biocidal additive formulation comprises a first polyurethane precursor, the copper(I) salt, and the copper-assisting additive; and wherein when the carrier is a second epoxy resin precursor, the biocidal additive formulation comprises a first epoxy resin precursor, the copper(I) salt, and the copper-assisting additive.
  • a twenty-fourth aspect relates to a biocidal additive formulation, comprising:a copper(I) salt; and a copper-assisting additive; wherein a biocidal composition comprising the biocidal additive formulation and a carrier, or a film of the biocidal composition, exhibits an antimicrobial efficacy of at least 3 log kill as measured with an EPA Test after storage of the biocidal composition or the film thereof at ambient temperature and ambient relative humidity for 90 days or at least 90 days (or any other time period disclosed herein); wherein the carrier comprises a polyurethane, a polyurethane precursor, an epoxy resin, an epoxy resin precursor, a melamine resin, or any combination thereof; wherein the biocidal composition exhibits a AE of less than 6, as calculated according to wherein L*, a*, and b* are CIE values of the biocidal composition after preparing and then storing the biocidal composition at ambient temperature and ambient relative humidity for 90 days or at least 90 days (or any other time period disclosed herein), and L’
  • a twenty-fifth aspect relates to the biocidal additive formulation of aspect 24, or any preceding aspect, further comprising an organic solvent, a first polyurethane precursor, a first epoxy resin precursor, or any combination thereof.
  • a twenty-sixth aspect relates to the biocidal additive formulation of aspect 24 or 25, or any preceding aspect, wherein the copper(I) salt is a copper(I) halide, iodo(triethyl phosphite)copper(I), or a tetrakis(acetonitrile)copper(I) salt.
  • the copper(I) salt is a copper(I) halide, iodo(triethyl phosphite)copper(I), or a tetrakis(acetonitrile)copper(I) salt.
  • a twenty-seventh aspect relates to the biocidal additive formulation of aspects 24 to 26, or any preceding aspect, wherein the copper(I) salt is copper(I) bromide or copper(I) iodide.
  • a twenty-eighth aspect relates to the biocidal additive formulation of aspects 24 to 27, or any preceding aspect, wherein the copper-assisting additive comprises a phosphite, a phosphine, or a combination thereof.
  • a twenty-ninth aspect relates to the biocidal additive formulation of aspect 28, or any preceding aspect, wherein the phosphite is a compound of formula (I): wherein each R 1 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally fluorosubstituted.
  • a thirtieth aspect relates to the biocidal additive formulation of aspect 28, or any preceding aspect, wherein the phosphine is a compound of formula (II): wherein each R 2 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally substituted with a hydroxy group.
  • a thirty-first aspect relates to the biocidal additive formulation of aspect 29, or any preceding aspect, wherein each R 1 is independently selected from C2-C13 alkyl (or Ci-Cs alkyl, or Ci-Ce alkyl, or C2-C5 alkyl, or C2-C4 alkyl).
  • a thirty-second aspect relates to the biocidal additive formulation of aspect 30, or any preceding aspect, wherein each R 2 is independently selected from C2-C13 alkyl (or Ci-Cs alkyl, or Ci-Ce alkyl, or C2-C5 alkyl, or C2-C4 alkyl).
  • a thirty-third aspect relates to the biocidal additive formulation of aspects 24 to 32, or any preceding aspect, wherein the copper-assisting additive is triethyl phosphite, tributyl phosphine, triphenyl phosphite, or any combination thereof.
  • a thirty-fourth aspect relates to the biocidal additive formulation of aspects 24 to 33, or any preceding aspect, wherein a molar ratio of the copper-assisting additive to the copper(I) salt is at least 0.5: 1.
  • a thirty-fifth aspect relates to the biocidal additive formulation of aspects 24 to 34, or any preceding aspect, further comprising a compound of formula (III), (IV), (V), or any combination thereof: wherein each R 3 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci- C4)alkyl, provided that all R 3 are not simultaneously hydrogen; wherein each R 4 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R 4 are not simultaneously hydrogen; and wherein each R 5 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R 5 are not simultaneously hydrogen.
  • a thirty-sixth aspect relates to the biocidal additive formulation of aspect 35, or any preceding aspect, wherein each R 3 is independently selected from C1-C13 alkyl (or Ci-Cs alkyl, or Ci-Ce alkyl, or C2-C5 alkyl, or C2-C4 alkyl).
  • a thirty-seventh aspect relates to the biocidal additive formulation of aspects 24 to 34, or any preceding aspect, further comprising 2-ethylhexyl phosphate.
  • a thirty-eighth aspect relates to the biocidal additive formulation of aspect 35, or any preceding aspect, wherein each R 4 is independently selected from C1-C13 alkyl (or Ci-Cs alkyl, or Ci-Ce alkyl, or C2-C5 alkyl, or C2-C4 alkyl).
  • a thirty-ninth aspect relates to the biocidal additive formulation of aspects 24 to 34, or any preceding aspect, further comprising tributyl borate.
  • a fortieth aspect relates to the biocidal additive formulation of aspect 35, or any preceding aspect, wherein each R 5 is independently selected from C1-C13 alkyl (or Ci-Cs alkyl, or Ci-Ce alkyl, or C2-C5 alkyl, or C2-C4 alkyl).
  • a forty-first aspect relates to the biocidal additive formulation of aspects 24 to 34, or any preceding aspect, further comprising tributyl citrate.
  • a forty-second aspect relates to the biocidal additive formulation of aspects 24 to 41, or any preceding aspect, wherein the biocidal composition or the film thereof exhibits a transmittance of at least 98% as measured at each wavelength from 400 to 700 nanometers when measured at a thickness of 40 pm.
  • a forty-third aspect relates to the biocidal additive formulation of aspect 42, or any preceding aspect, wherein the transmittance is within 10 percentage points of a second transmittance of an otherwise identical composition or film thereof without either the copper(I) salt or the copper-assisting additive when measured at a thickness of 40 pm.
  • a forty-fourth aspect relates to the biocidal additive formulation of aspects 24 to 43, or any preceding aspect, further comprising an antioxidant package.
  • a forty-fifth aspect relates to the biocidal additive formulation of aspects 24 to 43, or any preceding aspect, further comprising a reducing agent.
  • a forty-sixth aspect relates to the biocidal additive formulation of aspects 24 to 45, or any preceding aspect, wherein the formulation is in a sealed container comprising an inert atmosphere.
  • a forty-seventh aspect relates to a combination of any two or more preceding aspects, or any portion(s) thereof.
  • the compositions and methods described above may be better understood in connection with the following Examples, which are non-limiting examples provided as an illustration of the concepts disclosed herein. The illustrated methods are applicable to other examples of biocidal compositions of the present disclosure. The procedures described as general methods describe what is believed will be typically effective to prepare the compositions indicated. However, the person skilled in the art will appreciate that it may be necessary to vary the procedures for nay given example of the present disclosure, for example, vary the order or steps and/or the chemical reagents used.
  • the complexes with copper(I) salts may be compared to mixtures including copper-containing material including a plurality of copper-containing glass or glass-ceramic particles.
  • copper-containing glass is meant to include “copper-containing glass-ceramic” unless clearly contradicted by context.
  • the “ceramic” portion of the copper-containing glass-ceramic may include, in some aspects, cuprite crystals.
  • the copper-containing material may include copper-containing glass or copper-containing glass-ceramic particles.
  • the copper-containing glass or glassceramic particles may be a biocidal inorganic glass or glass-ceramic powder including copper particles.
  • the individual particles of the copper-containing glass particles may be effective as a biocidal agent, such copper-containing glass may have potential drawbacks related to color of the resulting composition and stability of copper(I).
  • the copper-containing glass or glass-ceramic particles may independently include a Cu metal, Cu 1+ , Cu 2+ , or a combination of Cu 1+ and Cu 2+ .
  • the combined total of the Cu species may be 10 weight % or more of the copper-containing material. However, as will be discussed in more detail below, the amount of Cu 2+ may be minimized or reduced such that the copper- containing glass or glass-ceramic particles may be substantially free of Cu 2+ .
  • the copper may be non-complexed or may have a ligand bonded thereto to form a complex.
  • the Cu 1+ ions may be present on or in the surface and/or the bulk of the copper-containing glass or glass-ceramic particles.
  • the copper-containing glass or glass-ceramic particles may include copper- containing glass or glass-ceramic, copper metal, copper(I) oxide, copper(II) oxide, or a combination thereof.
  • the copper-containing glass or glass-ceramic particles may include only one of copper-containing glass or glass-ceramic, copper metal, copper(I) oxide, or copper(II) oxide.
  • the Cu 1+ ions may be present in a glass or glass-ceramic network and/or a glass or glass-ceramic matrix of the copper-containing glass or glass-ceramic particles.
  • the Cu 1+ ions are present in the glass or glass-ceramic network, the Cu 1+ ions and atomically bonded to the atoms in the glass or glass-ceramic mixture.
  • the Cu 1+ ions may be present in the form of Cu 1+ crystals that are dispersed in the glass or glass-ceramic matrix.
  • the Cu 1+ crystals may include cuprite (CU2O).
  • the material may be referred to as a glass-ceramic or ceramic, which is intended to refer to a specific type of glass or glass-ceramic with crystals that may or may not be subjected to a traditional ceramming process by which one or more crystalline phases are introduced and/or generated in the glass or glass-ceramic.
  • the material may be referred to as a copper-containing glass.
  • both Cu 1+ crystals and Cu 1+ ions not associated with a crystal may be present in the copper-containing glasses or glass-ceramics described herein.
  • Copper-containing glasses or glass-ceramics may include a copper-containing oxide in an amount, in mole percent, in the range from 10 to 50, from 10 to 49, from 10 to 48, from 10 to 47, from 10 to 46, from 10 to 45, from 10 to 44, from 10 to 43, from 10 to 42, from 10 to 41, from 10 to 40, from 10 to 39, from 10 to 38, from 10 to 37, from 10 to 36, from 10 to 35, from 10 to 50, from 10 to 49, from 10 to 48, from 10 to 47, from 10 to 46, from 10 to 45, from 10 to 44, from 10 to 43, from 10 to 42, from 10 to 41, from 10 to 40, from 10 to 39, from 10 to 38, from 10 to 37, from 10 to 36, from 10 to 35, from
  • 10 to 34 from 10 to 33, from 10 to 32, from 10 to 31, from 10 to 30, from 10 to 29, from 10 to
  • the copper-containing oxide may be present in the copper-containing glasses or glass-ceramics in an amount of 20 mole percent, 25 mole percent, 30 mole percent, or 35 mole percent.
  • the copper-containing oxide may include CuO, CU2O, and/or combinations thereof.
  • the copper-containing glass or glass-ceramic particles may include cuprous oxide in an amount from 29.0 to 36.0 weight percent of the copper- containing glass or glass-ceramic particles.
  • the copper-containing oxides in the copper- containing glasses or glass-ceramics form the Cu 1+ ions present in the resulting glass or glass- ceramic.
  • Copper may be present in a glass or glass-ceramic, or compositions thereof, in various forms, including Cu°, Cu 1+ , and Cu 2+ .
  • the copper-containing glass or glass-ceramic portion of the individual particles of the copper-containing glass or glass-ceramic particles may be formed from a glass composition that may include, but is not limited to, in mole percent, SiCh in the range from 30 to 70, AI2O3 in the range from 0 to 20, a copper-containing oxide in the range from 10 to 50, CaO in the range from 0 to 15, MgO in the range from 0 to 15, P2O5 in the range from 0 to 25, B2O3 in the range from 0 to 25, K2O in the range from 0 to 20, ZnO in the range from 0 to 5, Na2O in the range from 0 to 20, and/or Fe2O3 in the range from 0 to 5, nanoparticles thereof, and/or a mixture thereof.
  • the amount of the copper-containing oxide is greater than the amount of AI2O3.
  • the glass composition may include a content of R2O, where R may include K, Na, Li, Rb, Cs, and
  • the glass composition may include one or more divalent cation oxides, such as alkaline earth oxides and/or ZnO.
  • the glass composition may include NiO, TiO2, Fe2O3, Cr2O3, or CO3O4 in an amount in the range up to 10 mol %, or from 0.01 mol % to 10 mol %, from 1 mol % to 10 mol %, from 2 mol % to 10 mol %, from 5 mol % to 10 mol %, from 0.01 mol % to 0.8 mol %, or from 0.01 mol % to 5 mol %.
  • the copper-containing glasses or glass-ceramics formed from the glass compositions may include a plurality of Cu 1+ ions. In certain examples, such Cu 1+ ions form part of the glass network. In certain examples, the Cu 1+ ions that are dispersed in the glass matrix are Cu 1+ crystals. The Cu 1+ may be present in the form of cuprite. The cuprite present in the copper- containing glass-ceramic may form a phase distinct from the glass matrix or glass phase. In other examples, the cuprite may form part of or may be associated with one or more glass phases.
  • the copper-containing glass may be produced by any suitable method.
  • the copper-containing glass may be performed using melting tanks that are typically used for melting glass compositions such as soda lime silicate.
  • the copper- containing glass may be formed into a sheet using forming processes known in the art. Forming methods may include float glass processes and down-draw processes such as fusion draw and slot draw. After formation, the copper-containing glass may be formed into sheets and may be shaped, polished, or otherwise processed for a desired end use.
  • the copper- containing glass may be ground to a powder or particulate form. In certain examples, the particulate copper-containing glass may be combined with other materials or carriers.
  • the EPA Test was used to test for antimicrobial efficacy for all examples herein.
  • a commercially available two-part polyurethane (Eastwood® 4: 1 High Solids Urethane Premium Show Clear) was added per the manufacturer’s instructions, using a 4: 1 weight: weight ratio of Part A and Part B.
  • Part A and Part B were mixed together first, and allowed to sit for 45 minutes before addition of copper source and copper-assisting additive.
  • the copper(I) salt and copper-containing glass were prepared first, during which the copper source was dissolved or dispersed in acetonitrile (“ACN”) (with EHP, if used), allowed to rest for 1 hour before addition of triethyl phosphite (“TEP”), and the mixture was added to the polyurethane mixture.
  • ACN acetonitrile
  • TEP triethyl phosphite
  • the resulting material was mixed thoroughly and a film was cast on a sheet of PVC and allowed to cure for 24 hours. Antimicrobial testing was performed on 1” x 1” cutouts of the resulting film.
  • the procedure for two-part polyurethanes and two-part epoxies was as follows: solvent and copper-assisting additive were mixed together into a homogeneous solution and added to copper species. The copper species and additive solution were mixed until the copper species was completely dissolved or a homogeneous liquid phase was formed. Additional additives were added to the mixture if necessary to achieve homogeneity. Prior to the addition of the copper species and additive solution to the two-part polyurethane, the polyurethane precursors were mixed according to the manufacturer’s specified ratio, and the polyurethane mixture was allowed to rest with exposure to air and occasional stirring to allow the polyurethane mixture to begin reacting.
  • the copper species and additive mixture was added to the polyurethane mixture, after filtering solids if necessary, and the entire mixture was stirred until homogeneous.
  • the mixture was applied to a substrate using conventional coating techniques, including spraying, spinning, dipping, and film applicating.
  • film applicating the dosed 2-part polyurethane solution was applied in front of the film applicator using a syringe and the film is drawn down over the substrate with a target wet film thickness between 2 and 10 mil. The film was then allowed to cure in either ambient conditions or elevated temperature according to product specifications. Additional coats may be applied as necessary.
  • An additional copper-assisting additive was used in combination with EHP in an attempt to keep the copper that is extracted by EHP from being oxidized.
  • TEP copper-assisting additive
  • the copper- containing glass achieved antimicrobial efficacy of at least 3 log kill.
  • Antimicrobial efficacy was lower using copper(I) salt as the copper source, a log kill of about 1-2.
  • the same additives in the same stoichiometry, with the same order of addition, were used for both the CCG samples and the copper(I) salt samples.
  • 5% CCG refers to 5 weight % CCG in solution
  • 0.45% Cu(ACN)4 refers to 0.45 weight % copper in solution (5% CCG equates to approximately 0.45 % available copper).
  • the following example illustrates experiments to determine the antimicrobial efficacy of copper(I)-additives complexes in epoxy resin prepared according to the procedure of Example 1 in which iodo(triethyl phosphite)copper(I) was the copper(I) salt.
  • the use of the iodo(triethyl phosphite)copper(I) complex did not yield full kill in epoxy resin, and did not change the antimicrobial efficacy above the base epoxy resin, as illustrated in FIGs. 5 and 6.
  • TEP tetrakis(acetonitrile)copper(I) (3 : 1 molar ratio) or to copper(I) iodide (3:1 molar ratio) illustrates that for epoxy resin, more TEP is required for antimicrobial efficacy as compared to polyurethanes.
  • the addition of more TEP did result in higher antimicrobial efficacy with higher amounts of TEP. While TEP may be a strong copper-assisting additive, there are more amine groups in an epoxy resin relative to binding groups in TEP.
  • An iodo- or bromo(triethyl phosphite)copper(I) complex may be generated in situ without the need for synthesizing the complex first.
  • acetonitrile it was possible to fully dissolve the copper(I) bromide, by addition of three molar equivalents of EHP in addition to 1 equivalent of TEP, resulting in antimicrobial efficacy (full kill) in the amounts according to Table 7 below, as illustrated in FIG. 7. Without addition of TEP, the copper(I) bromide was not solubilized in solution, resulting in no antimicrobial efficacy.
  • the solution of the copper(I) salt and the copper-assisting additive was pre-filtered prior to the addition to the two-part polyurethane, as particulates in the coating would have resulted in a bumpy coating. Incorporation of undissolved copper(I) salts may eventually result in antimicrobial efficacy.
  • SPDB iodine
  • I2 iodine
  • TEP, I2, and SPDB are molar equivalents relative to amount of copper in solution.
  • EHP may be substituted for another solubilizer such as tributyl citrate (“TBC”) or tributyl borate (“TBB”) in the amounts according to Table 9 below, which have both been shown to yield higher antimicrobial efficacy (tributyl citrate full kill, tributyl borate >4 log kill), as illustrated in FIG. 9.
  • TBC tributyl citrate
  • TB tributyl borate
  • TBC, and TBB are molar equivalents relative to amount of copper in solution.
  • TBP Tributyl phosphine

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

A biocidal composition including a carrier, including a polyurethane, a polyurethane precursor, an epoxy resin, an epoxy resin precursor, a melamine resin, or any combination thereof; a copper(I) salt; and a copper-assisting additive different from the carrier including a phosphite, a phosphine, or a combination thereof; and wherein the biocidal composition or a film thereof exhibits an antimicrobial efficacy of at least 3 log kill after storage of the biocidal composition or the film thereof at ambient temperature and ambient relative humidity for 90 days is provided. A biocidal additive formulation including a copper(I) salt and a copper-assisting additive, wherein a biocidal composition including the biocidal additive formulation and a carrier, or a film of the biocidal composition, exhibits an antimicrobial efficacy of at least 3 log kill as measured with an EPA Test, is further provided.

Description

COPPER-BASED ANTIMICROBIAL CLEAR AND COLORLESS REACTIVE COATINGS INCLUDING COPPER(I) AND ADDITIVES
CROSS-REFRENCE TO RELATED APPLICATIONS
[0001] This application claims priority to U.S. Provisional Patent Application No. 63/527,973, filed on July 20, 2023, which is incorporated herein by reference in its entirety for all purposes.
TECHNICAL FIELD
[0002] The present disclosure relates to biocidal compositions. More particularly, the disclosure relates to biocidal compositions comprising polyurethanes and/or epoxy resins, or precursors thereof, copper(I) salts, and copper-assisting additives.
BACKGROUND
[0003] Compositions may exist as articles, layers, or coatings, or as liquid compositions including suspensions and solutions, which may be applied on a surface or stored in a container (for example, prior to use). Copper-containing compositions initially having antimicrobial efficacy and/or color stability may experience reduced antimicrobial efficacy and/or color drift over time, which may render the compositions visually unattractive or unsuitable for a particular purpose. For example, although copper(I) ions and complexes may be colorless and have effective antimicrobial properties, over time copper(I) may be oxidized to copper(II), which has a green or blue/green color and has less effective antimicrobial properties. Such changes are typically undesired. Additionally, in certain compositions, the availability of copper at a surface (for example, the surface of an article) may be a challenge. Reactive systems dependent upon cross-linking and curing of reactive precursors, such as polyurethanes and epoxy resins, involve the added challenge of ensuring that copper ligands do not interfere with the curing process so as to retain high durability performance of a highly crosslinked coating material.
[0004] Thus, there is a need for copper-containing compositions including polyurethanes and/or epoxy resins, or precursors thereof, having improved availability of copper, such as copper(I).
SUMMARY
[0005] In an example, the present disclosure provides a biocidal composition, including: a carrier, including a polyurethane, a polyurethane precursor, an epoxy resin, an epoxy resin precursor, a melamine resin, or any combination thereof; a copper(I) salt; and copper-assisting additive from the carrier. The copper-assisting additive includes a phosphite, a phosphine, or a combination thereof. The biocidal composition or a film thereof exhibits an antimicrobial efficacy of at least 3 log kill as measured with an EPA Test after storage of the biocidal composition or the film thereof at ambient temperature and ambient relative humidity for 90 days or at least 90 days (or any other time period disclosed herein).
[0006] In certain examples, the phosphite may be a compound of formula (I):
Figure imgf000004_0001
wherein each R1 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally fluorosubstituted. In certain examples, the phosphine may be a compound of formula (II):
Figure imgf000004_0002
wherein each R2 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally substituted with a hydroxy group. In certain examples, the carrier may include a polyurethane, a polyurethane precursor, or a combination thereof. In certain examples, the carrier may include an epoxy resin, an epoxy resin precursor, or a combination thereof. In certain examples, the carrier may include an organic solvent. In certain examples, the copper(I) salt may be a copper(I) halide, iodo(triethyl phosphite)copper(I), or a tetrakis(acetonitrile)copper(I) salt. In certain examples, the copper(I) salt may be copper(I) bromide or copper(I) iodide. In certain examples, each R1 may be independently selected from C2-C13 alkyl and phenyl. In certain examples, each R3 may be independently selected from C2- C13 alkyl. In certain examples, the copper-assisting additive may be triethyl phosphite, tributyl phosphine, triphenyl phosphite, or any combination thereof. In certain examples, a molar ratio of the copper-assisting additive to the copper(I) salt may be at least 0.5: 1. In certain examples, the biocidal composition may further include a compound of formula (III), (IV), (V), or any combination thereof:
Figure imgf000004_0003
R4O.B„OR4
(IV);
OR4
Figure imgf000005_0001
wherein each R3 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci- C4)alkyl, provided that all R3 are not simultaneously hydrogen; wherein each R4 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R4 are not simultaneously hydrogen; wherein each R5 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R5 are not simultaneously hydrogen. In certain examples, each R3 may be independently selected from C1-C13 alkyl. In certain examples, the biocidal composition may further include 2-ethylhexyl phosphate. In certain examples, each R4 may be independently selected from C1-C13 alkyl. In certain examples, the biocidal composition may further include tributyl borate. In certain examples, each R5 may be independently selected from C1-C13 alkyl. In certain examples, the biocidal composition may further include tributyl citrate. In certain examples, the biocidal composition may exhibit a AE of less than 6, as calculated according to
Figure imgf000005_0002
wherein L*, a*, and b* are CIE values of the biocidal composition after preparing and then storing the biocidal composition at ambient temperature and ambient relative humidity for 90 days or at least 90 days (or any other time period disclosed herein), and L’ control, 3- control, and b*COntroi are CIE values of an otherwise identical composition without either the copper(I) salt or the copper-assisting additive. In certain examples, the biocidal composition or the film thereof may exhibit a transmittance of at least 98% as measured at each wavelength from 400 to 700 nanometers when measured at a thickness of 40 pm. In certain examples, the transmittance may be within 10 percentage points of a second transmittance of an otherwise identical composition or film thereof without either the copper(I) salt or the copper-assisting additive when measured at a thickness of 40 pm. In certain examples, a method of preparing the biocidal composition may include adding a biocidal additive formulation to a carrier; wherein when the carrier is a polyurethane or an epoxy resin, the biocidal additive formulation includes the copper(I) salt and the copper-assisting additive; wherein when the carrier is a second polyurethane precursor, the biocidal additive formulation includes a first polyurethane precursor, the copper(I) salt, and the copper-assisting additive; and wherein when the carrier is a second epoxy resin precursor, the biocidal additive formulation includes a first epoxy resin precursor, the copper(I) salt, and the copper-assisting additive. [0007] In another example, the present disclosure provides a biocidal additive formulation, including: a copper(I) salt; and a copper-assisting additive. A biocidal composition including the biocidal additive formulation and a carrier, or a film of the biocidal composition, exhibits an antimicrobial efficacy of at least 3 log kill as measured with an EPA Test after storage of the biocidal composition or the film thereof at ambient temperature and ambient relative humidity for 90 days or at least 90 days (or any other time period disclosed herein). The carrier includes a polyurethane, a polyurethane precursor, an epoxy resin, an epoxy resin precursor, a melamine resin, or any combination thereof. The biocidal composition exhibits a AE of less than 6, as calculated according to
Figure imgf000006_0001
L*, a*, and b* are CIE values of the biocidal composition after preparing and then storing the biocidal composition at ambient temperature and ambient relative humidity for 90 days or at least 90 days (or any other time period disclosed herein), and L’ control, 3- control, and b” control are CIE values of an otherwise identical composition without either the copper(I) salt or the copper-assisting additive.
[0008] In certain examples, the biocidal additive formulation may further include an organic solvent, a first polyurethane precursor, a first epoxy resin precursor, or any combination thereof. In certain examples, the copper(I) salt may be a copper(I) halide, iodo(triethyl phosphite)copper(I), or a tetrakis(acetonitrile)copper(I) salt. In certain examples, the copper(I) salt may be copper(I) bromide or copper(I) iodide. In certain examples, the copper-assisting additive may include a phosphite, a phosphine, or a combination thereof. In certain examples, the phosphite may be a compound of formula (I):
Figure imgf000006_0002
wherein each R1 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally fluorosubstituted. In certain examples, the phosphine may be a compound of formula (I):
Figure imgf000006_0003
wherein each R2 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally substituted with a hydroxy group. In certain examples, each R1 may be independently selected from C2-C13 alkyl and phenyl. In certain examples, each R2 may be independently selected from C2-C13 alkyl. In certain examples, the copper-assisting additive may be triethyl phosphite, tributyl phosphine, triphenyl phosphite, or any combination thereof. In certain examples, a molar ratio of the copper-assisting additive to the copper(I) salt may be at least 0.5: 1. In certain examples, the biocidal additive formulation may further include a compound of formula (III), (IV), (V), or any combination thereof:
Figure imgf000007_0001
wherein each R3 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-
C4)alkyl, provided that all R3 are not simultaneously hydrogen; wherein each R4 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R4 are not simultaneously hydrogen; wherein each R5 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R5 are not simultaneously hydrogen. In certain examples, each R3 may be independently selected from C1-C13 alkyl. In certain examples, the biocidal additive formulation may further include 2-ethylhexyl phosphate. In certain examples, each R4 may be independently selected from C1-C13 alkyl. In certain examples, the biocidal additive formulation may further include tributyl borate. In certain examples, each R5 may be independently selected from C1-C13 alkyl. In certain examples, the biocidal additive formulation may further include tributyl citrate. The biocidal composition or the film thereof may exhibit a transmittance of at least 98% as measured at each wavelength from 400 to 700 nanometers when measured at a thickness of 40 pm. In certain examples, the transmittance may be within 10 percentage points of a second transmittance of an otherwise identical composition or film thereof without either the copper(I) salt or the copper-assisting additive when measured at a thickness of 40 pm. In certain examples, the biocidal additive formulation may further include an antioxidant package. In certain examples, the biocidal additive formulation may further include a reducing agent. In certain examples, the formulation may be in a sealed container including an inert atmosphere. [0009] Further areas of applicability will become apparent from the description provided herein. It should be understood that the description and specific examples are intended for purposes of illustration only and are not intended to limit the scope of the present disclosure.
BRIEF DESCRIPTION OF THE DRAWINGS
[00010] In order that the present disclosure may be well understood, there will now be described various forms thereof, given by way of example, reference being made to the accompanying drawings. The components in the figures are not necessarily to scale. Moreover, in the figures, like-referenced numerals designate corresponding parts throughout the different views. The drawings described herein are for illustration purposes only and are not intended to limit the scope of the present disclosure in any way.
[0010] FIG. 1 illustrates a plot of antimicrobial efficacy for various examples of biocidal compositions including two-part polyurethanes as carrier and including copper sources such as tetrakis(acetonitrile)copper(I) and copper-containing glass (“CCG”), prepared according to the principles of the present disclosure;
[0011] FIG. 2 illustrates a plot of antimicrobial efficacy for examples of biocidal compositions including two-part polyurethanes as carrier, copper sources such as tetrakis(acetonitrile)copper(I) and CCG, triethyl phosphite (“TEP”) as copper-assisting additive, and also including 2-ethylhexyl phosphate (“EHP”), prepared according to the principles of the present disclosure;
[0012] FIG. 3 illustrates a plot of antimicrobial efficacy for examples of biocidal compositions including epoxy resins as carrier, copper sources such as tetrakis(acetonitrile)copper(I) and CCG, TEP as copper-assisting additive, and also including EHP, prepared according to the principles of the present disclosure;
[0013] FIG. 4 illustrates a plot of antimicrobial efficacy for examples of biocidal compositions including two-part polyurethanes as carrier, iodo(triethyl phosphite)copper(I) (“CuI(TEP)”) as copper source, TEP as copper-assisting additive, and also including EHP, prepared according to the principles of the present disclosure;
[0014] FIG. 5 illustrates a plot of antimicrobial efficacy for examples of biocidal compositions including epoxy resins as carrier, including copper(I) iodide and various molar ratios of TEP, prepared according to the principles of the present disclosure;
[0015] FIG. 6 illustrates a plot of antimicrobial efficacy for examples of biocidal compositions including epoxy resins as carrier, including iodo(tri ethyl phosphite)copper(I) and various molar ratios of potassium phosphate monobasic, prepared according to the principles of the present disclosure;
[0016] FIG. 7 illustrates a plot of antimicrobial efficacy for examples of biocidal compositions including two-part polyurethanes as carrier, copper(I) bromide as copper source, TEP as copper-assisting additive, and also including EHP, prepared according to the principles of the present disclosure;
[0017] FIG. 8 illustrates a plot of antimicrobial efficacy for examples of biocidal compositions including two-part polyurethanes as carrier, copper(I) bromide as copper source, TEP as copper-assisting additive, and varied molar excesses of EHP and ethyl acetate solvent, prepared according to the principles of the present disclosure;
[0018] FIG. 9 illustrates a plot of antimicrobial efficacy for examples of biocidal compositions including two-part polyurethanes as carrier, copper(I) bromide as copper source, TEP as copper-assisting additive, and varied molar ratios of tributyl citrate or tributyl borate, prepared according to the principles of the present disclosure; and
[0019] FIG. 10 illustrates a plot of antimicrobial efficacy for examples of biocidal compositions including two-part polyurethanes as carrier, copper(I) bromide as copper source, tributyl phosphine (“TBP”) as copper-assisting additive in varying molar ratios relative to copper, and also including EHP, prepared according to the principles of the present disclosure; and
[0020] FIG. 11 illustrates a plot of % transmittance at each wavelength from 350 nanometers to 750 nanometers, of a polyurethane film of a biocidal composition including copper(I) salt and a copper-assisting additive (“dosed”) as compared to a polyurethane film on glass that is not dosed (“undosed”) and further compared to the glass without any coating applied (“control”).
[0021] The drawings described herein are for illustration purposes only and are not intended to limit the scope of the present disclosure in any way.
DETAILED DESCRIPTION
[0022] The following description is merely exemplary in nature and is not intended to limit the present disclosure, application, or uses.
[0023] In describing elements of the present disclosure, the terms “1st,” “2nd,” “first,” “second,” “A,” “B,” “(a),” “(b),” and the like may be used herein. These terms are only used to distinguish one element from another element, but do not limit the corresponding elements irrespective of the nature or order of the corresponding elements.
[0024] Numerical values, including endpoints of ranges, may be expressed herein as approximations preceded by the term “about,” “approximately,” or the like. In such cases, other examples include the particular numerical values. Regardless of whether a numerical value is expressed as an approximation, two examples are included in this disclosure: one expressed as an approximation, and another not expressed as an approximation. It will be further understood that an endpoint of each range is significant both in relation to another endpoint, and independently of another endpoint.
[0025] As used herein, the term “antimicrobial” refers to a composition, a material, or a surface of a material, including when such composition or material is in the form of a coating or dry film, that will kill or inhibit the growth of microbes including, but not limited to, bacteria, viruses, mildew, mold, algae, fungi, or any combination thereof. The term “antimicrobial,” as used herein, does not necessarily mean the material or the surface of the material will kill or inhibit the growth of all species of microbes within such families, but that the material or the surface of the material will kill or inhibit the growth of one or more species of microbes from such families.
[0026] As used herein, the term “full kill” refers to a log reduction of a given microbe and/or virus that is comparable to the log reduction of the same microbe and/or virus on a copper metal surface.
[0027] As used herein, the term “dry film” refers to a coating that has been applied to a surface and allowed to actively or passively dry, such that the coating has a moisture content that has reached equilibrium with the ambient environment. In some aspects, a moisture content may be used to describe a dry film, such as a moisture content of less than 20 wt.%, for example, less than 15 wt.%, less than 10 wt.%, less than 5 wt.%, less than 4 wt.%, less than 3 wt.%, less than 2 wt.%, less than 1 wt.%, less than 0.5 wt.%, or less than 0.1 wt.%; alternatively, or additionally, a moisture content of greater than 0 wt.%, greater than 0.1 wt.%, greater than 0.5 wt.%, greater than 1 wt.%, greater than 2 wt.%, greater than 3 wt.%, greater than 4 wt.%, greater than 5 wt.%, greater than 10 wt.%, or greater than 15 wt.%; or a range formed from any two of the foregoing weight percentages; including any subranges therebetween.
[0028] As used herein, the term “biocidal” refers to a composition or material with an active substance that is intended to destroy, deter, render harmless, prevent the action of, or otherwise exert a controlling effect on undesired organisms such as bacteria, viruses, mildew, mold, algae, and/or fungi, and in some aspects a biocidal composition has antimicrobial properties.
[0029] As used herein, the term “logarithmic reduction” refers to the negative value of log (Ca/Co), where Ca refers to the colony form unit (“CFU”) number of the antimicrobial surface and Co refers to the CFU of the control surface that is not an antimicrobial surface. As an example, a 3 logarithmic reduction equals 99.9% of the microbes killed and a logarithmic reduction of 5 equals 99.999% of microbes killed. The logarithmic reduction value may be measured according to one or more of the ASTM D2574-16 (2016) “Standard Test Method for Resistance of Emulsion Paints in the Container to Attack by Microorganisms,” the Modified JIS Z 2801 Test for Bacteria, the Modified JIS Z 2801 Test for Viruses, or the EPA Test, as described in more detail elsewhere herein. “Logarithmic reduction” may also be referred to herein as “log kill.” Unless otherwise specified, all logarithmic reduction information disclosed herein employs the EPA Test.
[0030] The uses of the terms “a” and “an” and “the” and similar referents in the context of describing the present disclosure (especially in the context of the following claims) are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. Recitation of ranges of values herein are merely indicated to serve as a shorthand method of referring individually to each separate value falling within the range, unless otherwise indicated herein, and each separate value is incorporated into the specification as if it were individually recited herein. All methods described herein may be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context.
[0031] As used herein, the terms “comprise(s),” “include(s),” “having,” “has,” “can,” “contain(s),” and variants thereof, are intended to be open-ended transitional phrases, terms, or words that do not preclude the possibility of additional acts, structures, elements, or components. The present description also contemplates other examples “comprising,” “consisting of,” and “consisting essentially of,” the examples or elements presented herein, whether explicitly set forth or not.
[0032] As used herein, the term “about,” when used in the context of a numerical value or range set forth refers to a variation of ±15%, or less, of the numerical value. For example, a value differing by ±15%, ±14%, ±10%, or ±5%, among others, would satisfy the definition of “about,” unless more narrowly defined in particular instances. [0033] The term “alkyl,” by itself or as part of another substituent, refers, unless otherwise stated, to a straight, branched, or cyclic chain hydrocarbon (“cycloalkyl”) having the number of carbon atoms designated (in other words, “C1-C30” means one to thirty carbons). Examples include methyl, ethyl, propyl, isopropyl, cyclopropyl, butyl, isobutyl, ec-butyl, tert-butyl, cyclobutyl, methylcyclopropyl, cyclopropylmethyl, pentyl, neopentyl, hexyl, and cyclohexyl. Other examples are -(Ci-Cis)alkyl, -(Ci-Cis)alkyl, -(Ci-Cio)alkyl, -(Ci-Cs)alkyl, -(Ci- Ce)alkyl, and -(C2-Ce)alkyl. Such alkyl groups and depicted ranges of carbon counts may apply to any formula, R group, or chemical species disclosed herein. In certain examples of the present disclosure, a -(Ci-C3o)alkyl group, whether straight, branched, or cyclic, may not be a -Cialkyl group, and/or may not be a -C2alkyl group, and/or may not be a -Cnalkyl group, and/or may not be a -C4alkyl group, and/or may not be a -Csalkyl group, and/or may not be a -Cealkyl group, and/or may not be a -C?alkyl group, and/or may not be a -Csalkyl group, and/or may not be a -Chalky 1 group, and/or may not be a -Cioalkyl group, and/or may not be a -Cnalkyl group, and/or may not be a -Cnalkyl group, and/or may not be a -Cnalkyl group, and/or may not be a -Cnalkyl group, and/or may not be a -Cisalkyl group, and/or may not be a -Ciealkyl group, and/or may not be a -Cnalkyl group, and/or may not be a -Cisalkyl group, and/or may not be a -Cnalkyl group, and/or may not be a -C2oalkyl group, and/or may not be a -C2ialkyl group, and/or may not be a -C22alkyl group, and/or may not be a -C23alkyl group, and/or may not be a -C24alkyl group, and/or may not be a -C25 alkyl group, and/or may not be a -C26alkyl group, and/or may not be a -C2?alkyl group, and/or may not be a -C2salkyl group, and/or may not be a -C29alkyl group, and/or may not be a - Csoalkyl group. In certain examples of the present disclosure, at least one hydrogen of the alkyl group is replaced with a hydroxy group, represented by -OH.
[0034] The term “aromatic” generally refers to a carbocycle or heterocycle having one or more polyunsaturated rings having aromatic character (in other words, having (4n+2) delocalized 71 (pi) electrons where n is an integer).
[0035] The term “aryl,” by itself or in combination with another substituent, refers, unless otherwise stated, to a carbocyclic aromatic system containing one or more rings (typically one, two, or three rings) wherein such rings may be attached together in a pendant manner, such as a biphenyl, or may be fused, such as naphthalene. Examples may include phenyl, anthracyl, and naphthyl. Preferred are phenyl and naphthyl, most preferred is phenyl. [0036] The term “aryl(Ci-C4)alkyl” refers to a functional group wherein a one to four carbon alkylene chain is attached to an aryl group, for example, -CEh-CEh-phenyl. Examples may include benzyl.
[0037] The term “fluorosubstituted” refers to an organic chemical compound or moiety either (1) contains both carbon-hydrogen bonds and carbon-fluorine bonds; or (2) is “perfluorinated,” in which case carbon is bonded to fluorine atoms and no hydrogen atoms.
[0038] As used herein, unless otherwise specified, the term “carrier” may refer to a melamine resin, a polyurethane, a precursor thereof, an epoxy resin, a precursor thereof, or a combination thereof, as described herein.
[0039] As used herein, the term “polyurethane” refers to a class of polymers, such as alternating copolymers, including organic units joined by carbamate (urethane) links.
Figure imgf000013_0001
po yure ane n linkage polyurethane
Polyurethanes may have a highly crosslinked molecular structure. Examples of polyurethanes may be produced by reacting together two separate polyurethane precursors, optionally in the presence of a catalyst or upon exposure to ultraviolet light. In certain examples, a polyurethane precursor may include a diisocyanate species. Examples of diisocyanates may include toluene-
2,4-diisocyanate, toluene-2,6-diisocyanate, and 4,4 ’-diphenylmethane diisocyanate:
Figure imgf000013_0002
toluene-2,4-diisocyanate;
Figure imgf000013_0003
toluene-2,6-diisocyanate; and
Figure imgf000013_0004
4,4'-diphenylmethane diisocyanate. In other examples, a polyurethane precursor may include a polyol species. Polyol species may be compatible with examples of copper(I) salts and examples of copper-assisting additives of the present disclosure. Examples of bifunctional polyols may include ethylene glycol, diethylene glycol, triethylene glycol, tetraethylene glycol, 1,3 -propanediol, 1,4-butanediol, and 1,6-butanediol:
Figure imgf000014_0001
ethylene glycol;
Figure imgf000014_0002
triethylene glycol;
Figure imgf000014_0003
1,4-propanediol; and
Figure imgf000014_0004
1,6-propanediol.
Examples of commercially available polyurethanes may include Eastwood® 4: 1 High Solids Urethane Premium Show Clear.
[0040] As used herein, the term “epoxy resin” refers to a class of copolymers also known as “polyepoxides.” Examples of commercially available epoxy resins may include WiseBond® Bar & Table Top 1 : 1 Ratio. Examples of epoxy resins may be produced by reacting together two separate epoxy resin precursors. In certain examples, an epoxy resin precursor may include an epoxide functional group. Examples of epoxy resin precursors that include an epoxide functional group may include bisphenol A diglycidyl ether:
Figure imgf000014_0005
bisphenol A diglycidyl ether. In other examples, an epoxy resin precursor may include a polyfunctional amine, carboxylic acid, phenol, alcohol, thiol, or any combination thereof, which may react as a nucleophile with an epoxide-containing monomer to form the epoxy resin, and which may be compatible with examples of copper(I) salts and examples of copper-assisting additives of the present disclosure.
[0041] As used herein, the term “halide” refers to a negative ion (“anion”) of a halogen atom bearing a -1 formal charge. Examples of halides include fluoride (F'1), chloride (Cl-1), bromide (Br 1), and Iodide (I’1).
[0042] As used herein, the term “copper-assisting additive” refers to an additive that promotes the availability and/or persistence of copper(I) ions in a composition or material, including promoting availability of copper(I) at a surface and/or interface of a composition or material, consisting with the following explanation. Without wishing to be bound by theory, it is believed that copper(I) is largely colorless and more antimicrobially efficacious, while copper(II) is typically energetically favorable but produces color and has lower antimicrobial efficacy. As such, copper(I) is generally favored for function and color, but copper(II) is usually more stable. To promote the persistence and/or availability of copper(I) in a composition or material, several strategies/mechanisms may be considered, including employing a reducing agent (for example, to reduce copper(II) to copper(I), or to reduce other oxidants that may be present), an antioxidant (for example, to scavenge oxidants either by reduction or by sequestering by coordination or binding so as to make such oxidants unavailable to oxidize copper(II) to copper(I)), a ligand with a hydrophobic and/or bulky side chain (for example, to limit oxidant access to copper(I) in a copper complex), a ligand that favors complexation with copper(I) over copper(II) (for example, to energetically favor copper(I) to be maintained), a ligand that facilitates migration of copper(I) to a surface and/or interface, or any combination thereof. Accordingly, the copper-assisting additives disclosed herein generally are believed to perform one or more of the aforementioned functions to promote the persistence of copper(I), including in some aspects in a composition in liquid form (e.g., at ambient conditions (1 atm (-101.3 kPa) and 20 °C)), in a coating (for example, dry film), and/or in a bulk material (for example, a polyurethane, or an epoxy resin). In some aspects, the copper-assisting additive is a reducing agent, an antioxidant, a copper-coordinating ligand (for example, coordinating with copper(I) and/or copper(II)) with one or more hydrophobic side chains, a copper-coordinating ligand (for example, coordinating with copper(I) and/or copper(II)) with one or more bulky side chains, a copper-coordinating ligand (for example, coordinating with copper(I) and/or copper(II)) that complexes with copper(I) preferentially over complexing with copper(II), a copper-coordinating ligand (for example, coordinating with copper(I) and/or copper(II)) that has two or more copper coordination sites, or any combination thereof.
[0043] As used herein, the term “at.%” refers to atomic weight percent. In some aspects, “at.%” is used in reference to an amount of copper in a composition. Simply by way of example, the biocidal composition may include copper in an amount of “X at.%” (where X is a number), and this means the mass of copper atoms (using molecular weight) is summed and expressed as a percent relative to a given basis (for example, based on mass of biocidal composition). In this regard, the mass of other species in a copper complex or molecule (for example, the oxygen atom in CU2O) is exclude when determining mass of copper, but included as part of the biocidal composition. The amount of copper in terms of at.% may be determined by methods known in the art.
[0044] As used herein, “weight” and “mass” are used interchangeably.
[0045] As used herein, the naming convention for functional groups containing phosphorus are standardized herein. Generally, the naming convention of a functional group with respect to a given phosphorus atom is determined by how many oxygen atoms are double bonded to a phosphorus atom (“A”), the total number of carbon and hydrogen atoms single-bonded to the phosphorus atom (“B”), and the number of oxygen atoms single-bonded to the phosphorus atom (“C”). In this regard, the coordinate “(A,B,C)” may be employed to identify a phosphorus-containing functional group. In this regard, a “phosphate” has coordinate (1,0,3); a “phosphite” has coordinate (0,0,3); a “phosphine” has coordinate (0,3,0). Formula (I) is an example of a phosphite. Formula (II) is an example of a phosphine. Formula (III) is an example of a phosphate.
[0046] As used herein, the term “ambient temperature” refers to the temperature of the atmosphere in the immediate surrounding environment of an objection or equipment.
[0047] As used herein, the term “ambient relative humidity” refers to an amount of water vapor present in a specific volume of immediately surrounding atmosphere at ambient temperature expressed as a percentage of the amount of water vapor needed for saturation at the same temperature. In certain examples, ambient relative humidity may have a value of 42%.
[0048] As used herein, the term “percentage point” refers to a unit for an arithmetic difference between two percentages. For example, a difference between transmittance values of 88 percent and 98 percent for a particular measurement is a difference of 10 percentage points on the same measurement scale (calculated by subtracting 98 from 88; or 88 from 98). Percentages, by contrast, indicate the relative or proportionate part of a total; in the above example, 88 constitutes 90% of 98 (calculated by dividing 88 by 98 and multiplying by 100), and 98 constitutes 111% of 88 (calculated by dividing 98 by 88 and multiplying by 100).
[0049] In an example, the present disclosure provides a biocidal composition, including a carrier, a copper(I) salt, and a copper-assisting additive different from the carrier. In certain examples, a molar ratio of the copper-assisting additive to the copper(I) salt is at least 0.5: 1. In other examples, the copper-assisting additive may be combined with the copper(I) salt and added to a carrier at a sum total concentration of both components of from 1 to 300 grams per liter of biocidal composition.
[0050] In an example, the copper(I) salt may include a copper(I) halide, iodo(triethyl phosphite)copper(I), or a tetrakis(acetonitrile)copper(I) salt, or any combination thereof. In certain examples, the copper(I) halide may be copper(I) fluoride, copper(I) chloride, copper(I) bromide, copper(I) iodide, or any combination thereof. In certain examples, the tetrakis(acetonitrile)copper(I) salt may be tetrakis(acetonitrile)copper(I) hexafluorophosphate, tetrakis(acetonitrile)copper(I) tetrafluoroborate, tetrakis(acetonitrile)copper(I) perchlorate, tetrakis(acetonitrile)copper(I) trifluoromethanesulfonate, tetrakis(acetonitrile)copper(I) hydrogen oxalate-oxalic acid-acetonitrile, or any combination thereof.
[0051] In an example, the biocidal composition may include a carrier, a copper(I) salt, and a copper-assisting additive. In certain examples, the carrier may include a polyurethane, a polyurethane precursor, an epoxy resin, an epoxy resin precursor, a melamine resin, or any combination thereof. In other examples, the copper(I) salt may be combined with a copper- assisting additive and a carrier while maintaining antimicrobial efficacy (or preventing a decrease in antimicrobial efficacy to below a particular level) and/or stabilizing the color of the carrier when the copper(I) salt is combined with the copper-assisting additive and the carrier or when then copper(I) salt and the copper-assisting additive are combined with the carrier. Examples of the present disclosure may maintain antimicrobial efficacy (or prevent a decrease in antimicrobial efficacy to below a particular level) and/or reduce changes in color of the carrier at the time of combining the copper(I) salt with the copper-assisting additive and the carrier or combining the copper(I) salt and the copper-assisting additive with the carrier. Examples of the present disclosure may reduce changes in the antimicrobial efficacy and/or reduce changes in the color of the carrier between a period of time after combining the copper(I) salt with the copper-assisting additive and the carrier or combining the copper(I) salt and the copper-assisting additive with the carrier and the final antimicrobial efficacy and/or color of the carrier.
[0052] In an example, a material (for example, a coating such as a dry film) may exhibit the logarithmic reductions described herein under one or more of the U.S. Environmental Protection Agency “Test Method of Efficacy of Copper Alloy as a Sanitizer” (2009) (also referred to herein as “the EPA Test”), the Modified Japanese Industrial Standard (JIS) Z 2801 Test for Bacteria and/or the Modified JIS Z 2801 Test for Viruses, for a period of one month or greater or for a period of three months or greater, or any of the other time periods described elsewhere herein. The time periods (for example, one-month period or three-month period) may commence a tor after the application of the material to a surface as a layer. In such examples, the layer exhibits the logarithmic reductions described herein. Each of the EPA Test, the Modified Japanese Industrial Standard (JIS) Z 2801 Test for Bacteria, and the Modified JIS Z 2801 Test for Viruses are incorporated herein by reference in their entireties. [0053] In an example, antimicrobial efficacy of a composition or coating may be maintained, or at least a decrease in antimicrobial efficacy to below a particular level may be prevented, in the biocidal compositions disclosed herein, for example, by use of a copper-assisting additive. The effectiveness of a composition (for example, a coating such as a dry film) of the present disclosure as a biocidal composition may be measured as a function of the logarithmic reduction of the biocidal composition. The logarithmic reduction value of the biocidal composition may be relevant to the ability of the biocidal composition to kill a wide variety of biological organisms to which the biocidal composition is exposed, but may also allow the copper(I) salt to act as a preservative for the composition during storage (for example, in a container such as, but not limited to, a tank, a can, a bucket, a drum, a bottle, or a tube). According to examples of the present disclosure, a logarithmic reduction of the biocidal composition may be at least 2, at least 3, at least 4, at least 5, at least 6, at least 7, at least 8, at least 9, at least 10, in a range from 1 to 10, 3 to 7, 4 to 6, or less than, equal to, or greater than 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. In certain examples, the logarithmic reduction may be maintained (for example, prevented from falling below) at or above any of the aforementioned values over a given time period, as described elsewhere herein. The biocidal properties of the composition may make it effective for substantially killing a wide variety of biological organisms including bacteria, viruses, and fungi. Where the coating is configured to have biocidal properties with respect to bacteria, suitable examples of bacteria include Staphylococcus aureus, Enterobacter aerogenes, Pseudomonas aeruginosa, Methicillin Resistant Staphylococcus aureus, E. coli, and mixtures thereof. In certain examples, the copper(I) salt exhibits at least a logarithmic reduction, a 4 logarithmic reduction, a 5 logarithmic reduction, or even a 6 logarithmic reduction in the concentration of at least one of Staphylococcus aureus, Enterobacter aerogenes, Pseudomonas aeruginosa bacteria, Methicillin Resistant Staphylococcus aureus, and E coli under the EP A Test, or a 3 logarithmic reduction or greater, or a 4 logarithmic reduction or greater (for example, 5 logarithmic reduction or greater) under JIS Z 2801 (2000) testing conditions or under the Modified JIS Z 2801 Test for Bacteria. In other examples, the copper(I) salt exhibits a 2 logarithmic reduction or greater, a 3 logarithmic reduction or greater, a 4 logarithmic reduction or greater, or a 5 logarithmic reduction or greater in the concentration of Murine Novovirus or severe acute respiratory syndrome (“SARS”) coronavirus 2 (“SARS- CoV-2”) under a Modified JIS Z 2801 for Viruses test. The procedures for the Modified JIS Z 2801 (2000) Test for Bacteria, and the Modified JIS Z 2801 (2000) Test for Viruses, are provided in International Patent Application Pub. No. WO 2021/055300 Al, COLOR STABILIZATION OF BIOCIDAL COATINGS, which is incorporated by reference herein in its entirety.
[0054] Briefly, as used herein, Modified JIS Z 2801 Test for Bacteria includes evaluating the bacteria under the standard JIS Z 2801 (2000) test with modified conditions including heating the glass or article to a temperature of 23 degrees Celsius to 37 degrees Celsius at a humidity of 38 percent to 42 percent for 6 hours. The Modifed JIS Z 2801 (2000) Test for Viruses includes the following procedure. For each material tested (for example, a biocidal composition, a composition including the copper(I) salt, a composition including the copper- assisting additive, control compositions), three samples of the material (contained in individual sterile petri dishes) are each inoculated with a 20 pL aliquot of a test virus (where antimicrobial activity is measured) or a test medium including an organic soil load of 5% fetal bovine serum with or without the test virus (where cytotoxicity is measured). The inoculum is then covered with a film and the film is pressed down so the test virus and/or the test medium spreads over the film, but does not spread past the edge of the film. The exposure time begins when each sample was inoculated. The inoculated samples are transferred to a control chamber set to room temperature or “ambient” temperature (20 °C) in a relative humidity of 42% for 2 hours. Exposure time with respect to control samples are discussed below. Following the 2-hour exposure time, the film is lifted off using sterile forces and a 2.00 mL aliquot of the test virus and/or test medium is pipetted individually onto each sample of material and the underside of the film (or the side of the film exposed to the sample) used to cover each sample. The surface of each sample is individually scraped with a sterile plastic cell scraper to collect the test virus or test medium. The test virus and/or test medium is collected (at 102 dilution), mixed using a vortex type mixer and serial 10-fold dilutions are prepared. The dilutions are then assayed for antimicrobial activity and/or cytotoxicity.
[0055] To prepare a control sample for testing antimicrobial activity (which are also referred to as “zero time vims controls”) for the Modified JIS Z 2801 Test for Viruses, three control samples (contained in individual sterile petri dishes) are each inoculated with a 20 pL aliquot of the test virus. Immediately following inoculation, a 2.00 mL aliquot of test virus is pipetted onto each control sample. The surface of each sample was individually scraped with a sterile plastic cell scraper to collect test virus. The test virus is collected (at 102 dilution), mixed using a vortex type mixer, and serial 10-fold dilutions were prepared. The dilutions are assayed for antimicrobial activity.
[0056] To prepare control samples for cytotoxicity (which are also referred to as “2 hour control virus”) for the Modified JIS Z 2801 Test for Viruses, one control sample (contained in an individual sterile petri dish) is inoculated with a 20 pL aliquot of a test medium containing an organic soil load (5% fetal bovine serum), without the test virus. The inoculum is covered with a film and the film is pressed so the test medium spreads over the film but does not spread past the edge of the film. The exposure time begins when each control sample is inoculated. The control sample is transferred to a controlled chamber set to room temperature (20 °C) in a relative humidity of 42% for a duration of 2 hours exposure time. Following this exposure time, the film is lifted off using sterile forceps and a 2.00 mL aliquot of the test medium is pipetted individually onto each control sample and the underside of the film (the side exposed to the sample). The surface of each sample is individually scraped with a sterile plastic cell scraper to collect the test medium. The test medium is collected (at 102 dilution), mixed using a vortex type mixer, and serial 10-fold dilutions were prepared. The dilutions were assayed for cytotoxicity.
[0057] A representative description of performing the EPA Test is as follows. A copper(I) salt is milled to powder using a 2-inch jet mill. The jet milled powder of the copper(I) salt is then added to a carrier (for example, commercially available Eastwood® two-part urethane) and mixed. Control coupons coated with a carrier without copper(I) salt were prepared alongside coupons coated with the copper(I) salt. A 7-mil wet film thickness drawdown bar was used to form films onto Lenata Scrub Charts (P121-10N). The films were dried for 2 days at ambient lab temperature before the antimicrobial test was conducted. Dry film thickness was around 80 m. 1-Inch x 1-inch square coupons were cut from the center of the painted scrub test panels. Stainless steel carriers, used as reference, were cleaned and sterilized by immersion in a 75% ethanol solution following by rinsing with DI water. Vials containing Staphylococcus aureus (ATCC 6538) bacterial stock culture were stored at -80° C until use. 20 pL aliquots of thawed bacterial cultures were added to 10 mL of Tryptic Soy Broth. These bacterial suspensions were serially incubated 3X at 36°C for 18-24 hours in an orbital shaker, and then IX in polypropylene snap tubes for 48 hours. Cultures were subsequently mixed on a vortex mixer and allowed to settle. The upper two-thirds of suspension from each tube was aspirated and ODeoo was measured to estimate bacterial density. The culture was diluted with phosphate buffer saline to achieve a bacterial inoculum concentration near a target value of 1.0- 107 CFU/mL. 0.25 mL of 5% fetal bovine serum and 0.05 mL Triton™ X-100 were added to 4.70 mL bacterial suspension to aid in spreading the inoculum. Each test coupon was inoculated with 20 pL of the bacterial test culture. The inoculum volume was spread evenly using bent sterile pipette tips to ensure full and even coverage, spreading as close to the edge of the coupon as possible. Coupons were then incubated in a controlled environment set at 42% relative humidity and 23 °C for a period of 120 minutes. Following the 120-minute exposure period, coupons were neutralized in Letheen broth. Ten-fold serial dilutions of the neutralized solutions were plated using standard spread plate technique on Tryptic Soy Agar plates and incubated for 24 hours at 36°C to yield countable numbers of survivors (approximately 20-200 colonies per plate). Log and percentage of reductions for bactericidal efficacy tests measure differences in CFUs between stainless steel and glass containing coupons. The antimicrobial efficacy measurements in terms of logarithmic reduction were performed in duplicate and the results averaged to provide an average log kill value.
[0058] In an example, it is possible to combine the copper(I) salt with a copper-assisting additive to prevent reduction of antimicrobial efficacy below a certain threshold (for example, less than a 3 logarithmic reduction or any other value disclosed herein) and/or limit the shift of the color of the biocidal composition form the color of a standard carrier (for example, the carrier in the absence of either the copper(I) or the copper-assisting additive). For example, it is possible to achieve a CIE L*a*b* AE* between the observed color and a standard of less than 30, less than 25, less than 20, less than 15, less than 12, less than 10, less than 9, less than 8, less than 7, less than 6, less than 5, less than 4, less than 3, less than 2, less than 1, in a range of from 1 to 30, 2 to 25, 5 to 15, 3 to 8, 4 to 7, 5 to 6, less than, equal to, or greater than 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, or 30.
[0059] As understood, the CIE L*a*b* color space is a color scale for determining a color. The three coordinates (or dimensions/components) of CIE L*a*b* represent the lightness of the color (L*=0 indicates black and L*=100 indicates white), the position between red (sometimes referenced as magenta) and green (negative a* values indicate green while positive a* values indicate red), and the position between yellow and below (negative b* values indicate blue and positive b* values indicate yellow). The L* component closely matches human perception of lightness. Related to the CIE L*a*b* color space is the CIE L*C*h* color space that is a cylindrical representation of the three perceptual color correlates: lightness, chroma, and hue. The axial component of CIE L*C*h* is the same lightness attribute L* as CIE L*a*b*, the radial component is the chroma, and the angular component is hue. Using the CIE L*a*b* and CIE L*c*h* color spaces, the difference (for example, a AE*) in color between a standard and observed color may be measured, and the extent to which the desired color of a coating is altered by the components therein may be measured.
[0060] In an example, disclosed is a biocidal composition, including: a carrier; a copper(I) salt; and a copper-assisting additive. In certain examples, the carrier may include a polyurethane, a polyurethane precursor, an epoxy resin, an epoxy resin precursor, a melamine resin, or any combination thereof. In certain examples, the biocidal composition is in liquid form at ambient conditions (1 atm (-101.3 kPa) and 20 °C). In certain examples, the biocidal composition does not contain (for example, and/or the composition is not in the form of) a polyurethane, and/or does not contain a polyurethane precursor, and/or does not contain an epoxy resin, and/or does not contain an epoxy resin precursor, and/or does not contain a melamine precursor.
[0061] In certain examples, employing a copper-assisting additive allows the achievement of a desired level of antimicrobial efficacy (for example, via any test disclosed herein, such as the EP A Test).
[0062] In certain examples, the carrier and the copper-assisting additive are different. As used herein, “different” means that a given chemical species (for example, a polyurethane) cannot qualify as both the carrier and the copper-assisting additive; rather, if the carrier is, for example, a polyurethane, then the copper assisting additive cannot be a polyurethane but must instead be another chemical species (for example, triethyl phosphite). [0063] In certain examples, the biocidal composition includes a polymer, a monomer, a binder, an organic solvent, an inorganic solvent, water, a dispersion of finely divided solids in a liquid medium that may be applied to a surface to form a film, a pigment, a filler, an extender, a drier, a rheology modifier, or any combination thereof. In certain examples the biocidal composition does not contain (for example, and/or the carrier is not or does not contain) a polymer, and/or does not contain a monomer, and/or does not contain a binder, and/or does not contain an organic solvent, and/or does not contain an inorganic solvent, and/or does not contain water, and/or does not contain a dispersion of finely divided solids in a liquid medium that may be applied to a surface to form a film, and/or does not contain a pigment, and/or does not contain a filler, and/or does not contain an extender, and/or does not contain a drier, and/or does not contain a rheology modifier.
[0064] In an example, a copper-assisting additive is or includes a phosphite, a phosphine, or any combination thereof. In certain examples, the copper-assisting additive may be hydrophobic, hydrophilic, or amphiphilic, and any of the aforementioned copper-assisting additives (or any other copper-assisting additive disclosed herein) may be characterized as hydrophobic, hydrophilic, or amphiphilic. For example, the copper-assisting additive may be or may include a hydrophobic phosphite, a hydrophobic phosphine, or any combination thereof. [0065] In certain examples, the biocidal composition does not contain (for example, and/or the copper-assisting additive is not) a phosphite, and/or does not contain a phosphine, and/or does not contain a hydrophobic copper-assisting additive, and/or does not contain a hydrophilic copper-assisting additive, and/or does not contain an amphiphilic copper-assisting additive.
[0066] In an example, a copper-assisting additive is a compound of formula (I), formula (II), or any combination thereof.
[0067] In an example, a copper-assisting additive may be a compound of formula (I):
Figure imgf000023_0001
wherein each R1 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, and of which may be optionally fluorosubstituted.
[0068] In certain examples, each R1 is independently selected from C2-C13 alkyl, phenyl, and benzyl.
[0069] In certain examples, each R1 is independently selected from Ci-Cs alkyl.
[0070] In certain examples, each R1 is independently selected from C1-C5 alkyl.
[0071] In certain examples, the alpha-carbon of at least one R1 is a secondary or tertiary carbon. [0072] Certain examples of compounds of formula (I) may include particular combinations of R1 selected independently such that the compounds of formula (I) complex with, interact with, or otherwise affect copper (for example, by affecting the persistence of a given oxidation state, such as copper(I)), but not as desirably or preferably as other particular combinations of R1 due to the combined effects of chemical phenomena understood by those skilled in the art, including, but not limited to, hydrophobicity, solubility, electronic effects, and/or steric effects resulting from the chemical structure of a particular compound of formula (I). In certain examples of compounds of formula (I), each R1 independently may not be any one of C1-C20 alkyl, and/or may not be aryl, and/or may not be aryl(Ci-C4)alkyl. In certain examples, a biocidal composition does not include a compound of formula (I) and/or the copper-assisting additive is not a compound of formula (I).
[0073] Examples of compounds of formula (I) may include trimethyl phosphite, triethyl phosphite, triphenyl phosphite, tris(2,2,2-fluoroethyl) phosphite, tris(2-ethylhexyl) phosphite, triisopropyl phosphite, and tris(l,l,l,3,3,3-hexafluoro-2-propyl) phosphite. In certain examples, the biocidal composition does not include (for example, the copper-assisting additive is not) trimethyl phosphite, and/or does not include triethyl phosphite, and/or does not include tris(2,2,2-fluoroethyl) phosphite, and/or does not include tris(2-ethylhexyl) phosphite, triisopropyl phosphite, and/or does not contain tri s( 1,1, 1,3, 3,3 -hexafluoro-2-propyl) phosphite, and/or does not include triphenyl phosphite.
[0074] In certain examples, for compounds of any of formulae (I), (II), (III), (IV), or (V), Ci- C20 alkyl may include C1-C19 alkyl, Ci-Cis alkyl, C1-C17 alkyl, C1-C16 alkyl, C1-C15 alkyl, Ci- C14 alkyl, C1-C13 alkyl, C1-C12 alkyl, C1-C11 alkyl, C1-C10 alkyl, C1-C9 alkyl, Ci-C8 alkyl, Ci- C7 alkyl, Ci-C6 alkyl, C1-C5 alkyl, C1-C4 alkyl, C1-C3 alkyl, C1-C2 alkyl, C2-C20 alkyl, C2-C19 alkyl, C2-C18 alkyl, C2-C17 alkyl, C2-C16 alkyl, C2-C15 alkyl, C2-C14 alkyl, C2-C13 alkyl, C2-C12 alkyl, C2-C11 alkyl, C2-C10 alkyl, C2-C9 alkyl, C2-C8 alkyl, C2-C7 alkyl, C2-C6 alkyl, C2-C5 alkyl, C2-C4 alkyl, C2-C3 alkyl, C3-C20 alkyl, C3-C19 alkyl, C3-C18 alkyl, C3-C17 alkyl, C3-C16 alkyl, C3-C15 alkyl, C3-C14 alkyl, C3-C13 alkyl, C3-C12 alkyl, C3-C11 alkyl, C3-C10 alkyl, C3-C9 alkyl, C3-C8 alkyl, C3-C7 alkyl, C3-C6 alkyl, C3-C5 alkyl, C3-C4 alkyl, C4-C20 alkyl, C4-C19 alkyl, C4-C18 alkyl, C4-C17 alkyl, C4-Ci6 alkyl, C4-C15 alkyl, C4-C14 alkyl, C4-C13 alkyl, C4-C12 alkyl, C4-C11 alkyl, C4-C10 alkyl, C4-C9 alkyl, C4-C8 alkyl, C4-C7 alkyl, C4-C6 alkyl, C4-C5 alkyl, C5-C20 alkyl, C5-C19 alkyl, C5-C18 alkyl, C5-C17 alkyl, C5-C16 alkyl, C5-C15 alkyl, C5-C14 alkyl, C5-C13 alkyl, C5-C12 alkyl, C5-C11 alkyl, C5-C10 alkyl, C5-C9 alkyl, C5-C8 alkyl, C5-C7 alkyl, C5-C6 alkyl, C6-C2o alkyl, C6-Ci9 alkyl, C6-Ci8 alkyl, C6-Ci7 alkyl, C6-Ci6 alkyl, C6-Ci5 alkyl, C6-Ci4 alkyl, C6-Ci3 alkyl, C6-Ci2 alkyl, C6-Cn alkyl, C6-Cio alkyl, C6-C9 alkyl, C6-C8 alkyl, C6-C7 alkyl, C7-C20 alkyl, C7-C19 alkyl, C7-C18 alkyl, C7-C17 alkyl, C7-Ci6 alkyl, C7-Ci5 alkyl, C7-C14 alkyl, C7-C13 alkyl, C7-C12 alkyl, C7-Cn alkyl, C7-Cio alkyl, C7-C9 alkyl, C7-C8 alkyl, C8-C2o alkyl, C8-C19 alkyl, C8-C18 alkyl, C8-Ci7 alkyl, C8-Ci6 alkyl, C8-Ci5 alkyl, C8-Ci4 alkyl, C8-Ci3 alkyl, C8-Ci2 alkyl, C8-Cn alkyl, C8-Cio alkyl, C8-C9 alkyl, C9-C2o alkyl, C9-C19 alkyl, C9-C18 alkyl, C9-Ci7 alkyl, C9-Ci6 alkyl, C9-Ci5 alkyl, C9-C14 alkyl, C9-C13 alkyl, C9-C12 alkyl, C9-Cn alkyl, C9-Cio alkyl, Cio-C2O alkyl, C10-C19 alkyl, Cio-Ci8 alkyl, Cio-Ci7 alkyl, C10-
Ci6 alkyl, C10-C15 alkyl, C10-C14 alkyl, C10-C13 alkyl, C10-C12 alkyl, C10-C11 alkyl, C11-C20 alkyl, Cn-Ci9 alkyl, Cn-Cis alkyl, Cn-Ci7 alkyl, C11-C16 alkyl, C11-C15 alkyl, C11-C14 alkyl, C11-C13 alkyl, Cn-Ci2 alkyl, Ci2-C20 alkyl, C12-C19 alkyl, C12-C18 alkyl, Ci2-Ci7 alkyl, C12-C16 alkyl, Ci2-Ci5 alkyl, C12-C14 alkyl, C12-C13 alkyl, Ci3-C20 alkyl, C13-C19 alkyl, C13-C18 alkyl, Ci3-Ci7 alkyl, C13-C16 alkyl, C13-C15 alkyl, C13-C14 alkyl, Ci4-C20 alkyl, C14-C19 alkyl, Ci4-C18 alkyl, Ci4-C17 alkyl, C14-C16 alkyl, C14-C15 alkyl, Ci5-C20 alkyl, C15-C19 alkyl, Ci5-Ci8 alkyl, Ci5-Ci7 alkyl, C15-C16 alkyl, Ci6-C20 alkyl, C16-C19 alkyl, Ci6-Ci8 alkyl, Ci6-Ci7 alkyl, Ci7-C20 alkyl, Ci7-Ci9 alkyl, Ci7-Ci8 alkyl, Ci8-C2o alkyl, Ci8-Ci9 alkyl, and Ci9-C2o alkyl.
[0075] In certain examples of compounds of formula (I), each R1 may not be Ci alkyl, and/or may not be optionally fluorosubstituted Ci alkyl, and/or may not be C2 alkyl, and/or may not be optionally fluorosubstituted C2 alkyl, and/or may not be C3 alkyl, and/or may not be optionally fluorosubstituted C3 alkyl, and/or may not be C4 alkyl, and/or may not be optionally fluorosubstituted C4 alkyl, and/or may not be C5 alkyl, and/or may not be optionally fluorosubstituted C5 alkyl, and/or may not be Ce alkyl, and/or may not be optionally fluorosubstituted Ce alkyl, and/or may not be C7 alkyl, and/or may not be optionally fluorosubstituted C7 alkyl, and/or may not be C8 alkyl, and/or may not be optionally fluorosubstituted C8 alkyl, and/or may not be C9 alkyl, and/or may not be optionally fluorosubstituted C9 alkyl, and/or may not be C10 alkyl, and/or may not be optionally fluorosubstituted C10 alkyl, and/or may not be Cn alkyl, and/or may not be optionally fluorosubstituted Cn alkyl, and/or may not be C12 alkyl, and/or may not be optionally fluorosubstituted C12 alkyl, and/or may not be C13 alkyl, and/or may not be optionally fluorosubstituted C13 alkyl, and/or may not be Ci4 alkyl, and/or may not be optionally fluorosubstituted Ci4 alkyl, and/or may not be C15 alkyl, and/or may not be optionally fluorosubstituted C15 alkyl, and/or may not be Ci6 alkyl, and/or may not be optionally fluorosubstituted Ci6 alkyl, and/or may not be Ci7 alkyl, and/or may not be optionally fluorosubstituted Ci7 alkyl, and/or may not be Cis alkyl, and/or may not be optionally fluorosubstituted Cis alkyl, and/or may not be C19 alkyl, and/or may not be optionally fluorosubstituted C19 alkyl, and/or may not be C20 alkyl, and/or may not be optionally fluorosubstituted C20 alkyl, and/or may not be phenyl.
[0076] Without being bound by any particular theory, it is believed that the presence or maintenance of copper(I) is promoted by employing a compound of formula (I) or any salt thereof, and a biocidal composition containing a compound of formula (I) or any salt thereof exhibits one or more effects when combined with a copper(I) salt, including maintaining antimicrobial efficacy of a biocidal composition, preventing reduction of antimicrobial efficacy of a biocidal composition below a certain level (for example, less than 3 logarithmic reduction), minimizing color drift of a biocidal composition, or any combination thereof. Antimicrobial efficacy may be measured as described elsewhere herein, such as by using the EPA Test.
[0077] In an example, a copper-assisting additive may be a compound of formula (II) or any salt thereof:
Figure imgf000026_0001
wherein each R2 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally substituted with a hydroxy group.
[0078] In certain examples, each R2 is independently selected from C2-C13 alkyl, any of which is optionally substituted with a hydroxy group.
[0079] In certain examples, each R2 is independently selected from C1-C10 alkyl, any of which is optionally substituted with a hydroxy group.
[0080] In certain examples, each R2 is independently selected from Ci-Ce alkyl, any of which is optionally substituted with a hydroxy group.
[0081] In certain examples, an alpha-carbon of at least one R2 is a secondary carbon or a tertiary carbon.
[0082] Certain examples of compounds of formula (II) may include combinations of R2 selected independently such that the compounds of formula (II) complex with, interact with, or otherwise affect copper (for example, by affecting the persistence of a given oxidation state, such as copper (I)), but not as desirably or preferably as other particular combinations of R2 due to the combined effects of chemical phenomena understood by those skilled in the art, including, but not limited to, hydrophobicity, solubility, electronic effects, and/or steric effects resulting from the chemical structure of a particular compound of formula (II). In certain examples of compounds of formula (II), each R2 independently may not be Ci alkyl, and/or may not be Ci alkyl optionally substituted with a hydroxy group, and/or may not be C2 alkyl, and/or may not be C2 alkyl optionally substituted with a hydroxy group, and/or may not be C3 alkyl, and/or may not be C3 alkyl optionally substituted with a hydroxy group, and/or may not be C4 alkyl, and/or may not be C4 alkyl optionally substituted with a hydroxy group, and/or may not be C5 alkyl, and/or may not be C5 alkyl optionally substituted with a hydroxy group, and/or may not be Ce alkyl, and/or may not be Ce alkyl optionally substituted with a hydroxy group, and/or may not be C7 alkyl, and/or may not be C7 alkyl optionally substituted with a hydroxy group, and/or may not be Cs alkyl, and/or may not be Cs alkyl optionally substituted with a hydroxy group, and/or may not be C9 alkyl, and/or may not be C9 alkyl optionally substituted with a hydroxy group, and/or may not be C10 alkyl, and/or may not be C10 alkyl optionally substituted with a hydroxy group, and/or may not be Cn alkyl, and/or may not be Cn alkyl optionally substituted with a hydroxy group, and/or may not be C12 alkyl, and/or may not be C12 alkyl optionally substituted with a hydroxy group, and/or may not be C13 alkyl, and/or may not be C13 alkyl optionally substituted with a hydroxy group, and/or may not be C14 alkyl, and/or may not be C14 alkyl optionally substituted with a hydroxy group, and/or may not be C15 alkyl, and/or may not be C15 alkyl optionally substituted with a hydroxy group, and/or may not be Ci6 alkyl, and/or may not be Ci6 alkyl optionally substituted with a hydroxy group, and/or may not be C17 alkyl, and/or may not be C17 alkyl optionally substituted with a hydroxy group, and/or may not be Cis alkyl, and/or may not be Cis alkyl optionally substituted with a hydroxy group, and/or may not be C19 alkyl, and/or may not be C19 alkyl optionally substituted with a hydroxy group, and/or may not be C20 alkyl, and/or may not be C20 alkyl optionally substituted with a hydroxy group. In certain examples, a biocidal composition does not include a compound of formula (II) and/or the copper-assisting additive is not a compound of formula (II).
[0083] Examples of compounds of formula (II) may include tris(hydroxypropyl) phosphine and tributyl phosphine. In certain examples, the biocidal composition does not include (for example, the copper-assisting additive is not) one or more of tris(hydroxypropyl) phosphine or tributyl phosphine.
[0084] Without being bound by any particular theory, it is believed the presence or maintenance of copper(I) is promoted by employing a compound of formula (II), and a biocidal composition containing a compound of formula (II) exhibits one or more effects when combined with a copper(I) salt, including maintaining antimicrobial efficacy of a biocidal composition below a certain level (for example, less than 3 logarithmic reduction), minimizing color drift of a biocidal composition, or any combination thereof.
[0085] In an example, a biocidal composition of the present disclosure may include a compound of formula (III), (IV), (V), or any combination thereof:
Figure imgf000028_0001
wherein each R3 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-
C4)alkyl, provided that all R3 not simultaneously hydrogen; wherein each R4 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R4 are not simultaneously hydrogen; and wherein each R5 is independently selected from hydrogen, Ci-
C20 alkyl, aryl, and aryl(Ci-C4)alkyl.
[0086] In certain examples, each R3 is independently selected from the group consisting of hydrogen, C1-C13 alkyl, phenyl, and benzyl, provided that all R3 are not simultaneously hydrogen.
[0087] In certain examples, the alpha-carbon of at least one R3 is a secondary or tertiary carbon. [0088] Certain examples of compounds of formula (III) may include particular combinations of R3 selected independently such that the compounds of formula (III) complex with, interact with, or otherwise affect copper (for example, by affecting the persistence of a given oxidation state, such as copper (I)), but not as desirably or preferably as other particular combinations of R3 due to the combined effects of chemical phenomena understood by those skilled in the art, including, but not limited to, hydrophobicity, solubility, electronic effects, and/or steric effects resulting from the chemical structure of a particular compound of formula (III). In certain examples of compounds of formula (III), each R3 independently may not be hydrogen, and/or may not be any one of C1-C20 alkyl, and/or may not be aryl, and/or may not be aryl(Ci-C4)alkyl. In certain examples, a biocidal composition does not include a compound of formula (III).
[0089] Examples of compounds of formula (III) may include 2-ethylhexyl phosphate, bis(2- ethylhexyl)phosphate, tris(2-ethylhexyl)phosphate, methyl phosphate, diethyl phosphate, trimethyl phosphate, butyl phosphate (for example, //-butyl, sec-butyl, or tert-butyl), dibutyl phosphate (for example, //-butyl, sec-butyl, and/or tert-butyl), tributyl phosphate (for example, //-butyl, sec-butyl, and/or tert-butyl), phenyl phosphate, diphenyl phosphate, triphenyl phosphate, benzyl phosphate, dibenzyl phosphate, tribenzyl phosphate, or any combination thereof. In certain examples, the biocidal composition does not include 2-ethylhexyl phosphate, and/or does not include bis(2-ethylhexyl)phosphate, and/or does not include tris(2- ethylhexyl)phosphate, and/or does not include methyl phosphate, and/or does not include dimethyl phosphate, and/or does not include trimethyl phosphate, and/or does not include butyl phosphate (for example, //-butyl, sec-butyl, or tert-butyl), and/or does not include dibutyl phosphate (for example, //-butyl, sec-butyl, or tert-butyl), and/or does not include tributyl phosphate (for example, //-butyl, sec-butyl, or tert-butyl), and/or does not include phenyl phosphate, and/or does not include diphenyl phosphate, and/or does not include triphenyl phosphate, and/or does not include benzyl phosphate, and/or does not include dibenzyl phosphate, and/or does not include tribenzyl phosphate.
[0090] In certain examples of compounds of formula (III), each R3 may not be Ci alkyl, and/or may not be C2 alkyl, and/or may not be C3 alkyl, and/or may not be C4 alkyl, and/or may not be C5 alkyl, and/or may not be Ce alkyl, and/or may not be C7 alkyl, and/or may not be Cs alkyl, and/or may not be C9 alkyl, and/or may not be C10 alkyl, and/or may not be Cn alkyl, and/or may not be C12 alkyl, and/or may not be C13 alkyl, and/or may not be C14 alkyl, and/or may not be C15 alkyl, and/or may not be Ci6 alkyl, and/or may not be C17 alkyl, and/or may not be Cis alkyl, and/or may not be C19 alkyl, and/or may not be C20 alkyl.
[0091] In certain examples, each R4 is independently selected from the group consisting of hydrogen, C1-C13 alkyl, phenyl, and benzyl, provided that all R4 are not all simultaneously hydrogen.
[0092] In certain examples, the alpha-carbon of at least one R4 is a secondary or tertiary carbon. [0093] Certain examples of compounds of formula (IV) may include particular combinations of R4 selected independently such that the compounds of formula (IV) complex with, interact with, or otherwise affect copper (for example, by affecting the persistence of a given oxidation state, such as copper(I)), but not as desirably or preferably as other particular combinations of R4 due to the combined effects of chemical phenomena understood by those skilled in the art, including, but not limited to, hydrophobicity, solubility, electronic effects, and/or steric effects resulting from the chemical structure of a particular compound of formula (IV). In certain examples of compounds of formula (IV), each R4 independently may not be hydrogen, and/or may not be any one of C1-C20 alkyl, and/or may not be aryl, and/or may not be aryl(Ci-C4)alkyl. In certain examples, a biocidal composition does not include a compound of formula (IV).
[0094] Examples of compounds of formula (IV) may include tributyl borate. In certain examples, the biocidal composition does not include tributyl borate.
[0095] In certain examples of compounds of formula (IV), each R4 may not be Ci alkyl, and/or may not be C2 alkyl, and/or may not be C3 alkyl, and/or may not be C4 alkyl, and/or may not be C5 alkyl, and/or may not be Ce alkyl, and/or may not be C7 alkyl, and/or may not be Cs alkyl, and/or may not be C9 alkyl, and/or may not be C10 alkyl, and/or may not be Cn alkyl, and/or may not be C12 alkyl, and/or may not be C13 alkyl, and/or may not be C14 alkyl, and/or may not be C15 alkyl, and/or may not be Ci6 alkyl, and/or may not be C17 alkyl, and/or may not be Cis alkyl, and/or may not be C19 alkyl, and/or may not be C20 alkyl.
[0096] In certain examples, each R5 is independently selected from the group consisting of hydrogen, C1-C13 alkyl, phenyl, and benzyl, provided that all R5 are not all simultaneously hydrogen.
[0097] In certain examples, the alpha-carbon of at least one R5 is a secondary or tertiary carbon. [0098] Certain examples of compounds of formula (V) may include particular combinations of R5 selected independently such that the compounds of formula (V) complex with, interact with, or otherwise affect copper (for example, by affecting the persistence of a given oxidation state, such as copper(I)), but not as desirably or preferably as other particular combinations of R5 due to the combined effects of chemical phenomena understood by those skilled in the art, including, but not limited to, hydrophobicity, solubility, electronic effects, and/or steric effects resulting from the chemical structure of a particular compound of formula (V). In certain examples of compounds of formula (V), each R5 independently may not be hydrogen, and/or may not be any one of C1-C20 alkyl, and/or may not be aryl, and/or may not be aryl(Ci-C4)alkyl. In certain examples, a biocidal composition does not include a compound of formula (V).
[0099] Examples of compounds of formula (V) may include tributyl citrate. In certain examples, the biocidal composition does not include tributyl citrate.
[0100] In an example, the biocidal composition includes copper in an amount of at least 0.01 at.% based on 100 weight percent of the biocidal composition. In certain examples, the biocidal composition includes copper in an amount of less than 10 at.% based on a total 100 weight percent of the biocidal composition. In certain examples, the biocidal composition includes copper in an amount (at.% based on 100 weight percent of the biocidal composition) of 0.01 - 10, 0.01 - 9, 0.01 - 8, 0.01 - 7, 0.01 - 6, 0.01 - 5, 0.01 - 4, 0.01 - 3, 0.01 - 2, 0.01 - 1, 0.01 - 0.9, 0.01 - 0.8, 0.01 - 0.7, 0.01 - 0.6, 0.01 - 0.5, 0.01 - 0.4, 0.01 - 0.3, 0.01 - 0.2, 0.01 - 0.1, 0.01 - 0.05, 0.02 - 10, 0.02 - 9, 0.02 - 8, 0.02 - 7, 0.02 - 6, 0.02 - 5, 0.02 - 4, 0.02 - 3, 0.02
- 2, 0.02 - 1, 0.02 - 0.9, 0.02 - 0.8, 0.02 - 0.7, 0.02 - 0.6, 0.02 - 0.5, 0.02 - 0.4, 0.02 - 0.3,
0.02 - 0.2, 0.02 - 0.1, 0.02 - 0.05, 0.05 -10, 0.05 - 9, 0.05 - 8, 0.05 - 7, 0.05 - 6, 0.05 - 5, 0.05 - 4, 0.05 - 3, 0.05 - 2, 0.05 - 1, 0.05 - 0.9, 0.05 - 0.8, 0.05 - 0.7, 0.05 - 0.6, 0.05 - 0.5, 0.05 - 0.4, 0.05 - 0.3, 0.05 - 0.2, 0.05 - 0.1, 0.1 - 10, 0.1 - 9, 0.1 - 8, 0.1 - 7, 0.1 - 6, 0.1 - 5, 0.1 - 4, 0.1 - 3, 0.1 - 2, 0.1 - 1, 0.1 - 0.9, 0.1 - 0.8, 0.1 - 0.7, 0.1 - 0.6, 0.1 - 0.5, 0.1 - 0.4, 0.1 - 0.3, 0.1 - 0.2, 0.2 - 10, 0.2 - 9, 0.2 - 8, 0.2 - 7, 0.2 - 6, 0.2 - 5, 0.2 - 4, 0.2 - 3, 0.2 - 2, 0.2 - 1, 0.2 - 0.9, 0.2 - 0.8, 0.2 - 0.7, 0.2 - 0.6, 0.2 - 0.5, 0.2 - 0.4, 0.2 - 0.3, 0.3 -10, 0.3 - 9, 0.3 - 8, 0.3 - 7, 0.3 - 6, 0.3 - 5, 0.3 - 4, 0.3 - 3, 0.3 - 2, 0.3 - 1, 0.3 - 0.9, 0.3 - 0.8, 0.3 - 0.7, 0.3 - 0.6, 0.3 - 0.5, 0.3 - 0.4, 0.4 - 10, 0.4 - 9, 0.4 - 8, 0.4 - 7, 0.4 - 6, 0.4 - 5, 0.4 - 4, 0.4 - 3, 0.4 - 2, 0.4 - 1, 0.4 - 0.9, 0.4 - 0.8, 0.4 - 0.7, 0.4 - 0.6, 0.4 - 0.5, 0.5 - 10, 0.5 -9, 0.5 - 8, 0.5 - 7, 0.5 - 6, 0.5 - 5, 0.5 - 4, 0.5 - 3, 0.5 - 2, 0.5 - 1, 0.5 - 0.9, 0.5 - 0.8, 0.5 - 0.7, 0.5 -
0.6, 0.6 -10, 0.6 - 9, 0.6 - 8, 0.6 - 7, 0.6 - 6, 0.6 - 5, 0.6 - 4, 0.6 - 3, 0.6 - 2, 0.6 - 1, 0.6 -
0.9, 0.6 - 0.8, 0.6 - 0.7, 0.7 - 10, 0.7 - 9, 0.7 - 8, 0.7 - 7, 0.7 - 6, 0.7 - 5, 0.7 - 4, 0.7 - 3, 0.7
- 2, 0.7 - 1, 0.7 - 0.9, 0.7 - 0.8, 0.8 - 10, 0.8 - 9, 0.8 - 8, 0.8 - 7, 0.8 - 6, 0.8 - 5, 0.8 - 4, 0.8
- 3, 0.8 - 2, 0.8 - 1, 0.8 - 0.9, 0.9 - 10, 0.9 - 9, 0.9 - 8, 0.9 - 7, 0.9 - 6, 0.9 - 5, 0.9 - 4, 0.9 -
3, 0.9 - 2, 0.9 - 1, 1 - 10, 1 - 9, 1 - 8, 1 - 7, 1 - 6, 1 - 5, 1 - 4, 1 - 3, 1 - 2, 2 - 10, 2 - 9, 2 -
8, 2 - 7, 2 - 6, 2 - 5, 2 - 4, 2 - 3, 3 - 10, 3 - 9, 3 - 8, 3 - 7, 3 - 6, 3 - 5, 3 - 4, 4 - 10, 4 - 9, 4
- 8, 4 - 7, 4 - 6, 4 - 5, 5 - 10, 5 - 9, 5 - 8, 5 - 7, 5 - 6, 6 - 10, 6 - 9, 6 - 8, 6 - 7, 7 - 10, 7 -
9, 7 - 8, 8 - 10, 8 - 9, 9 - 10, 0.06 - 0.5, 0.07 - 0.4, 0.08 - 0.3, 0.09 - 0.2, 0.02 - 1.9, 0.03 - 1.8, 0.03 - 1.7, 0.04 - 1.7, 0.05 - 1.8, 0.06 - 1.7, 0.07 - 1.6, 0.08 - 1.5, 0.09 - 1.4, 0.1 - 1.3, 0.2 - 1.2, 0.3 - 1.1; or any combination thereof; or any range formed from any two of the foregoing at.% values; including any subranges therebetween.
[0101] In an example, the copper(I) salt alone, the copper-assisting additive alone, or a sum total of both the copper(I) salt and the copper-assisting additive may be described by any of the following numbers and ranges: from 0.01 wt.% based on total 100 wt.% of the carrier or the biocidal composition to 20 wt.% based on weight of the carrier of the biocidal composition, such as, an amount (wt.% based on 100 wt.% of the carrier or the biocidal composition) of 0.01
- 19, 0.01 - 18, 0.01 - 17, 0.01 - 16, 0.01 - 15, 0.01 - 14, 0.01 - 13, 0.01 - 12, 0.01 - 11, 0.01 -10, 0.01 - 9, 0.01 - 8, 0.01 - 7, 0.01 - 6, 0.01 - 5, 0.01 - 4.9, 0.01 - 4.8, 0.01 - 4.7, 0.01 - 4.6, 0.01 - 4.5, 0.01 - 4.4, 0.01 - 4.3, 0.01 - 4.2, 0.01 - 4.1, 0.01 - 4, 0.01 - 3.9, 0.01 - 3.8, 0.01 - 3.7, 0.01 - 3.6, 0.01 - 3.5, 0.01 - 3.4, 0.01 - 3.3, 0.01 - 3.2, 0.01 - 3.1, 0.01 - 3, 0.01 - 2.9, 0.01 - 2.8, 0.01 - 2.7, 0.01 - 2.6, 0.01 - 2.5, 0.01 - 2.4, 0.01 - 2.3, 0.01 - 2.2, 0.01 - 2.1, 0.01 - 2, 0.01 - 1.9, 0.01 - 1.8, 0.01 - 1.7, 0.01 - 1.6, 0.01 - 1.5, 0.01 - 1.4, 0.01 - 1.3, 0.01 - 1.2, 0.01 - 1.1, 0.01 - 1, 0.01 - 0.9, 0.01 - 0.8, 0.01 - 0.7, 0.01 - 0.6, 0.01 - 0.5, 0.01 - 0.4, 0.01 - 0.3, 0.01 - 0.2, 0.01 - 0. 1, 0.02 - 5, 0.03 - 5, 0.04 - 5, 0.05 - 5, 0.06 - 5, 0.07 - 5, 0.08
- 5, 0.09 - 5, 0.1 - 5, 0.2 - 5, 0.3 - 5, 0.4 - 5, 0.5 - 5, 0.6 - 5, 0.7 - 5, 0.8 - 5, 0.9 - 5, 1 - 5, 1 - 4, 1 - 3, 1 - 2, 2 - 5, 2 - 4, 2 - 3, 3 -5, 4 - 5, 0.1 - 3, 0.1 - 2, 0.1 - 1, 0.1 - 1.9, 0.1 - 1.8, 0.1
- 1.7, 0.1 - 1.6, 0.1 - 1.5, 0.1 - 1.4, 0.1 - 1.3, 0.1 - 1.2, 0.1 - 1.1, 0.1 -1, 0.1 - 0.9, 0.1 - 0.8, 0.1 - 0.7, 0.1 - 0.6, 0.1 - 0.5, 0.1 - 0.4, 0.1 - 0.3, 0.1 - 0.2, 0.1 - 5, 0.2 - 4.5, 0.3 - 4, 0.4 - 3.5, 0.5 - 3, 0.6 - 2.5, 0.7 - 2, 0.8 - 1.5, 0.9 - 1, 0.15 - 1.8, 0.2 - 1.6, 0.25 - 1.4, 0.3 - 1.2, 0.35
- 1, 0.4 - 0.95, 0.45 - 0.9, 0.5 - 0.85, 6 - 20, 7 -20, 8 - 20, 9 - 20, 10 - 20, 11 - 20, 12 - 20, 13 - 20, 14 - 20, 15 - 20, 16 - 20, 17 - 20, 18 - 20, 19 - 20, 0.1 - 15, 0.5 - 14, 1 - 13, 1.5 - 12, 2 - 10, or any combination thereof. Such numbers may refer to the absolute amount present, or to the amount added to a composition. The basis weight may be either the carrier or the biocidal composition, as will be made clear from context because, in certain examples, the carrier is a main component of the biocidal composition. As such, in certain examples, the amount of a given component (or components) relative to either the carrier or the biocidal composition will be a similar value.
[0102] In one or more examples, the copper(I) salt and the copper-assisting additive may be present in a sum total amount of at least 10 grams per liter of carrier (or biocidal composition), or at least 15 grams per liter of carrier (or biocidal composition), or at least 20 grams per liter of carrier (or biocidal composition), or at least 25 grams per liter of carrier (or biocidal composition), or at least 30 grams per liter of carrier (or biocidal composition), or at least 35 grams per liter of carrier (or biocidal composition), or at least 40 grams per liter of carrier (or biocidal composition).
[0103] In an example, the copper(I) salt and copper-assisting additive may be present in a sum total amount (grams per liter of carrier or biocidal composition) of from 1 - 50, 1 - 45, 1 - 40, 1 - 35, 1 - 30, 1 - 25, 1 - 20, 1 - 15, 1 - 10, 1 - 5, 2 - 50, 2 - 45, 2 - 40, 2 - 35, 2 - 30, 2 - 25, 2 - 20, 2 - 15, 2 - 10, 2 - 5, 3 - 50, 3 - 45, 3 - 40, 3 - 35, 3 - 30, 3 - 25, 3 - 20, 3 - 15, 3
- 10, 3 - 5, 4 - 50, 4 - 45, 4 - 40, 4 - 35, 4 - 30, 4 - 25, 4 - 20, 4 - 15, 4 - 10, 4 - 5, 5 - 50, 5
- 45, 5 - 40, 5 - 35, 5 - 30, 5 - 25, 5 - 20, 5 - 15, 5 - 10, 10 - 50, 10 - 45, 10 - 40, 10 - 35, 10 - 30, 10 - 25, 10 - 20, 10 - 15, 15 - 50, 15 - 45, 15 - 40, 15 - 35, 15 - 30, 15 - 25, 15 - 20, 20 - 50, 20 - 45, 20 - 40, 20 - 35, 20 - 30, 20 - 25, 25 - 50, 25 - 45, 25 - 40, 25 - 35, 25
- 30, 30 - 50, 30 - 45, 30 - 40, 30 - 35, 35 - 50, 35 - 45, 35 - 40, 40 - 50, 40 - 45, 45 - 50, 6 - 50, 6 - 45, 6 - 40, 6 - 35, 6 - 30, 6 - 25, 6 - 20, 6 - 15, 6 - 10, 7 - 50, 7 - 45, 7 - 40, 7 - 35, 7 - 30, 7 - 25, 7 - 20, 7 - 15, 7 - 10, 8 - 50, 8 - 45, 8 - 40, 8 - 35, 8 - 30, 8 - 25, 8 - 20, 8 - 15, 8 - 10, 9 - 50, 9 - 45, 9 - 40, 9 - 35, 9 - 30, 9 - 25, 9 - 20, 9 - 15, or 9 - 10. As disclosed elsewhere herein, the basis may be expressed as either carrier or biocidal composition.
[0104] In an example, the copper(I) salt may be present in the biocidal composition in an amount of at least 1 gram per liter of biocidal composition or carrier. In certain examples, the copper(I) salt may be present in the biocidal composition or carrier in an amount of less than 135 grams per liter of biocidal composition or carrier. In certain examples, the copper(I) salt may be present in the biocidal composition or carrier in an amount (grams per liter of biocidal composition or carrier) of 1 - 135, 1 - 130, 1 - 125, 1 - 120, 1 - 115, 1 - 110, 1 - 105, 1 - 100, 1 - 95, 1 - 90, 1 - 85, 1 - 80, 1 - 75, 1 - 70, 1 - 65, 1 - 60, 1 - 55, 1 - 50, 1 - 45, 1 - 40,
1 - 35, 1 - 30, 1 - 25, 1 - 20, 1 - 15, 1 - 10, 1 - 5, 2 - 135, 2 - 130, 2 - 125, 2 - 120, 2 - 115,
2 - 110, 2 - 105, 2 - 100, 2 - 95, 2 - 90, 2 - 85, 2 - 80, 2 - 75, 2 - 70, 2 - 65, 2 - 60, 2 - 55, 2 - 50, 2 - 45, 2 - 40, 2 - 35, 2 - 30, 2 - 25, 2 - 20, 2 - 15, 2 - 10, 2 - 5, 5 -135, 5 - 130, 5 - 125, 5 - 120, 5 - 115, 5 -110, 5 - 105, 5 - 100, 5 - 95, 5 - 90, 5 - 85, 5 - 80, 5 - 75, 5 - 70, 5 - 65, 5 - 60, 5 - 55, 5 - 50, 5 - 45, 5 - 40, 5 - 35, 5 - 30, 5 - 25, 5 - 20, 5 - 15, 5 - 10, 10 - 135, 10 - 130, 10 - 125, 10 - 120, 10 - 115, 10 - 110, 10 - 105, 10 - 100, 10 - 95, 10 - 90, 10
- 85, 10 - 80, 10 - 75, 10 - 70, 10 - 65, 10 - 60, 10 - 55, 10 - 50, 10 - 45, 10 - 40, 10 - 35, 10 -30, 10 - 25, 10 - 20, 10 - 15, 15 - 135, 15 - 130, 15 - 125, 15 - 120, 15 - 115, 15 - 110, 15 - 105, 15 - 100, 15 - 95, 15 - 90, 15 - 85, 15 - 80, 15 - 75, 15 - 70, 15 - 65, 15 - 60, 15 - 55, 15 - 50, 15 - 45, 15 - 40, 15 - 35, 15 - 30, 15 - 25, 15 - 20, 20 -135, 20 - 130, 20 - 125, 20 - 120, 20 - 115, 20 - 110, 20 - 105, 20 - 100, 20 - 95, 20 - 90, 20 - 85, 20 - 80, 20 - 75, 20 - 70, 20 - 65, 20 - 60, 20 - 55, 20 - 50, 20 - 45, 20 - 40, 20 - 35, 20 - 30, 20 - 25, 25 - 135, 25 - 130, 25 - 125, 25 - 120, 25 - 115, 25 - 110, 25 - 105, 25 - 100, 25 - 95, 25 - 90, 25
- 85, 25 - 80, 25 - 75, 25 - 70, 25 - 65, 25 - 60, 25 - 55, 25 - 50, 25 - 45, 25 - 40, 25 - 35, 25 - 30, 30 - 135, 30 - 130, 30 - 125, 30 - 120, 30 - 115, 30 - 110, 30 - 105, 30 - 100, SO OS, 30 - 90, 30 - 85, 30 - 80, 30 - 75, 30 - 70, 30 - 65, 30 - 60, 30 - 55, 30 - 50, 30 - 45, 30 - 40, 30 - 35, 35 - 135, 35 - 130, 35 - 125, 35 - 120, 35 - 115, 35 - 110, 35 - 105, 35 - 100, 35 - 95, 35 - 90, 35 - 85, 35 - 80, 35 - 75, 35 - 70, 35 - 65, 35 - 60, 35 - 55, 35 - 50, 35 - 45, 35 - 40, 40 - 135, 40 - 130, 40 - 125, 40 - 120, 40 - 115, 40 - 110, 40 - 105, 40 - 100, 40
- 95, 40 - 90, 40 - 85, 40 - 80, 40 - 75, 40 - 70, 40 - 65, 40 - 60, 40 - 55, 40 - 50, 40 - 45, 45 - 135, 45 - 130, 45 - 125, 45 - 120, 45 - 115, 45 - 110, 45 - 105, 45 - 100, 45 - 95, 45 - 90, 45 - 85, 45 - 80, 45 - 75, 45 - 70, 45 - 65, 45 - 60, 45 - 55, 45 - 50, 50 - 135, 50 - 130, 50 - 125, 50 - 120, 50 - 115, 50 - 110, 50 - 105, 50 -100, 50 - 95, 50 - 90, 50 - 85, 50 - 80, 50 - 75, 50 - 70, 50 - 65, 50 - 60, 50 - 55, 55 - 135, 55 - 130, 55 - 125, 55 - 120, 55 - 115, 55 - 110, 55 - 105, 55 - 100, 55 - 95, 55 - 90, 55 - 85, 55 - 80, 55 - 75, 55 - 70, 55 - 65, 55
- 60, 60 - 135, 60 - 130, 60 - 125, 60 - 120, 60 - 115, 60 - 110, 60 - 105, 60 - 100, 60 - 95, 60 - 90, 60 - 85, 60 - 80, 60 - 75, 60 - 70, 60 - 65, 65 - 135, 65 - 130, 65 - 125, 65 - 120, 65
- 115, 65 - 110, 65 - 105, 65 - 100, 65 - 95, 65 - 90, 65 - 85, 65 - 80, 65 - 75, 65 - 70, 70 - 135, 70- 130, 70- 125, 70- 120, 70- 115, 70- 110, 70- 105, 70- 100, 70-95, 70-90, 70
- 85, 70 - 80, 70 - 75, 75 - 135, 75 - 130, 75 - 125, 75 - 120, 75 - 115, 75 - 110, 75 - 105, 75 - 100, 75 - 95, 75 - 90, 75 - 85, 75 - 80, 80 - 135, 80 - 130, 80 - 125, 80 - 120, 80- 115, 80 - 110, 80 - 105, 80 - 100, 80 - 95, 80 - 90, 80 - 85, 85 - 135, 85 - 130, 85 - 125, 85 - 120, 85 - 115, 85 - 110, 85 - 105, 85 - 100, 85 - 95, 85 - 90, 90 - 135, 90 - 130, 90 - 125, 90 - 120, 90 - 115, 90 - 110, 90 - 105, 90 - 100, 90 - 95, 95 - 135, 95 - 130, 95 - 125, 95 - 120, 95 - 115, 95 - 110, 95 - 105, 95 - 100, 100 - 135, 100 - 130, 100 - 125, 100 - 120, 100 - 115, 100- 110, 100- 105, 105- 135, 105- 130, 105- 125, 105- 120, 105- 115, 105- 110, 110
- 135, 110 - 130, 110 - 125, 110 - 120, 110 - 115, 115 - 135, 115 - 130, 115 - 125, 115 - 120, 120 - 135, 120 - 130, 120 - 125, 125 - 135, 125 - 130, 130 - 135; any combination thereof; or any range formed from any two of the foregoing amounts of grams per liter; including any subranges therebetween.
[0105] In an example, the molar ratio of the copper-assisting additive to the copper(I) salt in the biocidal composition may be from 0.1 : 1 to 50: 1, including, for example, from 0.1:1 to 49: 1, from 0.1:1 to 48:1, from 0.1:1 to 47:1, from 0.1:1 to 46:1, from 0.1:1 to 45:1, from 0.1:1 to 44:1, from 0.1:1 to 43:1, from 0.1:1 to 42:1, from 0.1:1 to 41:1, from 0.1:1 to 40:1, from 0.1:1 to 39:1, from 0.1:1 to 38:1, from 0.1:1 to 37:1, from 0.1:1 to 36:1, from 0.1:1 to 35:1, from 0.1:1 to 34:1, from 0.1:1 to 33:1, from 0.1:1 to 32:1, from 0.1:1 to 31:1, from 0.1:1 to 30:1, from 0.1:1 to 29:1, from 0.1:1 to 28:1, from 0.1:1 to 27:1, from 0.1:1 to 26:1, from 0.1:1 to 25:1, from 0.1:1 to 24:1, from 0.1:1 to 23:1, from 0.1:1 to 22:1, from 0.1:1 to 21:1, from 0.1:1 to 20:1, from 0.1:1 to 19:1, from 0.1:1 to 18:1, from 0.1:1 to 17:1, from 0.1:1 to 16:1, from 0.1:1 to 15:1, from 0.1:1 to 14.9:1, from 0.1:1 to 14.8:1, from 0.1:1 to 14.7:1, from 0.1:1 to 14.6:1, from 0.1:1 to 14.5:1, from 0.1:1 to 14.4:1, from 0.1:1 to 14.3:1, from 0.1:1 to 14.2:1, from 0.1:1 to 14.1:1, from 0.1:1 to 14:1, from 0.1:1 to 13.9:1, from 0.1:1 to 13.8:1, from 0.1:1 to 13.7:1, from 0.1:1 to 13.6:1, from 0.1:1 to 13.5:1, from 0.1:1 to 13.4:1, from 0.1:1 to 13.3:1, from 0.1:1 to 13.2:1, from 0.1:1 to 13.1:1, from 0.1:1 to 13:1, from 0.1:1 to 12.9:1, from 0.1:1 to 12.8:1, from 0.1:1 to 12.7:1, from 0.1:1 to 12.6:1, from 0.1:1 to 12.5:1, from 0.1:1 to 12.4:1, from 0.1:1 to 12.3:1, from 0.1:1 to 12.2:1, from 0.1:1 to 12.1:1, from 0.1:1 to 12:1, from 0.1:1 to 11.9:1, from 0.1:1 to 11.8:1, from 0.1:1 to 11.7:1, from 0.1:1 to 11.6:1, from 0.1:1 to 11.5:1, from 0.1:1 to 11.4:1, from 0.1:1 to 11.3:1, from 0.1:1 to 11.2:1, from 0.1:1 to 11.1:1, from 0.1:1 to 11:1, from 0.1:1 to 10.9:1, from 0.1:1 to 10.8:1, from 0.1:1 to 10.7:1, from 0.1:1 to 10.6:1, from 0.1:1 to 10.5:1, from 0.1:1 to 10.4:1, from 0.1:1 to 10.3:1, from 0.1:1 to 10.2:1, from 0.1:1 to 10.1:1, from 0.1:1 to 10:1, from 0.1:1 to 9.9:1, from 0.1:1 to 9.8:1, from 0.1:1 to 9.7:1, from 0.1:1 to 9.6:1, from 0.1:1 to 9.5:1, from 0.1:1 to 9.4:1, from 0.1:1 to 9.3:1, from 0.1:1 to 9.2:1, from 0.1:1 to 9.1:1, from 0.1:1 to 9:1, from 0.1:1 to 8.9:1, from 0.1:1 to 8.8:1, from 0.1:1 to 8.7:1, from 0.1:1 to 8.6:1, from 0.1:1 to 8.5:1, from 0.1:1 to 8.4:1, from 0.1:1 to 8.3:1, from 0.1:1 to 8.2:1, from 0.1:1 to 8.1:1, from 0.1:1 to 8:1, from 0.1:1 to 7.9:1, from 0.1:1 to 7.8:1, from 0.1:1 to 7.7:1, from 0.1:1 to 7.6:1, from 0.1:1 to 7.5:1, from 0.1:1 to 7.4:1, from 0.1:1 to 7.3:1, from 0.1:1 to 7.2:1, from 0.1:1 to 7.1:1, from 0.1:1 to 7:1, from 0.1:1 to 6.9:1, from 0.1:1 to 6.8:1, from 0.1:1 to 6.7:1, from 0.1:1 to 6.6:1, from 0.1:1 to 6.5:1, from 0.1:1 to 6.4:1, from 0.1:1 to 6.3:1, from 0.1:1 to 6.2:1, from 0.1:1 to 6.1:1, from 0.1:1 to 6:1, from 0.1:1 to 5.9:1, from 0.1:1 to 5.8:1, from 0.1:1 to 5.7:1, from 0.1:1 to 5.6:1, from 0.1:1 to 5.5:1, from 0.1:1 to 5.4:1, from 0.1:1 to 5.3:1, from 0.1:1 to 5.2:1, from 0.1:1 to 5.1:1, from 0.1:1 to 5:1, from 0.1:1 to 4.9:1, from 0.1:1 to 4.8:1, from 0.1:1 to 4.7:1, from 0.1:1 to 4.6:1, from 0.1:1 to 4.5:1, from 0.1:1 to 4.4:1, from 0.1:1 to 4.3:1, from 0.1:1 to 4.2:1, from 0.1:1 to 4.1:1, from 0.1:1 to 4:1, from 0.1:1 to 3.9:1, from 0.1:1 to 3.8:1, from 0.1:1 to 3.7:1, from 0.1:1 to 3.6:1, from 0.1:1 to 3.5:1, from 0.1:1 to 3.4:1, from 0.1:1 to 3.3:1, from 0.1:1 to 3.2:1 from 0.1:1 to 3.1:1, from 0.1:1 to 3:1, from 0.1:1 to 2.9:1, from 0.1:1 to 2.8:1, from 0.1:1 to 2.7:1, from 0.1:1 to 2.6:1, from 0.1:1 to 2.5:1, from 0.1:1 to 2.4:1, from 0.1:1 to 2.3:1, from 0.1:1 to 2.2:1, from 0.1:1 to 2.1:1, from 0.1:1 to2:l, from 0.1:1 to 1.9:1, from 0.1:1 to 1.8:1, from 0.1:1 to 1.7:1, from 0.1:1 to 1.6:1, from 0.1:1 to 1.5:1, from 0.1:1 to 1.4:1, from 0.1:1 to 1.3:1, from 0.1:1 to 1.2:1, from 0.1:1 to 1.1:1, from 0.1:1 to 1:1, from 0.2:1 to 50:1, from 0.3:1 to 50:1, from 0.4:1 to 50:1, from 0.5:1 to 50:1, from 0.6:1 to 50:1, from 0.7:1 to 50:1, from 0.8:1 to 50:1, from 0.9:1 to 50:1, from 1:1 to 50:1, from 1.1:1 to 50:1, from 1.2:1 to 50:1, from 1.3:1 to 50:1, from 1.4:1 to 50:1, from 1.5:1 to 50:1, from 1.6:1 to 50:1, from 1.7:1 to 50:1, from 1.8:1 to 50:1, from 1.9:1 to 50:1, from 2:1 to 50:1, from 2.1:1 to 50:1, from 2.2:1 to 50:1, from 2.3:1 to 50:1, from 2.4:1 to 50:1, from 2.5:1 to 50:1, from 2.6:1 to 50:1, from 2.7:1 to 50:1, from 2.8:1 to 50:1, from 2.9:1 to 50:1, from 3:1 to 50:1, from 3.1:1 to 50:1, from 3.2:1 to 50:1, from 3.3:1 to 50:1, from 3.4:1 to 50:1, from 3.5:1 to 50:1, from 3.6:1 to 50:1, from 3.7:1 to 50:1, from 3.8:1 to 50:1, from 3.9:1 to 50:1, from 4:1 to 50:1, from 4.1:1 to 50:1 from 4.2:1 to 50:1, from 4.3:1 to 50:1, from 4.4:1 to 50:1, from 4.5:1 to 50:1, from 4.6:1 to 50:1, from 4.7:1 to 50:1, from 4.8:1 to 50:1, from 4.9:1 to 50:1, from 5:1 to 50:1, from 5.1:1 to 50:1, from 5.2:1 to 50:1, from 5.3:1 to 50:1, from 5.4:1 to 50:1, from 5.5:1 to 50:1, from 5.6:1 to 50:1, from 5.7:1 to 50:1, from 5.8:1 to 50:1, from 5.9:1 to 50:1, from 6:1 to 50:1, from 6.1:1 to 50:1, from 6.2:1 to 50:1, from 6.3:1 to 50:1, from 6.4:1 to 50:1, from 6.5:1 to 50:1, from 6.6:1 to 50:1, from 6.7:1 to 50:1, from 6.8:1 to 50:1, from 6.9:1 to 50:1, from 7:1 to 50:1, from 7.1:1 to 50:1, from 7.2:1 to 50:1, from 7.3:1 to 50:1, from 7.4:1 to 50:1, from 7.5:1 to 50:1, from 7.6:1 to 50:1, from 7.7:1 to 50:1, from 7.8:1 to 50:1, from 7.9:1 to 50:1, from 8:1 to 50:1, from 8.1:1 to 50:1, from 8.2:1 to 50:1, from 8.3:1 to 50:1, from 8.4:1 to 50:1, from 8.5:1 to 50:1, from 8.6:1 to 50:1, from 8.7:1 to 50:1, from 8.8:1 to 50:1, from 8.9:1 to 50:1, from 9:1 to 50:1, from 9.1:1 to 50:1, from 9.2:1 to 50:1, from 9.3:1 to 50:1, from 9.4:1 to 50:1, from 9.5:1 to 50:1, from 9.6:1 to 50:1, from 9.7:1 to 50:1, from 9.8:1 to 50:1, from 9.9:1 to 50:1, from 10:1 to 50:1, from 10.1:1 to 50:1, from
10.2:1 to 50:1, from 10.3:1 to 50:1, from 10.4:1 to 50:1, from 10.5:1 to 50:1, from 10.6:1 to
50:1, from 10.7:1 to 50:1, from 10.8:1 to 50:1, from 10.9:1 to 50:1, from 11:1 to 50:1, from
11.1:1 to 50:1, from 11.2:1 to 50:1, from 11.3:1 to 50:1, from 11.4:1 to 50:1, from 11.5:1 to
50:1, from 11.6:1 to 50:1, from 11.7:1 to 50:1, from 11.8:1 to 50:1, from 11.9:1 to 50:1, from 12: 1 to 50:1, from 12.1 : 1 to 50: 1, from 12.2: 1 to 50:1, from 12.3 : 1 to 50: 1, from 12.4: 1 to 50: 1, from 12.5:1 to 50:1, from 12.6:1 to 50:1, from 12.7:1 to 50:1, from 12.8:1 to 50:1, from 12.9:1 to 50:1, from 13:1 to 50:1, from 13.1:1 to 50:1, from 13.2:1 to 50:1, from 13.3:1 to 50:1, from 13.4:1 to 50:1, from 13.5:1 to 50:1, from 13.6:1 to 50:1, from 13.7:1 to 50:1, from 13.8:1 to 50:1, from 13.9:1 to 50:1, from 14:1 to 50:1, from 14.1:1 to 50:1, from 14.2:1 to 50:1, from 14.3:1 to 50:1, from 14.4:1 to 50:1, from 14.5:1 to 50:1, from 14.6:1 to 50:1, from 14.7:1 to 50:1, from 14.8:1 to 50:1, from 14.9:1 to 50:1, from 15:1 to 50:1, from 16:1 to 50:1, from 17:1 to 50:1, from 18:1 to 50:1, from 19:1 to 50:1, from 20:1 to 50:1, from 21:1 to 50:1, from 22:1 to 50:1, from 23:1 to 50:1, from 24:1 to 50:1, from 25:1 to 50:1, from 26:1 to 50:1, from 27:1 to 50:1, from 28:1 to 50:1, from 29:1 to 50:1, from 30:1 to 50:1, from 31:1 to 50:1, from 32:1 to 50:1, from 33:1 to 50:1, from 34:1 to 50:1, from 35:1 to 50:1, from 36:1 to 50:1, from 37:1 to 50:1, from 38:1 to 50:1, from 39:1 to 50:1, from 40:1 to 50:1, from 41:1 to 50:1, from 42:1 to 50:1, from 43:1 to 50:1, from 44:1 to 50:1, from 45:1 to 50:1, from 46:1 to 50:1, from 47:1 to 50:1, from 48:1 to 50:1, from 49:1 to 50:1; or any range formed from any two of the foregoing ratios, including any subratios therebetween. The foregoing ratios generally refer to the moles of copper-assisting additive relative to moles of copper(I) salt, but such ratios may also be used to express moles of copper-assisting additive relative to moles of copper (calculated on an atomic basis).
[0106] Upon combination of the copper(I) salt and the copper-assisting additive with a carrier, as described herein, the composition (for example, biocidal composition) or resulting material may be formed into a desired article or be applied to a surface. Where the composition includes or is, for example, a polyurethane, a polyurethane precursor, an epoxy resin, an epoxy resin precursor, a melamine resin, or the like, such a composition may be applied to a surface as a layer. Examples of surfaces to which the biocidal composition may be applied include wood, polymer, metal, glass, ceramic, stone, concrete, cement, mineral, drywall, asphalt, or any combination thereof. Examples of articles that may be formed using the compositions described herein include housings or cases for electronic devices (for example, mobile phones, smart phones, tablets, video players, information terminal devices, laptop computers), architectural structures (for examples, countertops, walls, trim, ceilings, floors, exterior facades, and trim), appliances 9for example, cooktops, refrigerator doors, and dishwasher doors), information displays (for example, whiteboards), automotive components (for example, dashboard panels, windshields, window components), and high touch surfaces (for example, a computer mouse, a computer keyboard, a railing, a door, a doorknob, a door push plate, a phone, a phone button, or an elevator button). Articles may be formed by any method known in the art, such as by molding (for example, injection molding), or otherwise forming the article into a desired shape. In certain examples, an entire article may include the biocidal composition (for example, an entire article is formed from the biocidal composition). In certain examples, disclosed is a method of forming an article, the method including providing a masterbatch of the biocidal composition, and then forming the article therefrom by any known technique, such as by extrusion or molding (for example, injection molding). In certain examples, disclosed is a method of preparing a masterbatch, including mixing a concentrated form of the biocidal composition.
[0107] The compositions described herein may include pigments to impart color. Accordingly, the coatings or layers made from such compositions may exhibit a wide variety of colors, depending on the carrier color, mixtures of carriers, and amount of particle loading. Moreover, it is contemplated that the compositions and/or coatings described herein will show no adverse effect to paint adhesion as measured by ASTM D4541. In certain examples, the adhesion of the composition or coating to an underlying substrate is greater than the cohesive strength of the substrate. In other words, in testing, the adhesion between the coating and the substrate is so strong that the underlying substrate failed before the coating was separated from the surface of the substrate.
[0108] In some aspects, the biocidal composition may be in the form of an article, a layer, a coating, a dry film, or as a liquid composition including suspensions and solutions, which may be applied on a surface or stored in a container (for example, prior to use). In some aspects, the biocidal composition is not in the form of a molded article, e.g., an injection molded article, or an extruded article.
[0109] One or more examples of the biocidal compositions of the present disclosure may include the copper(I) salt (which may optionally be pre-treated with a pretreatment solution), a copper-assisting additive, and a carrier with a loading level of the copper(I) salt such that the composition may exhibit resistance or preservation against the presence or growth of foulants (for example, microbes). Foulants include fungi, bacteria, viruses, mold, mildew, algae, and combinations thereof. In certain examples, the presence of foulants in materials, such as polyurethanes, epoxy resins, and the like may cause color changes to the composition, may degrade the integrity of the composition, and may negatively affect various properties of the composition. By including a minimum loading of copper(I) salt (for example, 5 weight % or less, 4 weight % or less, 3 weight % or less, 2 weight % or less, or 1 weight % or less; alternatively, or additionally, in an amount of 0 weight % or more, for example, greater than 0 weight %, 0.01 weight % or more, 0.05 weight % or more, 0.1 weight % or more, 0.5 weight % or more, 1 weight % or more, 2 weight % or more, 3 weight % or more, or 4 weight % or more, based on weight of the carrier or composition) and copper-assisting additive in the carrier, the foulants may be eliminated or reduced. In certain examples, the compositions may or may not include certain components, when fouling is eliminated or reduced. Therefore, the formulations used in one or more examples of the compositions described herein may have more flexibility and variations than previously possible, when used in known compositions that do not include the copper(I) salt.
[0110] In an example, a biocidal composition may exhibit one or more of the following effects: (1) a greater than 3 logarithmic reduction in a concentration of a microbe selected from the group consisting of Staphylococcus aureus, Enterobacter aerogenes, Pseudomonas aeruginosa, Methicillin Resistant Staphylococcus aureus, E. coli, SARS-Cov-2, and mixtures thereof; (2) a change in color in the biocidal composition is minimized relative to a change in color of a mixture of the carrier and the copper(I) salt in the absence of the copper-assisting additive or the carrier and the copper-assisting additive absent the copper(I) salt; or (3) any combination thereof. Antimicrobial efficacy may be measured as described elsewhere herein, such as by using the EP A Test.
[OHl] In an example, a biocidal composition including a carrier, a copper(I) salt, and a copper- assisting additive has better antimicrobial efficacy over time (for example, for 7 days or at least 7 days, or any other time period disclosed herein, such as 30 days or at least 30 days, or 90 days or or at least 90 days) compared to an otherwise identical composition that does not include the copper-assisting additive or does not include the copper(I) salt (for example, in the amounts specified, such as copper in an amount of 0.01 at.% to 10 at.% or 0.01 at.% to 2 at.%; copper(I) salt in the composition in an amount of 0.01 wt.% to 15 wt.%; and/or a molar ratio of the amount of the copper-assisting additive to the amount of copper is from 0.1 : 1 to 50: 1). Similarly, in certain examples, such a biocidal composition also has minimized color change (for example, color drift and/or color shift) compared to an otherwise identical composition, as disclosed elsewhere herein.
[0112] In an example, when the biocidal composition is formed into a coating (for example, a dry film) within one day of preparing the biocidal composition and the coating is stored at ambient conditions for 7 days or at least 7 days (for example, 10 days or at least 10 days, 15 days or at least 15 days, 20 days or at least 20 days, 25 days or at least 25 days, 30 days or at least 30 days, 40 days or at least 40 days, 50 days or at least 50 days, 60 days or at least 60 days, 75 days or at least 75 days, 90 days or at least 90 days, 100 days or at least 100 days, 120 days or at least 120 days, 150 days or at least 150 days, 180 days or at least 180 days, 365 days or at least 365 days, 2 years or at least 2 years, 3 years or at least 3 years, 4 years or at least 4 years, 5 years or at least 5 years, or 6 years or at least 6 years; alternatively, or additionally, less than 6 years, less than 5 years, less than 4 years, less than 3 years, less than 2 years, less than 365 days, less than 180 days, less than 150 days, less than 120 days, less than 100 days, less than 90 days, less than 75 days, less than 60 days, less than 50 days, less than 40 days, less than 30 days, less than 25 days, less than 20 days, less than 15 days, or less than 10 days) to form a stored coating or stored article, the stored coating or article exhibits greater than 1 logarithmic reduction (for example, greater than 2.5 logarithmic reduction, greater than 3 logarithmic reduction, greater than 3.5 logarithmic reduction, greater than 4 logarithmic reduction, greater than 4.5 logarithmic reduction, or greater than 5 logarithmic reduction; alternatively, or additionally, less than 6 logarithmic reduction, less than 5.5 logarithmic reduction, less than 5 logarithmic reduction, less than 4.5 logarithmic reduction, less than 4 logarithmic reduction, less than 3.5 logarithmic reduction, less than 3 logarithmic reduction, less than 2.5 logarithmic reduction, less than 2 logarithmic reduction, or less than 1.5 logarithmic reduction) in the concentration of microbe selected from the group consisting of Staphylococcus aureus, Enterobacter aerogenes, Pseudomonas aeruginosa, Methicillin Resistant Staphylococcus aureus, E. coli, SARS-Cov-2, and mixtures thereof. Generally, and without wishing to be bound by theory, it is believed that the above feature shows the longevity of antimicrobial efficacy of a coating (for example, dry film) or article including the biocidal composition over time. Antimicrobial efficacy can be measured as described elsewhere herein, such as by using the EP A Test.
[0113] As used herein, the term “for X days” or “for X years” in which X is a number, means that the longevity of a specified property lasts minimally for X days (or for X years). The longevity of the specified property may last for a longer period of time, and after such longer period of time the specified property (e.g., log reduction or color value) may begin to decrease; however, “for X days” (or “for X years”) is met if the specified property was present at X days (or X years). In this regard, the terms “for X days” and the term “for at least X days” are meant to be synonymous terms.
[0114] In an example, when the biocidal composition is stored as a liquid composition, mixture, or suspension at ambient conditions for a period of 7 days or at least 7 days (for example, 10 days or at least 10 days, 15 days or at least 15 days, 20 days or at least 20 days, 25 days or at least 25 days, 30 days or at least 30 days, 40 days or at least 40 days, 50 days or at least 50 days, 60 days or at least 60 days, 75 days or at least 75 days, 90 days or at least 90 days, 100 days or at least 100 days, 120 days or at least 120 days, 150 days or at least 150 days, 180 days or at least 180 days, 365 days or at least 365 days (1 year), 2 years or at least 2 years, 3 years or at least 3 years, 4 years or at least 4 years, 5 years or at least 5 years, or 6 years or at least 6 years; alternatively, or additionally, less than 6 years, less than 5 years, less than 4 years, less than 3 years, less than 2 years, less than 365 days, less than 180 days, less than 150 days, less than 120 days, less than 100 days, less than 90 days, less than 75 days, less than 60 days, less than 50 days, less than 40 days, less than 30 days, less than 25 days, less than 20 days, less than 15 days, or less than 10 days) to form a stored liquid composition, mixture, or suspension within one day exhibits greater than 1 logarithmic reduction (for example, greater than 2.5 logarithmic reduction, greater than 3 logarithmic reduction, greater than 3.5 logarithmic reduction, greater than 4 logarithmic reduction, greater than 4.5 logarithmic reduction, or greater than 5 logarithmic reduction; alternatively, or additionally, less than 6 logarithmic reduction, less than 5.5 logarithmic reduction, less than 5 logarithmic reduction, less than 4.5 logarithmic reduction, less than 4 logarithmic reduction, less than 3.5 logarithmic reduction, less than 3 logarithmic reduction, less than 2.5 logarithmic reduction, less than 2 logarithmic reduction, or less than 1.5 logarithmic reduction) in the concentration of microbe selected from the group consisting of Staphylococcus aureus, Enter obacter aerogenes, Pseudomonas aeruginosa, Methicillin Resistant Staphylococcus aureus, E. coli, SARS-Cov-2, and mixtures thereof. Generally, and without wishing to be bound by theory, it is believed that the above feature shows the antimicrobial efficacy of a coating (for example, dry film) or article after the biocidal composition has been stored in liquid form (for example, a can of polyurethane precursor or epoxy resin precursor) for a certain period of time. Antimicrobial efficacy may be measured as described elsewhere herein, such as by using the EPA Test.
[0115] In an example, minimizing a change in color corresponds to a CIE AE* value of the biocidal composition being less than 10, or less than 9, or less than 8, or less than 7, or less than 6, or less than 5, or less than 4, or less than 3, or less than 2, as measured according to formula (VI):
Figure imgf000041_0001
wherein L*, a*, and b* are the CIE L*, a*, and b* values of the biocidal compositions and the L’ control, 3- control, and b*COntroi are the CIE L*, a*, and b* values of an otherwise identical composition without either the copper(I) salt or the copper-assisting additive.
[0116] In an example, a biocidal composition or a film prepared from the biocidal composition may exhibit (1) a transmittance as measured at each wavelength from 400 to 700 nm, and/or (2) an average transmittance as measured over the wavelength range of from 400 to 700 nm, of at least 50%, or at least 51%, or at least 52%, or at least 53%, or at least 54%, or at least
55%, or at least 56%, or at least 57%, or at least 58%, or at least 59%, or at least 60%, or at least 61%, or at least 62%, or at least 63%, or at least 64%, or at least 65%, or at least 66%, or at least 67%, or at least 68%, or at least 69%, or at least 70%, or at least 71%, or at least 72%, or at least 73%, or at least 74%, or at least 75%, or at least 76%, or at least 77%, or at least 78%, or at least 79%, or at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%. or at least 90.5%. or at least 91.0%. or at least 91.5%. or at least 92.0%. or at least
92.5%, or at least 93.0%, or at least 93.5%, or at least 94.0%, or at least 94.5%, or at least 95.0%, or at least 95.1%, or at least 95.2%, or at least 95.3%, or at least 95.4%, or at least 95.5%, or at least 95.6%, or at least 95.7%, or at least 95.8%, or at least 95.9%, or at least 96.0%, or at least 96.1%, or at least 96.2%, or at least 96.3%, or at least 96.4%, or at least 96.5% or at least 96.6%, or at least 96.7%, or at least 96.8%, or at least 96.9%, or at least
97.0%, or at least 97.1%, or at least 97.2%, or at least 97.3%, or at least 97.4%, or at least
97.5% or at least 97.6%, or at least 97.7%, or at least 97.8%, or at least 97.9%, or at least
98.0%, or at least 98.1%, or at least 98.2%, or at least 98.3%, or at least 98.4%, or at least
98.5%, or at least 98.6%, or at least 98.7%, or at least 98.8%, or at least 98.9%, or at least
99.0%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least
99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9%, or at least
>99.9%; when measured at a thickness of 40 pm. Average transmittance is calculated by summing the transmittance at each wavelength between 400 and 700 nm and dividing by the total number of such wavelengths.
[0117] In an example, a biocidal composition, or a film thereof, may exhibit a transmittance as measured at each wavelength from 400 to 700 nanometers that is within 20 percentage points of a second transmittance of an otherwise identical composition or film thereof without either the copper(I) salt or the copper-assisting additive when measured at a thickness of 40 pm; including, for example, within 19.5 percentage points, or within 19.0 percentage points, or within 18.5 percentage points, or within 18.0 percentage points, or within 17.5 percentage points, or within 17.0 percentage points, or within 16.5 percentage points, or within 16.0 percentage points, or within 15.5 percentage points, or within 15.0 percentage points, or within 14.5 percentage points, or within 14.0 percentage points, or within 13.5 percentage points, or within 13.0 percentage points, or within 12.5 percentage points, or within 12.0 percentage points, or within 11.5 percentage points, or within 11.0 percentage points, or within 10.5 percentage points, or within 10.0 percentage points, or within 9.9 percentage points, or within 9.8 percentage points, or within 9.7 percentage points, or within 9.6 percentage points, or within 9.5 percentage points, or within 9.4 percentage points, or within 9.3 percentage points, or within 9.2 percentage points, or within 9.1 percentage points, or within 9.0 percentage points, or within 8.9 percentage points, or within 8.8 percentage points, or within 8.7 percentage points, or within 8.6 percentage points, or within 8.5 percentage points, or within 8.4 percentage points, or within 8.3 percentage points, or within 8.2 percentage points, or within 8.1 percentage points, or within 8.0 percentage points, or within 7.9 percentage points, or within 7.8 percentage points, or within 7.7 percentage points, or within 7.6 percentage points, or within 7.5 percentage points, or within 7.4 percentage points, or within 7.3 percentage points, or within 7.2 percentage points, or within 7.1 percentage points, or within 7.0 percentage points, or within 6.9 percentage points, or within 6.8 percentage points, or within 6.7 percentage points, or within 6.6 percentage points, or within 6.5 percentage points, or within 6.4 percentage points, or within 6.3 percentage points, or within 6.2 percentage points, or within 6.1 percentage points, or within 6.0 percentage points, or within 5.9 percentage points, or within 5.8 percentage points, or within 5.7 percentage points, or within 5.6 percentage points, or within 5.5 percentage points, or within 5.4 percentage points, or within 5.3 percentage points, or within 5.2 percentage points, or within 5.1 percentage points, or within 5.0 percentage points, or within 4.9 percentage points, or within 4.8 percentage points, or within 4.7 percentage points, or within 4.6 percentage points, or within 4.5 percentage points, or within 4.4 percentage points, or within 4.3 percentage points, or within 4.2 percentage points, or within 4.1 percentage points, or within 4.0 percentage points, or within 3.9 percentage points, or within 3.8 percentage points, or within 3.7 percentage points, or within 3.6 percentage points, or within 3.5 percentage points, or within 3.4 percentage points, or within 3.3 percentage points, or within 3.2 percentage points, or within 3.1 percentage points, or within 3.0 percentage points, or within 2.9 percentage points, or within 2.8 percentage points, or within 2.7 percentage points, or within 2.6 percentage points, or within 2.5 percentage points, or within 2.4 percentage points, or within 2.3 percentage points, or within 2.2 percentage points, or within 2.1 percentage points, or within 2.0 percentage points, or within 1.9 percentage points, or within 1.8 percentage points, or within 1.7 percentage points, or within 1.6 percentage points, or within 1.5 percentage points, or within 1.4 percentage points, or within 1.3 percentage points, or within 1.2 percentage points, or within 1.1 percentage points, or within 1.0 percentage points, or within 0.9 percentage points, or within 0.8 percentage points, or within 0.7 percentage points, or within 0.6 percentage points, or within 0.5 percentage points, or within 0.4 percentage points, or within 0.3 percentage points, or within 0.2 percentage points, or within 0. 1 percentage points.
[0118] In an example, a film of a biocidal composition may have a thickness of from 30 pm to 3000 pm, including, for example, from 40 pm, or from 50 pm, or from 60 pm, or from 70 pm, or from 80 pm, or from 90pm, or from 100 pm, or from 110 pm, or from 120 pm, or from 130 pm, or from 140 pm, or from 150 pm, or from 160 pm, or from 170 pm, or from 180 pm, or from 190 pm, or from 200pm, or from 210 pm, or from 220 pm, or from 230pm, or from 240 pm, or from 250 pm, or from 260 pm, or from 270 pm, or from 280 pm, or from 290 pm, or from 300 pm, or from 310pm, or from 320 pm, or from 330 pm, or from 340pm, or from 350 pm, or from 360 pm, or from 370 pm, or from 380 pm, or from 390 pm, or from 400 pm, or from 410 pm, or from 420pm, or from 430 pm, or from 440 pm, or from 450pm, or from 460 pm, or from 470 pm, or from 480 pm, or from 490 pm, or from 500 pm, or from 510 pm, or from 520 pm, or from 530pm, or from 540 pm, or from 550 pm, or from 560pm, or from 570 pm, or from 580 pm, or from 590 pm, or from 600 pm, or from 610 pm, or from 620 pm, or from 630 un, or from 640pm, or from 650 pm, or from 660 pm, or from 670pm, or from 680 pm, or from 690 pm, or from 700 pm, or from 710 pm, or from 720 pm, or from 730 pm, or from 740 pm, or from 750pm, or from 760 pm, or from 770 pm, or from 780pm, or from 790 pm, or from 800 pm, or from 810 pm, or from 820 pm, or from 830 pm, or from 840 pm, or from 850 pm, or from 860pm, or from 870 pm, or from 880 pm, or from 890pm, or from 900 pm, or from 910 pm, or from 920 pm, or from 930 pm, or from 940 pm, or from 950 pm, or from 960 pm, or from 970 pm, or from 980 pm, or from 990 pm, or from 1000 pm, or from
1050 pm, or from 1100 pm, or from 1150 pm, or from 1200 pm, or from 1250 pm, or from 1300 pm, or from 1350 pm, or from 1400 pm, or from 1450 pm, or from 1500 pm, or from 1550 pm, or from 1600 pm, or from 1650 pm, or from 1700 pm, or from 1750 pm, or from 1800 pm, or from 1850 pm, or from 1900 pm, or from 1950 pm, or from 2000 pm, or from 2050 pm, or from 2100 pm, or from 2150 pm, or from 2200 pm, or from 2250 pm, or from 2300 pm, or from 2350 pm, or from 2400 pm, or from 2450 pm, or from 2500 pm, or from 2550 pm, or from 2600 pm, or from 2650 pm, or from 2700 pm, or from 2750 pm, or from
2800 pm, or from 2850 pm, or from 2900 pm, or from 2950 pm to 3000 pm; or from 30 pm to
40 pm, or to 50 pm, or to 60 pm, or to 70 pm, or to 80 pm, or to 90 pm, or to 100 pm, or to
110 pm, or to 120 pm, or to 130 pm, or to 140 pm, or to 150 pm, or to 160 pm, or to 170 pm, or to 180 pm, or to 190 pm, or to 200 pm, or to 210 pm, or to 220 pm, or to 230 pm, or to 240 pm, or to 250 pm, or to 260 pm, or to 270 pm, or to 280 pm, or to 290 pm, or to 300 pm, or to 310 pm, or to 320 pm, or to 330 pm, or to 340 pm, or to 350 pm, or to 360 pm, or to 370 pm, or to 380 pm, or to 390pm, or to 400 pm, or to 410 pm, or to 420 pm, or to 430 pm, or to 440 pm, or to 450 pm, or to 460 pm, or to 470 pm, or to 480 pm, or to 490 pm, or to 500 pm, or to 510 pm, or to 520 pm, or to 530 pm, or to 540 pm, or to 550 pm, or to 560 pm, or to 570 pm, or to 580 pm, or to 590pm, or to 600 pm, or to 610 pm, or to 620 pm, or to 630 pm, or to 640 pm, or to 650 pm, or to 660 pm, or to 670 pm, or to 680 pm, or to 690 pm, or to 700 pm, or to 710 pm, or to 720 pm, or to 730 pm, or to 740 pm, or to 750 pm, or to 760 pm, or to 770 pm, or to 780 pm, or to 790pm, or to 800 pm, or to 810 pm, or to 820 pm, or to 830 pm, or to 840 pm, or to 850 pm, or to 860 pm, or to 870 pm, or to 880 pm, or to 890 pm, or to 900 pm, or to 910 pm, or to 920 pm, or to 930 pm, or to 940 pm, or to 950 pm, or to 960 pm, or to 970 pm, or to 980 pm, or to 990 pm, or to 1000 pm, or to 1050pm, or to 1100 pm, or to 1150 pm, or to 1200 pm, or to 1250 pm, or to 1300 pm, or to 1350pm, or to 1400 pm, or to 1450 pm, or to
1500 pm, or to 1550 pm, or to 1600 pm, or to 1650pm, or to 1700 pm, or to 1750 pm, or to
1800 pm, or to 1850 pm, or to 1900 pm, or to 1950 pm, or to 2000 pm, or to 2050 pm, or to
2100 pm, or to 2150 pm, or to 2200 pm, or to 2250pm, or to 2300 pm, or to 2350 pm, or to
2400 pm, or to 2450 pm, or to 2500 pm, or to 2550pm, or to 2600 pm, or to 2650 pm, or to
2700 pm, or to 2750 pm, or to 2800 pm, or to 2850 pm, or to 2900 pm, or to 2950 pm, or a range formed from any two of the foregoing thicknesses; including any subranges therebetween.
[0119] In an example, disclosed is a method of preparing a biocidal composition, the method including adding a biocidal additive formulation to a carrier. When the carrier is a polyurethane or an epoxy resin, the biocidal additive formulation may include the copper(I) salt and the copper-assisting additive. When the carrier is a second polyurethane precursor, the biocidal additive formulation may include a first polyurethane precursor, the copper(I) salt, and the copper-assisting additive. When the carrier is a second epoxy resin precursor, the biocidal additive formulation may include a first epoxy resin precursor, the copper(I) salt, and the copper-assisting additive.
[0120] In an example, disclosed is a method including applying a biocidal composition to a surface. The biocidal composition may include any of the components described elsewhere herein. In an example, the surface is or includes wood polymer (for example, plastic or rubber), metal (for example, steel, iron, copper, gold, silver, aluminum, tin, platinum, alloys thereof, or any combination thereof), glass (for example, lithium aluminosilicate, borosilicate, chemical strengthened, or ion-exchanged), ceramic, glass-ceramic, stone, concrete, cement, mineral, drywall, asphalt, or any combination thereof. In an example, the method of applying to a surface may be any suitable method, including spraying, spin coating, dipping, and the like, or any combination thereof. For example, the composition may be sprayed on a surface. In some aspects of applying to a surface, such as in a sprayed composition, the copper(I) species (for example, the ion or salt) may be at least partially in a solubilized form (for example, facilitated by complexation with a copper-assisting additive), though such copper(I) species may alternatively or additionally be in a suspension.
[0121] In an example, disclosed is a method of improving or sustaining antimicrobial efficacy in a biocidal composition (any biocidal composition disclosed herein), including: combining a carrier, a copper(I) salt, and a copper-assisting additive, wherein the biocidal composition includes copper in an amount of 0.01 at.% to 10 at.%, and the carrier and the copper-assisting additive are different. In certain examples, a molar ratio of the amount of copper-assisting additive to the amount of copper is from 0.1 : 1 to 50: 1. In certain examples, the copper(I) salt is first combined with the copper-assisting additive to form a mixture, and the mixture is then combined with the carrier to form the biocidal composition. In other examples, the color change in the biocidal composition is minimized relative to a change in color of an otherwise identical composition in the absence of the copper-assisting additive, or an otherwise identical composition absent the copper(I) salt, or an otherwise identical composition absent both the copper-assisting additive and the copper(I) salt. In still other examples, a method of minimizing a color change in a biocidal composition is provided, wherein the copper-assisting additive is any compound or formula disclosed herein (for example, a compound of formula (I), (II), or any combination thereof), by itself or themselves, or together with a compound of formula (III), (IV), (V), or any combination thereof. In still other examples, a method of minimizing a color change in a biocidal composition is provided, wherein the copper-assisting additive is any compound disclosed herein, such as trimethyl phosphite, triethyl phosphite, triphenyl phosphite, tris(2,2,2-trifluoroethyl) phosphite, tris(2-ethylhexyl) phosphite, triisopropyl phosphite, tris(l,l,l,3,3,3-hexafluoro-2-propyl) phosphite, tris(hydroxylpropyl) phosphine, tributyl phosphine, or any combination thereof, by itself or themselves, or together with a compound such as 2-ethylhexyl phosphate, bis(2-ethylhexyl)phosphate, tris(2- ethylhexyl)phosphate, methyl phosphate, dimethyl phosphate, trimethyl phosphate, butyl phosphate (for example, //-butyl, ec-butyl, or tert-butyl), dibutyl phosphate (for example, n- butyl, sec-butyl, or tert-butyl), tributyl phosphate (for example, //-butyl, sec-butyl, or tertbutyl), phenyl phosphate, diphenyl phosphate, triphenyl phosphate, benzyl phosphate, dibenzyl phosphate, tribenzyl phosphate, tributyl borate, tributyl citrate, or any combination thereof. In still other examples, a method of minimizing a color change in a biocidal composition is provided, wherein the composition demonstrates a greater than 3 logarithmic reduction in a concentration of a microbe selected from the group consisting of Staphylococcus aureus, Enterobacter aerogenes, Pseudomonas aeruginosa, Methicillin Resistant Staphylococcus aureus, E. coli, SARS-Cov-2, and mixtures thereof. Antimicrobial efficacy may be measured as described elsewhere herein, such as by using the EPA Test. In still other examples, a method of minimizing a color change in a biocidal composition is provided, wherein a CIE AE* value of the biocidal material is less than 10, as measured according to formula (VI):
Figure imgf000046_0001
wherein L*, a*, and b* are the CIE L*, a*, and b* values of the biocidal material and the L*COntroi, a*controi, and b*controi are the CIE L*, a*, and b* values of an otherwise identical composition without either the copper(I) salt or the copper-assisting additive.
[0122] In an example, a biocidal composition may exhibit a AE of less than 10, or less than 9, or less than 8, or less than 7, or less than 6, or less than 5, or less than 4, or less than 3, or less than 2, as measured according to formula (VI):
Figure imgf000047_0001
wherein L*, a*, and b* are CIE values of the biocidal composition after preparing and then, within one day of preparing, storing the biocidal composition at ambient temperature and ambient relative humidity for 7 days (for example, 10 days, 15 days, 20 days, 25 days, 30 days, 40 days, 50 days, 60 days, 75 days, 90 days, 100 days, 120 days, 150 days, 180 days, 365 days, 2 years, 3 years, 4 years, or 5 years, and the L’ control, 3- control, and b*COntroi are CIE values of an otherwise identical composition without either the copper(I) salt or the copper-assisting additive.
[0123] In an example, the present disclosure provides a biocidal additive formulation that includes a copper(I) salt and a copper-assisting additive. In some aspects, the biocidal additive formulation may be a relatively concentrated formulation to be added to a carrier so as to provide a biocidal composition. In this regard, in some aspects, the biocidal additive formulation may be in the form of a package that may be added to, for example, a polyurethane, a polyurethane precursor, an epoxy resin, an epoxy resin precursor, or a melamine resin by an end user, so as to make the polyurethane, the polyurethane precursor, the epoxy resin, the epoxy resin precursor, or the melamine resin have antimicrobial properties without substantially impacting color and/or transparency. Such a biocidal additive formulation may also be added by a manufacturer during or after production of a bulk quantity of polyurethane precursor or epoxy resin precursor so as to impart, for example, desired antimicrobial properties. Examples of a form of a biocidal additive formulation may include a powder, a slurry, a gel, a liquid, a concentrate, and a solution. In certain examples, the biocidal additive formulation is in liquid form at ambient conditions (1 atm (-101.3 kPa) and 20 °C). In some aspects, the biocidal additive formulation comprises solubilized copper(I) salt in the form of a copper complex, in which the copper(I) salt is coordinated to or otherwise associated with a copper-assisting additive that facilitates the solubility of the copper(I) salt. Without wishing to be bound by theory, it is believed that in some aspects, it is desirable to first prepare a biocidal additive formulation for addition to a composition, rather than simply adding a copper salt to a composition, or rather than simply adding a copper salt and a copper-assisting additive separately to a composition. For example, it is believed that addition of copper salt alone, or addition of copper salt and an additive separately to the same composition (without premixing) may, in some cases, not allow the copper-assisting additive to sufficiently promote the availability and/or persistence of copper(I) ions. For example, separate addition may not allow the copper-assisting additive to find and associate with the copper salt. However, in certain aspects, separate addition of the copper salt and copper-assisting additive may be sufficient, such as, for example, where the additive is present in a sufficiently high concentration and/or the medium of the composition otherwise does not inhibit the ability of the additive and copper salt to come together, such as because of viscosity, diffusion, or some other reason. In certain examples, the biocidal additive formulation may include an antioxidant package. Antioxidant packages may include single components or ternary mixtures. Examples of antioxidant packages may include primary antioxidants; phenolics, such as BHT; secondary antioxidants, such as Ultranox™ 626, Weston™ 430 ZP, thioester-based antioxidants (thiosynergists), such as dioctadecyl 3,3 ’-thiodipropionate; ascorbate esters, such as ascorbyl palmitate; or any combination thereof. In certain examples, the biocidal additive formulation may include a reducing agent. Examples of reducing agents may include ascorbic acid, hydroxylamine hydrochloride, various phosphines, sulfite compounds, oxalic acid, sodium thiosulfate, or any combination thereof. Examples of a form of a biocidal additive formulation may include a powder, a slurry, a gel, a liquid, a concentrate, and a solution. In certain examples, the biocidal additive formulation may include an antioxidant package. Antioxidant packages may include single components or ternary mixtures. Examples of antioxidant packages may include primary antioxidants; phenolics, such as BHT; secondary antioxidants, such as Ultranox™ 626, Weston™ 430 ZP, thioester-based antioxidants (thiosynergists), such as dioctadecyl 3,3’- thiodipropionate; ascorbate esters, such as ascorbyl palmitate; or any combination thereof. In certain examples, the biocidal additive formulation may include a reducing agent. Examples of reducing agents may include ascorbic acid, hydroxylamine hydrochloride, various phosphines, sulfite compounds, oxalic acid, sodium thiosulfate, or any combination thereof. In certain examples, the biocidal additive formulation may be in a sealed container including an inert atmosphere.
[0124] In an example, the biocidal additive formulation has a molarity of the copper(I) salt dissolved in the biocidal additive formulation of from 20 mA/ to 200 mA/, including, for example, from 25 mA/, or from 30 mA/, or from 35 mA/, or from 40 mA/, or from 45 mA/, or from 50 mA/, or from 55 mA/, or from 60 mA/, or from 65 mA/, or from 70 mA/, or from 75 mA/, or from 80 mA/, or from 85 mA/, or from 90 mA/, or from 95 mA/, or from 100 mA/, or from 105 mA/, or from 110 mA/, or from 115 mA/, or from 120 mA/, or from 125 mA/, or from 130 mA/, or from 135 mA/, or from 140 mA/, or from 145 mA/, or from 150 mA/, or from 155 mA/, or from 160 mA/, or from 165 mA/, or form 170 mA/, or from 175 mA/, or from 180 mA/, or from 185 mA/, or from 190 mA/, or from 195 mA/ to 200 mA/; or from 20 mA/ to 25 mA/, or to 30 mA/, or to 35 mA/, or to 40 mA/, or to 45 mA/, or to 50 mA/, or to 55 mA/, or to 60 mA/, or to 65 mA/, or to 70 mA/, or to 75 mA/, or to 80 mA/, or to 85 mA/, or to 90 mA/, or to 95 mA/, or to 100 mA/, or to 105 mA/, or to 110 mA/, or to 115 mA/, or to 120 mA/, or to 125 mA/, or to 130 mA/, or to 135 mA/, or to 140 mA/, or to 145 mA/, or to 150 mA/, or to 155 mA/, or to 160 mA/, or to 165 mA/, or to 170 mA/, or to 175 mA/, or to 180 mA/, or to 185 mA/, or to 190 mA/, or to 195 mA/; or a range formed from any two of the foregoing molarities; including any subranges therebetween.
[0125] In certain examples, the biocidal additive formulation may include a copper-assisting additive at a molarity of the copper-assisting additive in the biocidal additive formulation of from 0.06 mA/ to 0.6 mA/; including, for example, from 0.065 mA/, or from 0.07 mA/, or from 0.075 mA/, or from 0.08 mA/, or from 0.085 mA/, or from 0.09 mA/, or from 0.095 mA/, or from 0.1 mA/, or from 0.105 mA/, or from 0.110 mA/, or from 0.115 mA/, or from 0.120 mA/, or from 0.125 mA/, or from 0.130 mA/, or from 0.135 mA/, or from 0.140 mA/, or from 0.145 mA/, or from 0.150 mA/, or from 0.155 mA/, or from 0.160 mA/, or from 0.165 mA/, or from 0.170 mA/, or from 0.175 mA/, or from 0.180 mA/, or from 0.185 mA/, or from 0.190 mA/, or from 0.195 mA/, or from 0.200 mA/, or from 0.205 mA/, or from 0.210 mA/, or from 0.215 mA/, or from 0.220 mA/, or from 0.225 mA/, or from 0.230 mA/, or from 0.235 mA/, or from 0.240 mA/, or from 0.245 mA/, or from 0.250 mA/, or from 0.255 mA/, or from 0.260 mA/, or from 0.265 mA/, or from 0.270 mA/, or from 0.275 mA/, or from 0.280 mA/, or from 0.285 mA/, or from 0.290 mA/, or from 0.295 mA/, or from 0.300 mA/, or from 0.305 mA/, or from 0.310 mA/, or from 0.315 mA/, or from 0.320 mA/, or from 0.325 mA/, or from 0.330 mA/, or from 0.335 mA/, or from 0.340 mA/, or from 0.345 mA/, or from 0.350 mA/, or from 0.355 mA/, or from 0.360 mA/, or from 0.365 mA/, or from 0.370 mA/, or from 0.375 mA/, or from 0.380 mA/, or from 0.385 mA/, or from 0.390 mA/, or from 0.395 mA/, or from 0.400 mA/, or from 0.405 mA/, or from 0.410 mA/, or from 0.415 mA/, or from 0.420 mA/, or from 0.425 mA/, or from 0.430 mA/, or from 0.435 mA/, or from 0.440 mA/, or from 0.445 mA/, or from 0.450 mA/, or from 0.455 mA/, or from 0.460 mA/, or from 0.465 mA/, or from 0.470 mA/, or from 0.475 mA/, or from 0.480 mA/, or from 0.485 mA/, or from 0.490 mA/, or from 0.495 mA/, or from 0.500 mA/, or from 0.505 mA/, or from 0.510 mA/, or from 0.515 mA/, or from 0.520 mA/, or from 0.525 mA/, or from 0.530 mA/, or from 0.535 mA/, or from 0.540 mA/, or from 0.545 mA/, or from 0.550 mA/, or from 0.555 mA/, or from 0.560 mA/, or from 0.565 mA/, or from 0.570 mA/, or from 0.575 mA/, or from 0.580 mA/, or from 0.585 mA/, or from 0.590 mA/, or from 0.595 mA/ to 0.600 mA/; or from 0.06 mA/ to 0.065 mA/, or to 0.07 mA/, or to 0.075 mA/, or to 0.08 mA/, or to 0.085 mA/, or to 0.09 mA/, or to 0.095 mA/, or to 0.100 mA/, or to 0.105 mA/, or to 0.110 mA/, or to 0.115 mA/, or to 0.120 mA/, or to 0.125 mA/, or to 0.130 mA/, or to 0.135 mA/, or to 0. 140 mA/, or to 0.145 mA/, or to 0.150 mA/, or to 0.155 mA/, or to 0.160 mA/, or to 0.165 mA/, or to 0.170 mA/, or to 0.175 mA/, or to 0.180 mA/, or to 0.185 mA/, or to 0.190 mA/, or to 0.195 mA/, or to 0.200 mA/, or to 0.205 mA/, or to 0.210 mA/, or to 0.215 mA/, or to 0.220 mA/, or to 0.225 mA/, or to 0.230 mA/, or to 0.235 mA/, or to 0.240 mA/, or to 0.245 mA/, or to 0.250 mA/, or to 0.255 mA/, or to 0.260 mA/, or to 0.265 mA/, or to 0.270 mA/, or to 0.275 mA/, or to 0.280 mA/, or to 0.285 mA/, or to 0.290 mA/, or to 0.295 mA/, or to 0.300 mA/, or to 0.305 mA/, or to 0.310 mA/, or to 0.315 mA/, or to 0.320 mA/, or to 0.325 mA/, or to 0.330 mA/, or to 0.335 mA/, or to 0.340 mA/, or to 0.345 mA/, or to 0.350 mA/, or to 0.355 mA/, or to 0.360 mA/, or to 0.365 mA/, or to 0.370 mA/, or to 0.375 mA/, or to 0.380 mA/, or to 0.385 mA/, or to 0.390 mA/, or to 0.395 mA/, or to 0.400 mA/, or to 0.405 mA/, or to 0.410 mA/, or to 0.415 mA/, or to 0.420 mA/, or to 0.425 mA/, or to 0.430 mA/, or to 0.435 mA/, or to 0.440 mA/, or to 0.445 mA/, or to 0.450 mA/, or to 0.455 mA/, or to 0.460 mA/, or to 0.465 mA/, or to 0.470 mA/, or to 0.475 mA/, or to 0.480 mA/, or to 0.485 mA/, or to 0.490 mA/, or to 0.495 mA/, or to 0.500 mA/, or to 0.505 mA/, or to 0.510 mA/, or to 0.515 mA/, or to 0.520 mA/, or to 0.525 mA/, or to 0.530 mA/, or to 0.535 mA/, or to 0.540 mA/, or to 0.545 mA/, or to 0.550 mA/, or to 0.555 mA/, or to 0.560 mA/, or to 0.565 mA/, or to 0.570 mA/, or to 0.575 mA/, or to 0.580 mA/, or to 0.585 mA/, or to 0.590 mA/, or to 0.595 mA/; or a range formed from any two of the foregoing molarities; including any subranges therebetween.
[0126] In some examples, the biocidal additive formulation may include a copper(I) salt and a copper-assisting additive at any of the ratios disclosed elsewhere herein.
[0127] In certain examples, the biocidal additive formulation may include a solvent at a molarity of the solvent in the biocidal additive formulation of from 0.8 mA/ to 8.00 mA/, including, for example, from 0.85 mA/, or from 0.90 mA/, or from 0.95 mA/, or from 1.00 mA/, or from 1.05 mA/, or from 1.10 mA/, or from 1.15 mA/, or from 1.20 mA/, or from 1.25 mA/, or from 1.30 mA/, or from 1.35 mA/, or from 1.40 mA/, or from 1.45 mA/, or from 1.50 mA/, or from 1.55 mA/, or from 1.60 mA/, or from 1.65 mA/, or from 1.70 mA/, or from 1.75 mA/, or from 1.80 mA/, or from 1.85 mA/, or from 1.90 mA/, or from 1.95 mA/, or from 2.00 mA/, or from 2.05 mA/, or from 2.10 mA/, or from 2.15 mA/, or from 2.20 mA/, or from 2.25 mA/, or from 2.30 mA/, or from 2.35 mA/, or from 2.40 mA/, or from 2.45 mA/, or from 2.50 mA/, or from 2.55 mA/, or from 2.60 mA/, or from 2.65 mA/, or from 2.70 mA/, or from 2.75 mA/, or from 2.80 mA/, or from 2.85 mA/, or from 2.90 mA/, or from 2.95 mA/, or from 3.00 mA/, or from 3.05 mA/, or from 3.10 mA/, or from 3.15 mA/, or from 3.20 mA/, or from 3.25 mA/, or from 3.30 mA/, or from 3.35 mA/, or from 3.40 mA/, or from 3.45 mA/, or from 3.50 mA/, or from 3.55 mA/, or from 3.60 mA/, or from 3.65 mA/, or from 3.70 mA/, or from 3.75 mA/, or from 3.80 mA/, or from 3.85 mA/, or from 3.90 mA/, or from 3.95 mA/, or from 4.00 mA/, or from 4.05 mA/, or from 4.10 mA/, or from 4.15 mA/, or from 4.20 mA/, or from 4.25 mA/, or from 4.30 mA/, or from 4.35 mA/, or from 4.40 mA/, or from 4.45 mA/, or from 4.50 mA/, or from 4.55 mA/, or from 4.60 mA/, or from 4.65 mA/, or from 4.70 mA/, or from 4.75 mA/, or from 4.80 mA/, or from 4.85 mA/, or from 4.90 mA/, or from 4.95 mA/, or from 5.00 mA/, or from 5.05 mA/, or from 5.10 mA/, or from 5.15 mA/, or from 5.20 mA/, or from 5.25 mA/, or from 5.30 mA/, or from 5.35 mA/, or from 5.40 mA/, or from 5.45 mA/, or from 5.50 mA/, or from 5.55 mA/, or from 5.60 mA/, or from 5.65 mA/, or from 5.70 mA/, or from 5.75 mA/, or from 5.80 mA/, or from 5.85 mA/, or from 5.90 mA/, or from 5.95 mA/, or from 6.00 mA/, or from 6.05 mA/, or from 6.10 mA/, or from 6.15 mA/, or from 6.20 mA/, or from 6.25 mA/, or from 6.30 mA/, or from 6.35 mA/, or from 6.40 mA/, or from 6.45 mA/, or from 6.50 mA/, or from 6.55 mA/, or from 6.60 mA/, or from 6.65 mA/, or from 6.70 mA/, or from 6.75 mA/, or from 6.80 mA/, or from 6.85 mA/, or from 6.90 mA/, or from 6.95 mA/, or from 7.00 mA/, or from 7.05 mA/, or from 7.10 mA/, or from 7.15 mA/, or from 7.20 mA/, or from 7.25 mA/, or from 7.30 mA/, or from 7.35 mA/, or from 7.40 mA/, or from 7.45 mA/, or from 7.50 mA/, or from 7.55 mA/, or from 7.60 mA/, or from 7.65 mA/, or from 7.70 mA/, or from 7.75 mA/, or from 7.80 mA/, or from 7.85 mA/, or from 7.90 mA/, or from 7.95 mA/ to 8.00 mA/; or from
0.80 mA/ to 0.85 mA/, or to 0.90 mA/, or to 0.95 mA/, or to 1.00 mA/, or to 1.05 mA/, or to 1.10 mA/, or to 1.15 mA/, or to 1.20 mA/, or to 1.25 mA/, or to 1.30 mA/, or to 1.35 mA/, or to 1.40 mA/, or to 1.45 mA/, or to 1.50 mA/, or to 1.55 mA/, or to 1.60 mA/, or to 1.65 mA/, or to 1.70 mA/, or to 1.75 mA/, or to 1.80 mA/, or to 1.85 mA/, or to 1.90 mA/, or to 1.95 mA/, or to 2.00 mA/, or to 2.05 mA/, or to 2.10 mA/, or to 2.15 mA/, or to 2.20 mA/, or to 2.25 mA/, or to 2.30 mA/, or to 2.35 mA/, or to 2.40 mA/, or to 2.45 mA/, or to 2.50 mA/, or to 2.55 mA/, or to 2.60 mA/, or to 2.65 mA/, or to 2.70 mA/, or to 2.75 mA/, or to 2.80 mA/, or to 2.85 mA/, or to 2.90 mA/, or to 2.95 mA/, or to 3.00 mA/, or to 3.05 mA/, or to 3.10 mA/, or to 3.15 mA/, or to 3.20 mA/, or to 3.25 mA/, or to 3.30 mA/, or to 3.35 mA/, or to 3.40 mA/, or to 3.45 mA/, or to 3.50 mA/, or to 3.55 mA/, or to 3.60 mA/, or to 3.65 mA/, or to 3.70 mA/, or to 3.75 mA/, or to 3.80 mA/, or to 3.85 mA/, or to 3.90 mA/, or to 3.95 mA/, or to 4.00 mA/, or to 4.05 mA/, or to 4.10 mA/, or to 4.15 mA/, or to 4.20 mA/, or to 4.25 mA/, or to 4.30 mA/, or to 4.35 mA/, or to 4.40 mA/, or to 4.45 mA/, or to 4.50 mA/, or to 4.55 mA/, or to 4.60 mA/, or to 4.65 mA/, or to 4.70 mA/, or to 4.75 mA/, or to 4.80 mA/, or to 4.85 mA/, or to 4.90 mA/, or to 4.95 mA/, or to 5.00 mA/, or to 5.05 mA/, or to 5.10 mA/, or to 5.15 mA/, or to 5.20 mA/, or to 5.25 mA/, or to 5.30 mA/, or to 5.35 mA/, or to 5.40 mA/, or to 5.45 mA/, or to 5.50 mA/, or to 5.55 mA/, or to 5.60 mA/, or to 5.65 mA/, or to 5.70 mA/, or to 5.75 mA/, or to 5.80 mA/, or to 5.85 mA/, or to 5.90 mA/, or to 5.95 mA/, or to 6.00 mA/, or to 6.05 mA/, or to 6.10 mA/, or to 6.15 mA/, or to 6.20 mA/, or to 6.25 mA/, or to 6.30 mA/, or to 6.35 mA/, or to 6.40 mA/, or to 6.45 mA/, or to 6.50 mA/, or to 6.55 mA/, or to 6.60 mA/, or to 6.65 mA/, or to 6.70 mA/, or to 6.75 mA/, or to 6.80 mA/, or to 6.85 mA/, or to 6.90 mA/, or to 6.95 mA/, or to 7.00 mA/, or to 7.05 mA/, or to 7.10 mA/, or to 7.15 mA/, or to 7.20 mA/, or to 7.25 mA/, or to 7.30 mA/, or to 7.35 mA/, or to 7.40 mA/, or to 7.45 mA/, or to 7.50 mA/, or to 7.55 mA/, or to 7.60 mA/, or to 7.65 mA/, or to 7.70 mA/, or to 7.75 mA/, or to 7.80 mA/, or to 7.85 mA/, or to 7.90 mA/, or to 7.95 mA/; or a range formed from any two of the foregoing molarities; including any subranges therebetween. Examples of organic solvents in biocidal compositions and biocidal additive formulations may include acetonitrile and ethyl acetate.
[0128] In an example, the present disclosure provides a biocidal composition, including: a carrier, including a polyurethane, a polyurethane precursor, an epoxy resin, an epoxy resin precursor, a melamine resin, or any combination thereof; a copper(I) salt; and a copper- assisting additive different from the carrier; wherein the copper-assisting additive includes a phosphite, a phosphine, or a combination thereof; and wherein the biocidal composition or a film thereof exhibits an antimicrobial efficacy of at least 3 log kill as measured with an EPA Test after storage of the biocidal composition or the film thereof at ambient temperature and ambient relative humidity for 90 days or at least 90 days (or any other time period disclosed herein).
[0129] In certain examples, the phosphite may be a compound of formula (I):
Figure imgf000052_0001
wherein each R1 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally fluorosubstituted.
[0130] In certain examples, the phosphine may be a compound of formula (II):
Figure imgf000053_0001
wherein each R2 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally substituted with a hydroxy group.
[0131] In certain examples, the carrier may include a polyurethane, a polyurethane precursor, or a combination thereof.
[0132] In certain examples, the carrier may include an epoxy resin, an epoxy resin precursor, or a combination thereof.
[0133] In certain examples, the carrier may include an organic solvent.
[0134] In certain examples, the copper(I) salt may be a copper(I) halide, iodo(triethyl phosphite)copper(I), or a tetrakis(acetonitrile)copper(I) salt.
[0135] In certain examples, the copper(I) salt may be copper(I) bromide or copper(I) iodide.
[0136] In certain examples, each R1 may be independently selected from C2-C13 alkyl, Ci-Cs alkyl, Ci-Ce alkyl, C2-C5 alkyl, C2-C4 alkyl, or phenyl.
[0137] In certain examples, each R2 may be independently selected from C2-C13 alkyl, Ci-Cs alkyl, Ci-Ce alkyl, C2-C5 alkyl, or C2-C4 alkyl.
[0138] In certain examples, the copper-assisting additive may be triethyl phosphite, tributyl phosphine, triphenyl phosphite, or any combination thereof.
[0139] In certain examples, a molar ratio of the copper-assisting additive to the copper(I) salt may be at least 0.5: 1.
[0140] In certain examples, the biocidal composition may further include a compound of formula (III), (IV), (V), or any combination thereof:
Figure imgf000053_0002
wherein eachR3 may be independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci- C4)alkyl, provided that all R3 are not simultaneously hydrogen; wherein each R4 may be independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R4 are not simultaneously hydrogen; and wherein each R5 may be independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R5 are not simultaneously hydrogen.
[0141] In certain examples, each R3 may be independently selected from C1-C13 alkyl, Ci-Cs alkyl, Ci-Ce alkyl, C2-C5 alkyl, or C2-C4 alkyl.
[0142] In certain examples, the biocidal composition may further include 2-ethylhexyl phosphate.
[0143] In certain examples, each R4 may be independently selected from C1-C13 alkyl, Ci-Cs alkyl, Ci-Ce alkyl, C2-C5 alkyl, or C2-C4 alkyl.
[0144] In certain examples, the biocidal composition may further include tributyl borate.
[0145] In certain examples, each R5 may be independently selected from C1-C13 alkyl, Ci-Cs alkyl, Ci-Ce alkyl, C2-C5 alkyl, or C2-C4 alkyl.
[0146] In certain examples, the biocidal composition may further include tributyl citrate.
[0147] In certain examples, the biocidal composition may exhibit a AE of less than 6, as calculated according to
Figure imgf000054_0001
wherein L*, a*, and b* are CIE values of the biocidal composition after preparing and then storing the biocidal composition at ambient temperature and ambient relative humidity for 90 days or at least 90 days (or any other time period disclosed herein), and L” control, 3- control, and b*COntroi are CIE values of an otherwise identical composition without either the copper(I) salt or the copper-assisting additive.
[0148] In certain examples, the biocidal composition or the film thereof may exhibit a transmittance of at least 98% as measured at each wavelength from 400 to 700 nanometers when measured at a thickness of 40 pm.
[0149] In certain examples, the transmittance may be within 10 percentage points of a second transmittance of an otherwise identical composition or film thereof without either the copper(I) salt or the copper-assisting additive when measured at a thickness of 40 pm.
[0150] In certain examples, a method of preparing the biocidal composition may include: adding a biocidal additive formulation to a carrier; wherein when the carrier is a polyurethane or an epoxy resin, the biocidal additive formulation may include the copper(I) salt and the copper-assisting additive; wherein when the carrier is a second polyurethane precursor, the biocidal additive formulation may include a first polyurethane precursor, the copper(I) salt, and the copper-assisting additive; and wherein when the carrier is a second epoxy resin precursor, the biocidal additive formulation may include a first epoxy resin precursor, the copper(I) salt, and the copper-assisting additive.
[0151] In an example, a biocidal additive formulation, including: a copper(I) salt; and a copper-assisting additive; wherein a biocidal composition including the biocidal additive formulation and a carrier, or a film of the biocidal composition, exhibits an antimicrobial efficacy of at least 3 log kill as measured with an EPA Test after storage of the biocidal composition or the film thereof at ambient temperature and ambient relative humidity for 90 days or at least 90 days (or any other time period disclosed herein); wherein the carrier includes a polyurethane, a polyurethane precursor, an epoxy resin, an epoxy resin precursor, a melamine resin, or any combination thereof; wherein the biocidal composition exhibits a AE of less than 6, as calculated according to
Figure imgf000055_0001
wherein L*, a*, and b* are CIE values of the biocidal composition after preparing and then storing the biocidal composition at ambient temperature and ambient relative humidity for 90 days or at least 90 days (or any other time period disclosed herein), and L’ control, 3- control, and b*COntroi are CIE values of an otherwise identical composition without either the copper(I) salt or the copper-assisting additive.
[0152] In certain examples, the biocidal additive formulation may include an organic solvent, a first polyurethane precursor, a first epoxy resin precursor, or any combination thereof.
[0153] In certain examples, the copper(I) salt may be a copper(I) halide, iodo(triethyl phosphite)copper(I), or a tetrakis(acetonitrile)copper(I) salt.
[0154] In certain examples, the copper(I) salt may be copper(I) bromide or copper(I) iodide.
[0155] In certain examples, the copper-assisting additive may include a phosphite, a phosphine, or a combination thereof.
[0156] In certain examples the phosphite may be a compound of formula (I):
Figure imgf000055_0002
wherein each R1 may be independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally fluorosubstituted, provided that all R1 are not simultaneously hydrogen. [0157] In certain examples, the phosphine may be a compound of formula (II):
Figure imgf000056_0001
wherein each R2 may be independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally substituted with a hydroxy group, provided that all R2 are not simultaneously hydrogen.
[0158] In certain examples, each R1 may be independently selected from C2-C13 alkyl, Ci-Cs alkyl, Ci-Ce alkyl, C2-C5 alkyl, or C2-C4 alkyl, or phenyl.
[0159] In certain examples, each R2 may be independently selected from C2-C13 alkyl, Ci-Cs alkyl, Ci-Ce alkyl, C2-C5 alkyl, or C2-C4 alkyl.
[0160] In certain examples, the copper-assisting additive may be triethyl phosphite, tributyl phosphine, triphenyl phosphite, or any combination thereof.
[0161] In certain examples, a molar ratio of the copper-assisting additive to the copper(I) salt may be at least 0.5: 1.
[0162] In certain examples, the biocidal additive formulation may further include a compound of formula (III), (IV), (V), or any combination thereof:
Figure imgf000056_0002
wherein eachR3 may be independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci- C4)alkyl, provided that all R3 are not simultaneously hydrogen; wherein each R4 may be independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R4 are not simultaneously hydrogen; and wherein each R5 may be independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R5 are not simultaneously hydrogen.
[0163] In certain examples, each R3 may be independently selected from C1-C13 alkyl, Ci-Cs alkyl, Ci-Ce alkyl, C2-C5 alkyl, or C2-C4 alkyl. [0164] In certain examples, the biocidal additive formulation may further include 2-ethylhexyl phosphate.
[0165] In certain examples, each R4 may be independently selected from C1-C13 alkyl, Ci-Cs alkyl, Ci-Ce alkyl, C2-C5 alkyl, or C2-C4 alkyl.
[0166] In certain examples, the biocidal additive formulation may further include tributyl borate.
[0167] In certain examples, each R5 may be independently selected from C1-C13 alkyl, Ci-Cs alkyl, Ci-Ce alkyl, C2-C5 alkyl, or C2-C4 alkyl.
[0168] In certain examples, the biocidal additive formulation may further include tributyl citrate.
[0169] In certain examples, the biocidal composition or the film thereof may exhibit a transmittance of at least 98% as measured at each wavelength from 400 to 700 nanometers when measured at a thickness of 40 pm.
[0170] In certain examples, the transmittance may be within 10 percentage points of a second transmittance of an otherwise identical composition or film thereof without either the copper(I) salt or the copper-assisting additive when measured at a thickness of 40 pm.
[0171] In certain examples, the biocidal additive formulation may further include an antioxidant.
[0172] In certain examples, the biocidal additive formulation may further include a reducing agent.
[0173] In certain examples, the formulation may be in a sealed container including an inert atmosphere.
[0174] Although the present disclosure has been described with reference to examples and the accompanying figures and charts, the present disclosure is not limited thereto, but may be variously modified and altered by those skilled in the art to which the present disclosure pertains without department from the spirit and scope of the present disclosure.
[0175] Various aspects are contemplated herein, several of which are set forth in the paragraphs below. It is explicitly contemplated that any aspect or portion thereof may be combined to form a combination.
[0176] A first aspect relates to a biocidal composition, comprising: a carrier, comprising a polyurethane, a polyurethane precursor, an epoxy resin, an epoxy resin precursor, a melamine resin, or any combination thereof; a copper(I) salt; and a copper-assisting additive different from the carrier; wherein the copper-assisting additive comprises a phosphite, a phosphine, or a combination thereof; and wherein the biocidal composition or a film thereof exhibits an antimicrobial efficacy of at least 3 log kill as measured with an EPA Test after storage of the biocidal composition or the film thereof at ambient temperature and ambient relative humidity for 90 days or at least 90 days (or any other time period disclosed herein).
[0177] A second aspect relates to the biocidal composition of aspect 1, or any preceding aspect, wherein the phosphite is a compound of formula (I):
Figure imgf000058_0001
wherein each R1 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally fluorosubstituted.
[0178] A third aspect relates to the biocidal composition of any preceding aspect, wherein the phosphine is a compound of formula (II):
Figure imgf000058_0002
wherein each R2 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally substituted with a hydroxy group.
[0179] A fourth aspect relates to the biocidal composition of any preceding aspect, wherein the carrier comprises a polyurethane, a polyurethane precursor, or a combination thereof.
[0180] A fifth aspect relates to the biocidal composition of aspects 1 to 3, or any preceding aspect, wherein the carrier comprises an epoxy resin, an epoxy resin precursor, or a combination thereof.
[0181] A sixth aspect relates to the biocidal composition of any preceding aspect, wherein the carrier comprises an organic solvent.
[0182] A seventh aspect relates to the biocidal composition of any preceding aspect, wherein the copper(I) salt is a copper(I) halide, iodo(triethyl phosphite)copper(I), or a tetrakis(acetonitrile)copper(I) salt.
[0183] An eighth aspect relates to the biocidal composition of any preceding aspect, wherein the copper(I) salt is copper(I) bromide or copper(I) iodide.
[0184] A ninth aspect relates to the biocidal composition of aspects 2 to 8, or any preceding aspect, wherein each R1 is independently selected from C2-C13 alkyl (or Ci-Cs alkyl, or Ci-Ce alkyl, or C2-C5 alkyl, C2-C4 alkyl), or phenyl. [0185] A tenth aspect relates to the biocidal composition of aspects 3 to 9, or any preceding aspect, wherein each R2 is independently selected from C2-C13 alkyl (or Ci-Cs alkyl, or Ci-Ce alkyl, or C2-C5 alkyl, or C2-C4 alkyl).
[0186] An eleventh aspect relates to the biocidal composition of any preceding aspect, wherein the copper-assisting additive is triethyl phosphite, triphenyl phosphite, tributyl phosphine, or any combination thereof.
[0187] A twelfth aspect relates to the biocidal composition of any preceding aspect, wherein a molar ratio of the copper-assisting additive to the copper(I) salt is at least 0.5: 1.
[0188] A thirteenth aspect relates to the biocidal composition of any preceding aspect, further comprising a compound of formula (III), (IV), (V), or any combination thereof:
Figure imgf000059_0001
wherein each R3 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci- C4)alkyl, provided that all R3 are not simultaneously hydrogen; wherein each R4 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R4 are not simultaneously hydrogen; and wherein each R5 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R5 are not simultaneously hydrogen.
[0189] A fourteenth aspect relates to the biocidal composition of aspect 13, or any preceding aspect, wherein each R3 is independently selected from C1-C13 alkyl (or Ci-Cs alkyl, or Ci-Ce alkyl, or C2-C5 alkyl, or C2-C4 alkyl).
[0190] A fifteenth aspect relates to the biocidal composition of any preceding aspect, further comprising 2-ethylhexyl phosphate.
[0191] A sixteenth aspect relates to the biocidal composition of aspect 13, or any preceding aspect, wherein each R4 is independently selected from C1-C13 alkyl (or Ci-Cs alkyl, or Ci-Ce alkyl, or C2-C5 alkyl, or C2-C4 alkyl). [0192] A seventeenth aspect relates to the biocidal composition of any preceding aspect, further comprising tributyl borate.
[0193] An eighteenth aspect relates to the biocidal composition of aspect 13, or any preceding aspect, wherein each R5 is independently selected from C1-C13 alkyl (or Ci-Cs alkyl, or Ci-Ce alkyl, or C2-C5 alkyl, or C2-C4 alkyl).
[0194] A nineteenth aspect relates to the biocidal composition of any preceding aspect, further comprising tributyl citrate.
[0195] A twentieth aspect relates to the biocidal composition of any preceding aspect, wherein the biocidal composition exhibits a AE of less than 6, as calculated according to
Figure imgf000060_0001
wherein L*, a*, and b* are CIE values of the biocidal composition after preparing and then storing the biocidal composition at ambient temperature and ambient relative humidity for 90 days or at least 90 days (or any other time period disclosed herein), and L” control, 3- control, and b*COntroi are CIE values of an otherwise identical composition without either the copper(I) salt or the copper-assisting additive.
[0196] A twenty-first aspect relates to the biocidal composition of any preceding aspect, wherein the biocidal composition or the film thereof exhibits a transmittance of at least 98% as measured at each wavelength from 400 to 700 nanometers when measured at a thickness of 40 pm.
[0197] A twenty-second aspect relates to the biocidal composition of aspect 21, or any preceding aspect, wherein the transmittance is within 10 percentage points of a second transmittance of an otherwise identical composition or film thereof without either the copper(I) salt or the copper-assisting additive when measured at a thickness of 40 pm.
[0198] A twenty -third aspect relates to a method of preparing the biocidal composition of any preceding aspect, comprising: adding a biocidal additive formulation to a carrier; wherein when the carrier is a polyurethane or an epoxy resin, the biocidal additive formulation comprises the copper(I) salt and the copper-assisting additive; wherein when the carrier is a second polyurethane precursor, the biocidal additive formulation comprises a first polyurethane precursor, the copper(I) salt, and the copper-assisting additive; and wherein when the carrier is a second epoxy resin precursor, the biocidal additive formulation comprises a first epoxy resin precursor, the copper(I) salt, and the copper-assisting additive.
[0199] A twenty-fourth aspect relates to a biocidal additive formulation, comprising:a copper(I) salt; and a copper-assisting additive; wherein a biocidal composition comprising the biocidal additive formulation and a carrier, or a film of the biocidal composition, exhibits an antimicrobial efficacy of at least 3 log kill as measured with an EPA Test after storage of the biocidal composition or the film thereof at ambient temperature and ambient relative humidity for 90 days or at least 90 days (or any other time period disclosed herein); wherein the carrier comprises a polyurethane, a polyurethane precursor, an epoxy resin, an epoxy resin precursor, a melamine resin, or any combination thereof; wherein the biocidal composition exhibits a AE of less than 6, as calculated according to
Figure imgf000061_0001
wherein L*, a*, and b* are CIE values of the biocidal composition after preparing and then storing the biocidal composition at ambient temperature and ambient relative humidity for 90 days or at least 90 days (or any other time period disclosed herein), and L’ control, 3- control, and b*COntroi are CIE values of an otherwise identical composition without either the copper(I) salt or the copper-assisting additive.
[0200] A twenty-fifth aspect relates to the biocidal additive formulation of aspect 24, or any preceding aspect, further comprising an organic solvent, a first polyurethane precursor, a first epoxy resin precursor, or any combination thereof.
[0201] A twenty-sixth aspect relates to the biocidal additive formulation of aspect 24 or 25, or any preceding aspect, wherein the copper(I) salt is a copper(I) halide, iodo(triethyl phosphite)copper(I), or a tetrakis(acetonitrile)copper(I) salt.
[0202] A twenty-seventh aspect relates to the biocidal additive formulation of aspects 24 to 26, or any preceding aspect, wherein the copper(I) salt is copper(I) bromide or copper(I) iodide.
[0203] A twenty-eighth aspect relates to the biocidal additive formulation of aspects 24 to 27, or any preceding aspect, wherein the copper-assisting additive comprises a phosphite, a phosphine, or a combination thereof.
[0204] A twenty-ninth aspect relates to the biocidal additive formulation of aspect 28, or any preceding aspect, wherein the phosphite is a compound of formula (I):
Figure imgf000061_0002
wherein each R1 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally fluorosubstituted.
[0205] A thirtieth aspect relates to the biocidal additive formulation of aspect 28, or any preceding aspect, wherein the phosphine is a compound of formula (II):
Figure imgf000062_0001
wherein each R2 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally substituted with a hydroxy group.
[0206] A thirty-first aspect relates to the biocidal additive formulation of aspect 29, or any preceding aspect, wherein each R1 is independently selected from C2-C13 alkyl (or Ci-Cs alkyl, or Ci-Ce alkyl, or C2-C5 alkyl, or C2-C4 alkyl).
[0207] A thirty-second aspect relates to the biocidal additive formulation of aspect 30, or any preceding aspect, wherein each R2 is independently selected from C2-C13 alkyl (or Ci-Cs alkyl, or Ci-Ce alkyl, or C2-C5 alkyl, or C2-C4 alkyl).
[0208] A thirty-third aspect relates to the biocidal additive formulation of aspects 24 to 32, or any preceding aspect, wherein the copper-assisting additive is triethyl phosphite, tributyl phosphine, triphenyl phosphite, or any combination thereof.
[0209] A thirty-fourth aspect relates to the biocidal additive formulation of aspects 24 to 33, or any preceding aspect, wherein a molar ratio of the copper-assisting additive to the copper(I) salt is at least 0.5: 1.
[0210] A thirty-fifth aspect relates to the biocidal additive formulation of aspects 24 to 34, or any preceding aspect, further comprising a compound of formula (III), (IV), (V), or any combination thereof:
Figure imgf000062_0002
wherein each R3 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci- C4)alkyl, provided that all R3 are not simultaneously hydrogen; wherein each R4 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R4 are not simultaneously hydrogen; and wherein each R5 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R5 are not simultaneously hydrogen. [0211] A thirty-sixth aspect relates to the biocidal additive formulation of aspect 35, or any preceding aspect, wherein each R3 is independently selected from C1-C13 alkyl (or Ci-Cs alkyl, or Ci-Ce alkyl, or C2-C5 alkyl, or C2-C4 alkyl).
[0212] A thirty-seventh aspect relates to the biocidal additive formulation of aspects 24 to 34, or any preceding aspect, further comprising 2-ethylhexyl phosphate.
[0213] A thirty-eighth aspect relates to the biocidal additive formulation of aspect 35, or any preceding aspect, wherein each R4 is independently selected from C1-C13 alkyl (or Ci-Cs alkyl, or Ci-Ce alkyl, or C2-C5 alkyl, or C2-C4 alkyl).
[0214] A thirty-ninth aspect relates to the biocidal additive formulation of aspects 24 to 34, or any preceding aspect, further comprising tributyl borate.
[0215] A fortieth aspect relates to the biocidal additive formulation of aspect 35, or any preceding aspect, wherein each R5 is independently selected from C1-C13 alkyl (or Ci-Cs alkyl, or Ci-Ce alkyl, or C2-C5 alkyl, or C2-C4 alkyl).
[0216] A forty-first aspect relates to the biocidal additive formulation of aspects 24 to 34, or any preceding aspect, further comprising tributyl citrate.
[0217] A forty-second aspect relates to the biocidal additive formulation of aspects 24 to 41, or any preceding aspect, wherein the biocidal composition or the film thereof exhibits a transmittance of at least 98% as measured at each wavelength from 400 to 700 nanometers when measured at a thickness of 40 pm.
[0218] A forty-third aspect relates to the biocidal additive formulation of aspect 42, or any preceding aspect, wherein the transmittance is within 10 percentage points of a second transmittance of an otherwise identical composition or film thereof without either the copper(I) salt or the copper-assisting additive when measured at a thickness of 40 pm.
[0219] A forty-fourth aspect relates to the biocidal additive formulation of aspects 24 to 43, or any preceding aspect, further comprising an antioxidant package.
[0220] A forty-fifth aspect relates to the biocidal additive formulation of aspects 24 to 43, or any preceding aspect, further comprising a reducing agent.
[0221] A forty-sixth aspect relates to the biocidal additive formulation of aspects 24 to 45, or any preceding aspect, wherein the formulation is in a sealed container comprising an inert atmosphere.
[0222] A forty-seventh aspect relates to a combination of any two or more preceding aspects, or any portion(s) thereof. [0223] The compositions and methods described above may be better understood in connection with the following Examples, which are non-limiting examples provided as an illustration of the concepts disclosed herein. The illustrated methods are applicable to other examples of biocidal compositions of the present disclosure. The procedures described as general methods describe what is believed will be typically effective to prepare the compositions indicated. However, the person skilled in the art will appreciate that it may be necessary to vary the procedures for nay given example of the present disclosure, for example, vary the order or steps and/or the chemical reagents used.
EXAMPLES
[0224] Comparison of Complexes with Copper(T) Salts to Mixtures including Copper- Containing Glass (“CCG”).
[0225] In the Examples herein, the complexes with copper(I) salts may be compared to mixtures including copper-containing material including a plurality of copper-containing glass or glass-ceramic particles. As used herein, the term “copper-containing glass” is meant to include “copper-containing glass-ceramic” unless clearly contradicted by context. In this regard, the “ceramic” portion of the copper-containing glass-ceramic may include, in some aspects, cuprite crystals.
[0226] In certain examples, the copper-containing material may include copper-containing glass or copper-containing glass-ceramic particles. The copper-containing glass or glassceramic particles may be a biocidal inorganic glass or glass-ceramic powder including copper particles. Although the individual particles of the copper-containing glass particles may be effective as a biocidal agent, such copper-containing glass may have potential drawbacks related to color of the resulting composition and stability of copper(I).
[0227] The copper-containing glass or glass-ceramic particles may independently include a Cu metal, Cu1+, Cu2+, or a combination of Cu1+ and Cu2+. The combined total of the Cu species may be 10 weight % or more of the copper-containing material. However, as will be discussed in more detail below, the amount of Cu2+ may be minimized or reduced such that the copper- containing glass or glass-ceramic particles may be substantially free of Cu2+. The copper may be non-complexed or may have a ligand bonded thereto to form a complex. The Cu1+ ions may be present on or in the surface and/or the bulk of the copper-containing glass or glass-ceramic particles. The copper-containing glass or glass-ceramic particles may include copper- containing glass or glass-ceramic, copper metal, copper(I) oxide, copper(II) oxide, or a combination thereof. In certain examples, the copper-containing glass or glass-ceramic particles may include only one of copper-containing glass or glass-ceramic, copper metal, copper(I) oxide, or copper(II) oxide. In certain examples, the Cu1+ ions may be present in a glass or glass-ceramic network and/or a glass or glass-ceramic matrix of the copper-containing glass or glass-ceramic particles. Where the Cu1+ ions are present in the glass or glass-ceramic network, the Cu1+ ions and atomically bonded to the atoms in the glass or glass-ceramic mixture. Where the Cu1+ ions are present in the glass or glass-ceramic matrix, the Cu1+ ions may be present in the form of Cu1+ crystals that are dispersed in the glass or glass-ceramic matrix. In certain examples, the Cu1+ crystals may include cuprite (CU2O). In certain examples, where Cu1+ crystals are present, the material may be referred to as a glass-ceramic or ceramic, which is intended to refer to a specific type of glass or glass-ceramic with crystals that may or may not be subjected to a traditional ceramming process by which one or more crystalline phases are introduced and/or generated in the glass or glass-ceramic. Where the Cu1+ ions are present in a non-crystalline form, the material may be referred to as a copper-containing glass. In certain examples, both Cu1+ crystals and Cu1+ ions not associated with a crystal may be present in the copper-containing glasses or glass-ceramics described herein.
[0228] Copper-containing glasses or glass-ceramics may include a copper-containing oxide in an amount, in mole percent, in the range from 10 to 50, from 10 to 49, from 10 to 48, from 10 to 47, from 10 to 46, from 10 to 45, from 10 to 44, from 10 to 43, from 10 to 42, from 10 to 41, from 10 to 40, from 10 to 39, from 10 to 38, from 10 to 37, from 10 to 36, from 10 to 35, from
10 to 34, from 10 to 33, from 10 to 32, from 10 to 31, from 10 to 30, from 10 to 29, from 10 to
28, from 10 to 27, from 10 to 26, from 10 to 25, from 10 to 24, from 10 to 23, from 10 to 22, from 10 to 21, from 10 to 20, from 11 to 50, from 12 to 50, from 13 to 50, from 14 to 50, from
15 to 50, from 16 to 50, from 17 to 50, from 18 to 50, from 19 to 50, from 20 to 50, from 10 to
30, from 11 to 29, from 12 to 28, from 13 to 27, from 14 to 26, from 15 to 25, from 16 to 24, from 17 to 23, from 18 to 22, from 19 to 21; or a range formed from any two of the foregoing mole percents; and all sub-ranges therebetween. The copper-containing oxide may be present in the copper-containing glasses or glass-ceramics in an amount of 20 mole percent, 25 mole percent, 30 mole percent, or 35 mole percent. The copper-containing oxide may include CuO, CU2O, and/or combinations thereof. The copper-containing glass or glass-ceramic particles may include cuprous oxide in an amount from 29.0 to 36.0 weight percent of the copper- containing glass or glass-ceramic particles. The copper-containing oxides in the copper- containing glasses or glass-ceramics form the Cu1+ ions present in the resulting glass or glass- ceramic. Copper may be present in a glass or glass-ceramic, or compositions thereof, in various forms, including Cu°, Cu1+, and Cu2+.
[0229] The copper-containing glass or glass-ceramic portion of the individual particles of the copper-containing glass or glass-ceramic particles may be formed from a glass composition that may include, but is not limited to, in mole percent, SiCh in the range from 30 to 70, AI2O3 in the range from 0 to 20, a copper-containing oxide in the range from 10 to 50, CaO in the range from 0 to 15, MgO in the range from 0 to 15, P2O5 in the range from 0 to 25, B2O3 in the range from 0 to 25, K2O in the range from 0 to 20, ZnO in the range from 0 to 5, Na2O in the range from 0 to 20, and/or Fe2O3 in the range from 0 to 5, nanoparticles thereof, and/or a mixture thereof. In such examples, the amount of the copper-containing oxide is greater than the amount of AI2O3. In certain examples, the glass composition may include a content of R2O, where R may include K, Na, Li, Rb, Cs, and combinations thereof.
[0230] In certain examples, the glass composition may include one or more divalent cation oxides, such as alkaline earth oxides and/or ZnO. In certain examples, the glass composition may include NiO, TiO2, Fe2O3, Cr2O3, or CO3O4 in an amount in the range up to 10 mol %, or from 0.01 mol % to 10 mol %, from 1 mol % to 10 mol %, from 2 mol % to 10 mol %, from 5 mol % to 10 mol %, from 0.01 mol % to 0.8 mol %, or from 0.01 mol % to 5 mol %.
[0231] The copper-containing glasses or glass-ceramics formed from the glass compositions may include a plurality of Cu1+ ions. In certain examples, such Cu1+ ions form part of the glass network. In certain examples, the Cu1+ ions that are dispersed in the glass matrix are Cu1+ crystals. The Cu1+ may be present in the form of cuprite. The cuprite present in the copper- containing glass-ceramic may form a phase distinct from the glass matrix or glass phase. In other examples, the cuprite may form part of or may be associated with one or more glass phases.
[0232] The copper-containing glass may be produced by any suitable method. For example, the copper-containing glass may be performed using melting tanks that are typically used for melting glass compositions such as soda lime silicate. In certain examples, the copper- containing glass may be formed into a sheet using forming processes known in the art. Forming methods may include float glass processes and down-draw processes such as fusion draw and slot draw. After formation, the copper-containing glass may be formed into sheets and may be shaped, polished, or otherwise processed for a desired end use. In certain examples, the copper- containing glass may be ground to a powder or particulate form. In certain examples, the particulate copper-containing glass may be combined with other materials or carriers. [0233] The EPA Test was used to test for antimicrobial efficacy for all examples herein.
EXAMPLE 1
[0234] The following example illustrates the determination of baseline antimicrobial efficacy of a 2-part polyurethane with copper sources (copper(I) salts).
[0235] The addition of copper sources in 2-part polyurethane resulted in negligible antimicrobial efficacy with or without addition of 2-ethylhexyl phosphate (“EHP”). Drawdowns of thin samples as well as thick samples were prepared to ensure that enough copper was present in the bulk to have sufficient antimicrobial efficacy, in ingredient amounts as provided in Table 1 below. Copper-containing glass was used as a comparator in conjunction with tetrakis(acetonitrile)copper(I), but neither attained close to 3 log kill, as illustrated in FIG. 1.
[0236] A commercially available two-part polyurethane (Eastwood® 4: 1 High Solids Urethane Premium Show Clear) was added per the manufacturer’s instructions, using a 4: 1 weight: weight ratio of Part A and Part B. Part A and Part B were mixed together first, and allowed to sit for 45 minutes before addition of copper source and copper-assisting additive. The copper(I) salt and copper-containing glass were prepared first, during which the copper source was dissolved or dispersed in acetonitrile (“ACN”) (with EHP, if used), allowed to rest for 1 hour before addition of triethyl phosphite (“TEP”), and the mixture was added to the polyurethane mixture. The resulting material was mixed thoroughly and a film was cast on a sheet of PVC and allowed to cure for 24 hours. Antimicrobial testing was performed on 1” x 1” cutouts of the resulting film.
TABLE 1
Figure imgf000067_0001
Figure imgf000068_0001
[0237] An equivalent procedure was performed using an epoxy resin, except the ratio of the epoxy Part A to the epoxy Part B was 1 : 1.
[0238] In subsequent experiments, the procedure for two-part polyurethanes and two-part epoxies was as follows: solvent and copper-assisting additive were mixed together into a homogeneous solution and added to copper species. The copper species and additive solution were mixed until the copper species was completely dissolved or a homogeneous liquid phase was formed. Additional additives were added to the mixture if necessary to achieve homogeneity. Prior to the addition of the copper species and additive solution to the two-part polyurethane, the polyurethane precursors were mixed according to the manufacturer’s specified ratio, and the polyurethane mixture was allowed to rest with exposure to air and occasional stirring to allow the polyurethane mixture to begin reacting. The copper species and additive mixture was added to the polyurethane mixture, after filtering solids if necessary, and the entire mixture was stirred until homogeneous. The mixture was applied to a substrate using conventional coating techniques, including spraying, spinning, dipping, and film applicating. In the case of film applicating, the dosed 2-part polyurethane solution was applied in front of the film applicator using a syringe and the film is drawn down over the substrate with a target wet film thickness between 2 and 10 mil. The film was then allowed to cure in either ambient conditions or elevated temperature according to product specifications. Additional coats may be applied as necessary.
EXAMPLE 2
[0239] The following example illustrates experiments to determine the antimicrobial efficacy of copper(I) salt and copper-assisting additives in commercial two-part polyurethane and two- part epoxy resin prepared according to the procedure of Example 1.
[0240] An additional copper-assisting additive (TEP) was used in combination with EHP in an attempt to keep the copper that is extracted by EHP from being oxidized. However, in both 2- part polyurethane in amounts according to Table 2 below, and in two-part epoxy resin, in amounts according to Table 3 below, as illustrated in FIGs. 2 and 3, respectively, the copper- containing glass achieved antimicrobial efficacy of at least 3 log kill. Antimicrobial efficacy was lower using copper(I) salt as the copper source, a log kill of about 1-2. The same additives in the same stoichiometry, with the same order of addition, were used for both the CCG samples and the copper(I) salt samples.
TABLE 2
Figure imgf000069_0001
Note: 5% CCG refers to 5 weight % CCG in solution, 0.45% Cu(ACN)4 refers to 0.45 weight % copper in solution (5% CCG equates to approximately 0.45 % available copper).
TABLE 3
Figure imgf000069_0002
Figure imgf000070_0001
EXAMPLE 3
[0241] The following example illustrates experiments demonstrating the antimicrobial efficacy of copper(I)-additive complexes in two-part polyurethane prepared according to the procedure of Example 1 in which iodo(tri ethyl phosphite)copper(I) (“CuI(TEP)”) was the copper(I) salt. [0242] CuI(TEP) resulted in full kill, whether EHP was added or not. While the EHP seemingly had no effect on antimicrobial efficacy, EHP addition in the amount according to Table 4 below advantageously provides a more neutral color hue in the resultant film. The further addition of TEP surprisingly and unexpectedly resulted in a reduction of antimicrobial activity for at least 90 days, as illustrated in FIG. 4, suggesting that there is a narrow range of TEP to Cu(I) stoichiometry that is antimicrobially efficacious, and excess TEP (greater than 2: 1 molar ratio of TEP to copper(I)) results in dramatically reduced antimicrobial efficacy.
TABLE 4
Figure imgf000070_0002
“0.45%” refers to 0.45 weight % copper in solution.
EXAMPLE 4
[0243] The following example illustrates experiments to determine the antimicrobial efficacy of copper(I)-additives complexes in epoxy resin prepared according to the procedure of Example 1 in which iodo(triethyl phosphite)copper(I) was the copper(I) salt. [0244] The use of the iodo(triethyl phosphite)copper(I) complex did not yield full kill in epoxy resin, and did not change the antimicrobial efficacy above the base epoxy resin, as illustrated in FIGs. 5 and 6. The addition of TEP to tetrakis(acetonitrile)copper(I) (3 : 1 molar ratio) or to copper(I) iodide (3:1 molar ratio) illustrates that for epoxy resin, more TEP is required for antimicrobial efficacy as compared to polyurethanes. The addition of more TEP (from 0.5: 1 to 9: 1 moles relative to copper(I) according to Table 5) did result in higher antimicrobial efficacy with higher amounts of TEP. While TEP may be a strong copper-assisting additive, there are more amine groups in an epoxy resin relative to binding groups in TEP.
TABLE 5
Figure imgf000071_0001
[0245] Even a strongly binding ligand such as TEP cannot outcompete amines present in an epoxy resin in a reasonable quantity, so it makes sense to reduce the effectiveness of amines as ligands to allow TEP to bind to copper(I). The use of potassium phosphate monobasic in the amounts according to Table 6 below, was only partly effective, as the salt form was not very soluble in epoxy resin. The acid form (phosphoric acid or boric acid) of soluble glass components may catalyze epoxy ring opening, and protonation of amines may limit the effectiveness of the amines ligand, but the epoxy reaction should not be negatively impacted.
TABLE 6
Figure imgf000071_0002
Figure imgf000072_0001
EXAMPLE 5
[0246] The following example illustrates antimicrobial efficacy for copper-ligand complexes generated in situ in two-part polyurethane coating prepared according to the procedure of Example 1.
[0247] An iodo- or bromo(triethyl phosphite)copper(I) complex may be generated in situ without the need for synthesizing the complex first. In acetonitrile, it was possible to fully dissolve the copper(I) bromide, by addition of three molar equivalents of EHP in addition to 1 equivalent of TEP, resulting in antimicrobial efficacy (full kill) in the amounts according to Table 7 below, as illustrated in FIG. 7. Without addition of TEP, the copper(I) bromide was not solubilized in solution, resulting in no antimicrobial efficacy. The solution of the copper(I) salt and the copper-assisting additive was pre-filtered prior to the addition to the two-part polyurethane, as particulates in the coating would have resulted in a bumpy coating. Incorporation of undissolved copper(I) salts may eventually result in antimicrobial efficacy.
TABLE 7
Figure imgf000072_0002
“0.45%” refers to 0.45 weight % copper in solution, and the values for EHP and TEP refer to molar equivalents relative to amount of copper in solution. [0248] In situ formation was also demonstrated using ethyl acetate as a solvent instead of acetonitrile. Copper(I) bromide and TEP were added together in ethyl acetate and stirred for 2 hours in the amounts according to Table 8 below, then EHP was added to the mixture and stirred for another hour before addition into a mixture of Parts A and B of polyurethane. The mixture yielded essentially no efficacy. Doubling the amount of solvent increased the solubility, and the efficacy increased to ~4 log kill, as illustrated in FIG. 8. Doubling the amount of EHP further increased the efficacy to full kill. Even the addition of EHP at the start of the procedure of preparing the mixture, rather than after 2 hours) gave a slight boost to antimicrobial efficacy (log 2 instead of 0.5). The addition of sodium phosphate dibasic
(“SPDB”) or iodine (“I2”) did not improve the solubility or antimicrobial efficacy.
TABLE 8
Figure imgf000073_0001
Figure imgf000074_0001
“0.45%” refers to 0.45 weight % copper in solution, and the “equiv.” values for EtOAc, EHP,
TEP, I2, and SPDB are molar equivalents relative to amount of copper in solution.
[0249] EHP may be substituted for another solubilizer such as tributyl citrate (“TBC”) or tributyl borate (“TBB”) in the amounts according to Table 9 below, which have both been shown to yield higher antimicrobial efficacy (tributyl citrate full kill, tributyl borate >4 log kill), as illustrated in FIG. 9.
TABLE 9
Figure imgf000074_0002
Figure imgf000075_0001
“0.45%” refers to 0.45 weight % copper in solution, and the “equiv.” values for ACN, TEP,
TBC, and TBB are molar equivalents relative to amount of copper in solution.
[0250] Tributyl phosphine (“TBP”) was also shown to be effective as a copper-assisting additive in 2-part polyurethane with copper(I) bromide and EHP in the amounts as provided below in Table 10. TBP demonstrated full kill antimicrobial efficacy at slight excess of TBP relative to copper, but not demonstrating antimicrobial efficacy at larger molar excess of TBP relative to copper, as illustrated in FIG. 10. TABLE 10
Figure imgf000076_0001
“0.45%” refers to 0.45 weight % copper in solution and the “equiv.” values for ACN, EHP, and TBP are molar equivalents relative to amount of copper in solution.
[0251] Coatings (~40 pm) spun coat on glass with and without copper(I) resulted in minimal changes in color and only a slight loss of transmission for dosed copper, with AE* of 0.1 for the undosed polyurethane (“undosed”) relative to uncoated glass (“glass (control)”), and 0.6 for the copper-dosed polyurethane coating. The copper-dosed polyurethane coating (“dosed”) used the Iodo(TEP)Cu(I) in ACN + EHP (0.45%) exemplary composition including amounts as recited above in Table 4. The transmission loss was minimal, with minor absorbance at approximately 350 nm, as illustrated in FIG. 11. The CIE values for glass, undosed polyurethane, and copper-additive dosed polyurethane are provided below in Table 11.
TABLE 11
Figure imgf000076_0002
Figure imgf000077_0001
[0252] It will be appreciated that the various disclosed aspects or examples may involve particular features, elements, or steps that are described in connection with that particular aspect or example. It will also be appreciated that a particular feature, element, or step, although described in relation to one particular aspect or example, may be interchanged or combined with alternate aspects or examples in various non-illustrated combinations or permutations.
[0253] While various features, elements, or steps of particular aspects or examples may be disclosed using the transitional phrase “comprising,” it is to be understood that alternative aspects or examples, including those that may be described using the transitional phrases “consisting of’ or “consisting essentially of,” are implied. Thus, for example, implied alternative aspects or examples to a device that comprises A+B+C include aspects or examples where a device consists of A+B+C and aspects or examples where a device consists essentially of A+B+C.
[0254] It will be apparent to those ordinarily skilled in the art that various modifications and variations may be made to the present disclosure without departing from the spirit and scope of the disclosure. Because modifications, combinations, sub-combinations, and variations of the disclosed examples incorporating the spirit and substance of the disclosure may occur to persons ordinarily skilled in the art, the disclosure should be construed to include everything within the scope of the appended claims and their equivalents.

Claims

1. A biocidal composition, comprising: a carrier, comprising a polyurethane, a polyurethane precursor, an epoxy resin, an epoxy resin precursor, a melamine resin, or any combination thereof; a copper(I) salt; and a copper-assisting additive different from the carrier; wherein the copper-assisting additive comprises a phosphite, a phosphine, or a combination thereof; and wherein the biocidal composition or a film thereof exhibits an antimicrobial efficacy of at least 3 log kill as measured with an EPA Test after storage of the biocidal composition or the film thereof at ambient temperature and ambient relative humidity for 90 days.
2. The biocidal composition of claim 1, wherein the phosphite is a compound of formula (I):
Figure imgf000078_0001
wherein eachR1 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally fluorosubstituted.
3. The biocidal composition of any preceding claim, wherein the phosphine is a compound of formula (II):
Figure imgf000078_0002
wherein each R2 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci- C4)alkyl, any of which is optionally substituted with a hydroxy group.
4. The biocidal composition of any preceding claim, wherein the carrier comprises a polyurethane, a polyurethane precursor, or a combination thereof.
5. The biocidal composition of claims 1 to 3, wherein the carrier comprises an epoxy resin, an epoxy resin precursor, or a combination thereof.
6. The biocidal composition of any preceding claim, wherein the carrier comprises an organic solvent.
7. The biocidal composition of any preceding claim, wherein the copper(I) salt is a copper(I) halide, iodo(tri ethyl phosphite)copper(I), or a tetrakis(acetonitrile)copper(I) salt.
8. The biocidal composition of any preceding claim, wherein the copper(I) salt is copper(I) bromide or copper(I) iodide.
9. The biocidal composition of claims 2 to 8, wherein each R1 is independently selected from C2-C13 alkyl and phenyl.
10. The biocidal composition of claims 3 to 9, wherein each R2 is independently selected from C2-C13 alkyl.
11. The biocidal composition of any preceding claim, wherein the copper-assisting additive is triethyl phosphite, tributyl phosphine, triphenyl phosphite, or any combination thereof.
12. The biocidal composition of any preceding claim, wherein a molar ratio of the copper-assisting additive to the copper(I) salt is at least 0.5: 1.
13. The biocidal composition of any preceding claim, further comprising a compound of formula (III), (IV), (V), or any combination thereof:
O 11 R3O'""YOR3 (IN)’ OR3
R4O. ZOR4
B (IV);
OR4
Figure imgf000079_0001
wherein each R3 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R3 are not simultaneously hydrogen; wherein each R4 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R4 are not simultaneously hydrogen; and wherein each R5 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R5 are not simultaneously hydrogen.
14. The biocidal composition of claim 13, wherein each R3 is independently selected from C1-C13 alkyl.
15. The biocidal composition of any preceding claim, further comprising 2- ethylhexyl phosphate.
16. The biocidal composition of claim 13, wherein each R4 is independently selected from C1-C13 alkyl.
17. The biocidal composition of any preceding claim, further comprising tributyl borate.
18. The biocidal composition of claim 13, wherein each R5 is independently selected from C1-C13 alkyl.
19. The biocidal composition of any preceding claim, further comprising tributyl citrate.
20. The biocidal composition of any preceding claim, wherein the biocidal composition exhibits a AE of less than 6, as calculated according to
Figure imgf000080_0001
wherein L*, a*, and b* are CIE values of the biocidal composition after preparing and then storing the biocidal composition at ambient temperature and ambient relative humidity for 90 days, and L” control, 3- control, and b*COntroi are CIE values of an otherwise identical composition without either the copper(I) salt or the copper-assisting additive.
21. The biocidal composition of any preceding claim, wherein the biocidal composition or the film thereof exhibits a transmittance of at least 98% as measured at each wavelength from 400 to 700 nanometers when measured at a thickness of 40 pm.
22. The biocidal composition of claim 21, wherein the transmittance is within 10 percentage points of a second transmittance of an otherwise identical composition or film thereof without either the copper(I) salt or the copper-assisting additive when measured at a thickness of 40 pm.
23. A method of preparing the biocidal composition of any preceding claim, comprising: adding a biocidal additive formulation to a carrier; wherein when the carrier is a polyurethane or an epoxy resin, the biocidal additive formulation comprises the copper(I) salt and the copper-assisting additive; wherein when the carrier is a second polyurethane precursor, the biocidal additive formulation comprises a first polyurethane precursor, the copper(I) salt, and the copper- assisting additive; and wherein when the carrier is a second epoxy resin precursor, the biocidal additive formulation comprises a first epoxy resin precursor, the copper(I) salt, and the copper-assisting additive.
24. A biocidal additive formulation, comprising: a copper(I) salt; and a copper-assisting additive; wherein a biocidal composition comprising the biocidal additive formulation and a carrier, or a film of the biocidal composition, exhibits an antimicrobial efficacy of at least 3 log kill as measured with an EPA Test after storage of the biocidal composition or the film thereof at ambient temperature and ambient relative humidity for 90 days; wherein the carrier comprises a polyurethane, a polyurethane precursor, an epoxy resin, an epoxy resin precursor, a melamine resin, or any combination thereof; wherein the biocidal composition exhibits a AE of less than 6, as calculated according to
Figure imgf000081_0001
wherein L*, a*, and b* are CIE values of the biocidal composition after preparing and then storing the biocidal composition at ambient temperature and ambient relative humidity for 90 days, and L” control, 3- control, and b*COntroi are CIE values of an otherwise identical composition without either the copper(I) salt or the copper-assisting additive.
25. The biocidal additive formulation of claim 24, further comprising an organic solvent, a first polyurethane precursor, a first epoxy resin precursor, or any combination thereof.
26. The biocidal additive formulation of claims 24 or 25, wherein the copper(I) salt is a copper(I) halide, iodo(triethyl phosphite)copper(I), or a tetrakis(acetonitrile)copper(I) salt.
27. The biocidal additive formulation of claims 24 to 26, wherein the copper(I) salt is copper(I) bromide or copper(I) iodide.
28. The biocidal additive formulation of claims 24 to 27, wherein the copper- assisting additive comprises a phosphite, a phosphine, or a combination thereof.
29. The biocidal additive formulation of claim 28, wherein the phosphite is a compound of formula (I):
Figure imgf000082_0001
wherein eachR1 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, any of which is optionally fluorosubstituted.
30. The biocidal additive formulation of claim 28, wherein the phosphine is a compound of formula (II):
Figure imgf000082_0002
wherein each R2 is independently selected from C1-C20 alkyl, aryl, and aryl(Ci- C4)alkyl, any of which is optionally substituted with a hydroxy group.
31. The biocidal additive formulation of claim 29, wherein each R1 is independently selected from C2-C13 alkyl and phenyl.
32. The biocidal additive formulation of claim 30, wherein each R2 is independently selected from C2-C13 alkyl.
33. The biocidal additive formulation of claims 24 to 32, wherein the copper- assisting additive is triethyl phosphite, tributyl phosphine, triphenyl phosphite, or any combination thereof.
34. The biocidal additive formulation of claims 24 to 33, wherein a molar ratio of the copper-assisting additive to the copper(I) salt is at least 0.5: 1.
35. The biocidal additive formulation of claims 24 to 34, further comprising a compound of formula (III), (IV), (V), or any combination thereof:
Figure imgf000083_0001
wherein each R3 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R3 are not simultaneously hydrogen; wherein each R4 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R4 are not simultaneously hydrogen; and wherein each R5 is independently selected from hydrogen, C1-C20 alkyl, aryl, and aryl(Ci-C4)alkyl, provided that all R5 are not simultaneously hydrogen.
36. The biocidal additive formulation of claim 35, wherein each R3 is independently selected from C1-C13 alkyl.
37. The biocidal additive formulation of claims 24 to 34, further comprising 2- ethylhexyl phosphate.
38. The biocidal additive formulation of claim 35, wherein each R4 is independently selected from C1-C13 alkyl.
39. The biocidal additive formulation of claims 24 to 34, further comprising tributyl borate.
40. The biocidal additive formulation of claim 35, wherein each R5 is independently selected from C1-C13 alkyl.
41. The biocidal additive formulation of claims 24 to 34, further comprising tributyl citrate.
42. The biocidal additive formulation of claims 24 to 41, wherein the biocidal composition or the film thereof exhibits a transmittance of at least 98% as measured at each wavelength from 400 to 700 nanometers when measured at a thickness of 40 pm.
43. The biocidal additive formulation of claim 42, wherein the transmittance is within 10 percentage points of a second transmittance of an otherwise identical composition or film thereof without either the copper(I) salt or the copper-assisting additive when measured at a thickness of 40 pm.
44. The biocidal additive formulation of claims 24 to 43, further comprising an antioxidant package.
45. The biocidal additive formulation of claims 24 to 43, further comprising a reducing agent.
46. The biocidal additive formulation of claims 24 to 45, wherein the formulation is in a sealed container comprising an inert atmosphere.
PCT/US2024/037025 2023-07-20 2024-07-08 Copper-based antimicrobial clear and colorless reactive coatings including copper(i) and additives Pending WO2025019173A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363527973P 2023-07-20 2023-07-20
US63/527,973 2023-07-20

Publications (1)

Publication Number Publication Date
WO2025019173A1 true WO2025019173A1 (en) 2025-01-23

Family

ID=94282525

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2024/037025 Pending WO2025019173A1 (en) 2023-07-20 2024-07-08 Copper-based antimicrobial clear and colorless reactive coatings including copper(i) and additives

Country Status (1)

Country Link
WO (1) WO2025019173A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180011807A (en) * 2015-06-08 2018-02-02 마이코 사이언시즈 리미티드 Antimicrobial and agricultural chemical composition
CN110330693A (en) * 2019-07-30 2019-10-15 安徽正合雅聚新材料科技有限公司 The antibacterial polymer and preparation method thereof of one metal ion species enhancing
EP3695724A1 (en) * 2017-10-12 2020-08-19 Ibiden Co., Ltd. Antiviral substrate, antiviral composition, method for manufacturing antiviral substrate, antimicrobial substrate, antimicrobial composition and method for manufacturing antimicrobial substrate
CN113712042A (en) * 2021-05-24 2021-11-30 常州崇高纳米材料有限公司 Multifunctional persistent antibacterial composition and preparation method thereof
CN116171302A (en) * 2020-08-14 2023-05-26 Ppg建筑涂层有限公司 antimicrobial coating

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180011807A (en) * 2015-06-08 2018-02-02 마이코 사이언시즈 리미티드 Antimicrobial and agricultural chemical composition
EP3695724A1 (en) * 2017-10-12 2020-08-19 Ibiden Co., Ltd. Antiviral substrate, antiviral composition, method for manufacturing antiviral substrate, antimicrobial substrate, antimicrobial composition and method for manufacturing antimicrobial substrate
CN110330693A (en) * 2019-07-30 2019-10-15 安徽正合雅聚新材料科技有限公司 The antibacterial polymer and preparation method thereof of one metal ion species enhancing
CN116171302A (en) * 2020-08-14 2023-05-26 Ppg建筑涂层有限公司 antimicrobial coating
CN113712042A (en) * 2021-05-24 2021-11-30 常州崇高纳米材料有限公司 Multifunctional persistent antibacterial composition and preparation method thereof

Similar Documents

Publication Publication Date Title
EP3291678B1 (en) Antimicrobial materials exhibiting synergistic efficacy
US11884841B2 (en) Antimicrobial paint composition and related methods
JP4740322B2 (en) Antibacterial resin composition containing silver-containing solution and steel sheet coated with resin composition
CA2282462C (en) Discoloration prevention in pyrithione-containing coating compositions
TWI795145B (en) Colorless material with improved antimicrobial performance
CN114727600A (en) Color stabilization of biocidal coatings
TWI282351B (en) Compositions providing physical biocide synergist activity in paints, coatings, sealants and adhesives during storage
JP2023165705A (en) Antibacterial and antiviral agents, antibacterial and antiviral coating compositions, laminates, antibacterial and antiviral resin compositions, and molded bodies
JP2017201009A (en) Composition
KR20180022893A (en) Colorless copper-containing material
WO2025019173A1 (en) Copper-based antimicrobial clear and colorless reactive coatings including copper(i) and additives
WO2023034393A1 (en) Additives for color drift reduction in copper-based antimicrobial polymeric formulations
US12063933B1 (en) Antimicrobial compositions including copper(I) salts and additives
JP2003155205A (en) Industrial mildewproofing agent composition
DE19935230A1 (en) Inhibitor of biofilm formation comprises metal oxide xerogel containing noble metal compounds and immobilized antimicrobial agents
PL160910B1 (en) Antimicrobial agent PL PL PL PL
WO2019178341A1 (en) Stabilized copper glass
CN107136075A (en) One kind is used for ancient metal historical relic duplicate protection Antimicrobial preservative aerosol and application
US20140005294A1 (en) Water based silicone coating compositions
JP2006188468A (en) Water-based mildew-proofing agent
KR102787130B1 (en) Antimicrobial composite comprising of metal organic framework and antimicrobial agents
CN119423089A (en) A kind of preservative and its preparation method and application
US20240099307A1 (en) Antimicrobial composite film and method for making the same
CN117701128A (en) Coating agent and preparation method thereof
CN113429814A (en) Environment-friendly fireproof inorganic interior wall primer and preparation method thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24843692

Country of ref document: EP

Kind code of ref document: A1